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Å    Angstrom (1 Å = 0.1 nm = 10-10 m) 
AA   Amino acid 
Boc                             tert-Butyloxycarbonyl 
BSA                            Bovine serum albumin 
CBD   Chitin-binding domain 
CBR   C-terminus binding region 
CHAPS  3-[(3-Cholamidopropyl)-dimethylammonio]-propansulfonat 
CHM   Choroideremia 
Cmc   Critical micelle concentration 
2-Cl-Trt                       2-Chlorotrityl chloride 
CTAB   Cetyltrimethylammoniumbromide 
Da    Dalton 
Dansyl                         5-Dimethylaminonaphtalin-1-sulfonyl 
DTE   1,4-Dithioerythritol 
DIPEA                         N,N-diisopropylethylamine 
DCC                            Dicyclohexylcarbodiimide 
DIC                             N,N’-diisopropylcarbodiimide 
EDTA                          Ethylenediaminetetraacetic acid 
EPL   Expressed protein ligation 
EGFP                          Enhanced green fluorescent protein 
EYFP                          Enhanced yellow fluorescent protein 
ESI-MS                       Electronspray ionization mass spectrometry 
Fmoc                          Fluorenylmethoxycarbonyl 
FTase   Farnesyltransferase 
FRET   Fluorescence resonance energy transfer 
FITC                            Fluorescein 5(6)-isothiocyanate 
GAP   GTPase activating protein 
GDF   GDI displacement factor 
GDI   GDP dissociation inhibitor 
GDP                            Guaninediphosphate  
G.HCl              Guanidinium hydrochloride 
GEF   Guaninenucleotide exchange factor 
GF   Gel filtration 
GG   Geranylgeranyl 
GGPP   Geranylgeranylpyrophosphate 
GGTase  Geranylgeranyltransferase 
GTP                            Guaninetriphosphate  
GTPase  GTP-binding protein 
HEPES                       4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
HPLC   High performance liquid chromatography 
HRMS                         High resolution ESI mas spectra 
Hsp   Heat shock protein 
IPTG   Isopropyl-β-D-thiogalactoside 
KCL                            Kinetically controlled ligation     
LC-MS              Liquid chromatography-mass spectrometry 
MPR                           Mannose-6-phosphate receptor 
Mant                           N-methylanthraniloyl 
MALDI-TOF-MS Matrix assisted laser desorption/ionization-time of flight  
   mass spectrometry 
MCS                           Multiple cloning site 
MESNA                      2-Mercaptoethanesulfonic acid 
MIC                             Maleimidocaproyl 
MPAA                         (4-Carboxymethyl)thiophenol 
MWCO  Molecular weight cut off 
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NBD   7-Nitrobenz-2-oxa-1,3-diazol-4-yl 
NBD-FPP                   NBD-farnesyl pyrophosphate 
NCL   Native chemical ligation 
NHS                            N-hydroxysuccinimide 
NTA                            Nitrilotriacetic acid 
NMR                           Nuclear magnetic resonance spectroscopy 
NSF   N-ethyl-maleimide sensitive fusion protein 
OD600   Optical density at 600 nm  
PEG                            Polyethylenglycol 
PI(4,5)P2                    Phosphatidylinositol 4,5-bisphosphate 
PI(3,4,5)P3                 Phosphatidylinositol 3,4,5-trisphosphate 
PM                              Plasma membrane  
PMSF                         Phenylmethylsulfonyl fluoride 
PKA                            Protein kinase kines A α-subunit 
Rab   Ras-like (protein) from Rat brain 
Ras   Rat adeno sarcoma 
RBP                            Rab binding platform 
REP   Rab escort protein 
RP-HPLC  Reversed-phase high performance liquid chromatography 
RRF   Rab recyling factor 
RT   Room temperature 
SDS   Sodium dodecyl sulfate 
SNAP   Soluble NSF attachment protein 
SNARE  Soluble NSF attachment protein receptor 
SPPS   Solid phase peptide synthesis 
StBu   S-tert-butyl 
TBTA                          Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amin 
TEV   Tobacco Etch Virus 
TFA   Trifluoroacetic acid 
TLC                             Thin layer chromatography 
TTD                             (4,7,10)-Trioxa-1,13-tridecanediamine 
Yip   Ypt-interacting protein 
Ypt   Yeast protein transport 
 
One- and three-letter abbreviations for amino acids were used according to the 
recommendations of the International Union of Pure and Applied Chemistry (IUPAC) and the 
International Union of Biochemistry (IUB).  
 
 
 
 
 
 
 
1. General Introduction 
 
 
 
“Most of the important things in the world have been accomplished by people who have kept 
on trying when there seemed to be no hope at all.” 
 
Dale Carnegie 
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1.1. Function of Rab GTPases 
1.1.1. Rab proteins 
  Rab proteins are small Ras-related GTP-binding proteins (GTPases) that are believed to be 
key regulators of vesicular transport. With more than 60 members identified in mammalian 
cells and 11 members in yeast (termed Ypt proteins and Sec4p) they form the largest group of 
the Ras superfamily (Pereira-Leal et al., 2001). Apparently, the increased complexity of 
vesicular transport routes inside mammalian cell types compared to lower eukaryotes resulted 
in a significant expansion of the Rab family (Bock et al., 2001). Indeed, certain Rab proteins 
could be assigned to distinct compartments and transport steps present in all eukaryotes, 
whereas other Rab isoforms were found to participate in specialized fusion processes in 
differentiated cells. The number of rab proteins in the eukaryotic cell is dwarfed by the 
number of rab interacting proteins, reflecting the complexity of Rab controlled networks (for 
review see Segev, 2001; Ohbayashi et al., 2012). For example, more than 20 proteins were 
shown to be bound to Rab5 in its GTP bound form (Christoforidis et al., 1999).    
 
Figure 1.1. The GTPase cycle. GAP: GTPase-activating protein; GEF: guanine nucleotide 
exchange factor. 
 
  As for other GTPases, central to Rab functioning is their ability to cycle between active 
GTP- and inactive GDP-bound conformations, thereby acting as molecular ‘on/off’ switches. 
The GTPase cycle (Figure 1.1) is strictly regulated by guanine nucleotide exchange factors 
(GEFs) that mediates GDP/GTP exchange and by GTPase-activating proteins (GAPs) that 
accelerate the otherwise intrinsically slow GTP hydrolysis of GTPases (Bos et al., 2007). In 
the active conformation Rab proteins recruit Rab effectors, a heterogeneous group of proteins, 
which exert various functions during vesicular transport. Rabs are converted into the inactive 
conformation by GTP hydrolysis, which leads to effector dissociation and Rab extraction 
from the membrane. The Rab protein is then recycled back to the donor compartment and 
reactivated by exchange of GDP for GTP. The combined cycles, i.e. GTP/GDP cycling and 
membrane association/cytosolic localization, are known as the Rab cycle (Figure 1.2).  
  Several studies suggest a role of rab proteins and their effectors in vesicle formation 
(Smythe, 2002). For example, the mannose-6-phosphate receptor (MPR), which sequesters 
cargo proteins into budding clathrin-coated vesicles, was shown to bind indirectly to Rab9-
GTP via its effector TIP47 (tail interacting protein of 47 kDa). It seems reasonable that the 
endosome specific Rab protein triggers the recruitment of TIP47 to MPRs in a organelle 
specific manner resulting in specific and efficient MPR recycling (Carroll et al., 2001). 
Besides assisting cargo incorporation into budding vesicles (McLauchlan et al., 1998), Rabs 
might additionally define the destination of the budding vesicle by recruiting proteins 
necessary for subsequent docking and fusion steps (Allan et al., 2000).  
 
Figure 1.2. Schematic showing the general Rab recycling. (1) Newly synthesized Rab 
proteins bind to REP. (2) REP presents Rab proteins to heterodimeric RabGGTase for 
modification of (usually) two geranylgeranyl moieties. (3) REP delivers the prenylated Rab 
proteins to their target membranes. (4) Once REP is released, it recycles into cytosol to 
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support additional rounds of Rab prenylation. (5) Prenylated Rab proteins associate with the 
membrane. (6) Subsequently GEFs facilitate exchange of GTP for GDP. (7) GTP bound Rab 
proteins can bind to effectors that are involved in vesicle budding and cargo selection. (8) 
GTP-Rab proteins directly or via effectors recruit motor proteins to drive the movement of 
vesicles along microtubules and actin filaments. (9) The vesicles are transported to the target 
compartment. GTP-Rab proteins mediate recruitment of effectors, tethering factors, SNAREs, 
facilitating tethering, docking and fusion of vesicles at the target membrane. (10, 11) 
Hydrolysis of GTP is accelerated by GAPs, resulting dissociation of related effectors. (12) 
Extraction of GDP-bound Rab proteins from membranes is medicated by GDI. This 
extraction process may involve Rab recycling factors (13) GDI makes prenylated Rab 
proteins soluble in cytosol and delivers them to the donor membrane. GDF (GDI-
displacement factor) facilitates dislodgement of prenylated Rab proteins from GDI, enabling 
them to re-associate with the donor membrane. (14, 15) GDI is released and is reused in 
additional rounds of Rab extraction. (The picture is from Dr. Yao-Wen Wu’s PhD thesis) 
 
  Following vesicle formation, at least some Rabs link transport vesicles to the cytoskeleton 
via kinesin/dynein-like motor-proteins, which confer actively directed vesicle movement 
along these structures (Hammer et al., 2002; Murray et al., 2003). Rab6 has been shown to 
interact directly with a kinesin-like effector protein, termed Rabkinesin-6, which probably 
acts as a microtubule plus-end directed motor (Figure 1.2, step 8) and has been implicated in 
cytokinesis during mitosis (Echard et al., 1998; Hill et al., 2000). Another well studied 
example involves the interaction of Rab27a with Myosin Va via melanophilin, the potential 
Rab27a effector (Fukuda et al., 2002). Myosin Va is believed to tether melanosomes to the 
actin cytoskeleton, which actively retains these organelles near the cell peripherie of 
melanocytes, where they are eventually transferred to keratinocytes for proper skin and hair 
pigmentation (Hume et al., 2001; Bahadoran et al., 2001). This model is supported by several 
mutations in Rab27a (Menasche et al., 2000) and Myosin Va (Pastural et al., 1997) that lead 
to Griscelli Syndrome, a rare inherited disorder of pigmentation arising from the arrest and 
the accumulation of melanosomes in the perinuclear region of melanocytes, that is 
accompanied by severe immunological or neurological defects (Stein et al., 2003).  
  When the transport vesicle approaches its target membrane (Figure 1.2, step 9), Rab proteins 
initiate the assembly of tethering complexes by interacting with soluble effector proteins (Cao 
et al., 1998; Ungermann et al., 1998). Tethering effectors fall into two main classes: a group 
of proteins forming extended homodimeric coil-coil structures (e.g. EEA1, Uso1p, p115) and 
oligomeric complexes (e.g. HOPS, Exocyst, TRAPP and COGcomplexes) (Deneka et al., 
2003; Whyte et al., 2002). Although the details of their functioning remains elusive, most of 
them could be assigned to a distinct transport step and were shown to bind to Rabs and 
membranes (Guo et al., 1999; Sacher et al., 1998). Apparently, tethering complexes and Rabs 
precede trans-SNARE pairing representing the first specificity determinant during vesicle 
fusion. Moreover, Rabs and the tethering complexes might either directly or indirectly trigger 
SNARE pairing and subsequent fusion, as can be inferred from their numerous interactions 
with components of the SNARE fusion machinery (e.g. with NSF (McBride et al., 1999), 
Sec1-like proteins (Seals et al., 2000), or SNAREs directly (Sato et al., 2000; Zerial et al., 
2001)).   
  Rab GTP hydrolysis is not obligatory for fusion (Stenmark et al., 1994; Rybin et al., 1996), 
rather the rate of nucleotide hydrolysis seems to define the time frame for rab effector 
recruitment and therefore influences the progression of tethering, docking and fusion steps 
(Richardson et al., 1998). Hence, the steady-state level of activated Rab-GTP regulates the 
extent of fusion reactions and is, not surprisingly, highly regulated by additional factors. For 
example some of the above mentioned tethering complexes were shown to preserve the GTP 
bound state, thereby locking Rabs in the activated state by either promoting GDP to GTP 
exchange (Horiuchi et al., 1997) or inhibiting GTPase activating protein (GAP) induced 
GTPase activity (Kishida et al., 1993). Following fusion, Rab proteins are inactivated by GTP 
hydrolysis stimulated by GAPs (Figure 1.2, step 10), which converts them back to their GDP 
bound form (Figure 1.2, step 11) (Bernards, 2003).    
  GDP-bound Rab is targeted by Rab GDPdissociation inhibitor (RabGDI), which upon 
binding inhibits Rab reactivation (Sasaki et al., 1990) and extracts them from the membrane 
into the cytosol (Araki et al., 1990) (Figure 1.2, step 12). It is likely that this step is mediated 
by additional factors, termed Rab recycling factors (RRFs) (Luan et al., 1999). One potential 
RRF candidate essential for Rab3A membrane extraction at the synapse was identified as a 
heat shock protein (Hsp) complex, consisting of Hsp90, Hsc70 and cysteine string protein 
(CSP) (Sakisaka et al., 2002). RabGDI delivers Rab proteins back to the donor membrane 
(Figure 1.2, step 13), consequently ensuring efficient Rab recycling (Soldati et al., 1994; 
Ullrich et al., 1994). The delivery process probably involves proteins termed GDI 
displacement factors (GDFs), that serve as the membrane receptor for Rabs and are believed 
to be key for the Rab compartment specific localization (DiracSvejstrup et al., 1997). 
Although the above mentioned Hsp complex might potentially also serve as a GDF (Sakisaka 
et al., 2002), the precise identity of GDFs has remained elusive, hindering a deeper 
understanding of the process. Recently, human Yip3p (PRA-1) was shown to catalytically 
displace RabGDI and to specifically recruit endosomal Rabs to reconstituted liposomes 
(Sivars et al., 2003). Yeast Yip (Ypt-interacting protein) family members (analogs exist in 
mammals, termed prenylated Rab acceptor (PRA)) were initially identified as proteins that 
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can interact with Rabs in either their GDP or GTP bound state (Martincic et al., 1997) and 
with each other (Calero et al., 2002; Matern et al., 2000), and some members were found to be 
essential for yeast viability and vesicular transport (Yang et al., 1998). Although the assigned 
GDF activity offers an interesting model for Yip mediated Rab recruitment, additional 
interactions with other components of the fusion machinery (e.g. with SNAREs (Martincic et 
al., 1997) and vesicle coat proteins (Tang et al., 2001)) suggest a broader role for Yips in 
vesicular transport, which needs to be addressed (Barrowman et al., 2003). Upon membrane 
binding, Rabs are converted to the active form by GDP to GTP exchange mediated by GEF 
(Figure 1.2, step 6) and the cycle starts again (Ullrich et al., 1994). Interestingly, Rab 
activation seems often to be spatially and temporally restricted to the site of function, which is 
supported by the finding that numerous GEFs are in fact members of large protein complexes, 
which also act as rab effectors (Jones et al., 2000; Wurmser et al., 2000).  
1.1.2. The structural basis of Rab function 
 
  Rab GTPases contain conserved sequence elements that mediate GDP/GTP binding, effector 
recognition and subcellular localization. Although distantly related to Ras and other small 
GTPases (< 30 % amino acid overall identity), they share short highly conserved motifs, 
termed PM and G motifs, which participate in phosphate/magnesium and guanine base 
binding, respectively (see Figure 1.3 B,C) (Valencia et al., 1991). The Rab structural fold is 
similar to all small GTPases of the Ras superfamily (also referred to as the GTPase-fold) 
consisting of a six stranded beta sheet surrounded by five alpha helices (Dumas et al., 1999; 
Sprang, 1997).  
  Conformational changes accompanying GTP to GDP hydrolysis and γ-phosphate release, as 
originally observed in Ras (Schlichting et al., 1990; Milburn et al., 1990), were also 
confirmed for Rab proteins (Stroupe et al., 2000; Constantinescu et al., 2002; Brennwald et 
al., 2004), although significant variations exist, which might explain differences in the rates of 
GTP hydrolysis and GDP exchange. These regions of major conformational changes, were 
termed switch I and switch II and form the β,γ-phosphate-magnesium ion binding pocket 
together with the so called P-loop (Figure 1.3). As mentioned above, key to Rab functioning 
is their participation in numerous interactions with upstream regulators and downstream 
effector molecules. The interacting proteins were proposed to recognize the correct nucleotide 
bound state by binding to switch I (also known as effector domain) and switch II regions 
based on genetic and functional studies employing mutant chimeric Rab proteins (Brennwald 
et al., 1993; Dunn et al., 1993). Further extensive sequence analysis studies revealed the 
presence of five Rab family motifs (RabF1-5) and four Rab subfamily motifs (RabSF1-4), 
which localize mainly around switch I and II and are conserved among different species 
(Figure 1-3) (Pereira-Leal et al., 2000). RabF motifs can be used for unambiguous 
identification of Rab proteins, whereas RabSF motifs determine the relatedness to one of the 
four Rab subfamilies.  
 
 
Figure 1.3. a) and b) Structures of Rab4a in GDP (PDB code: 2BMD) and GppNHp (non-
hydrolysable analogue of GTP) (PDB code: 2BME) bound form, respectively. Rab4a is 
displayed in ribbon representation, nucleotides in stick representation and Mg2+ in cyan 
sphere. Switch I is orange and switch II is light blue. The dashed ribbon in Rab4a-GDP 
represents the invisible part in the crystal structure. c) Surface representation of location of 
PM and G motifs (green), Rab family motifs (F, red) and Rab subfamily motifs (SF, blue). d) 
Organization of the identified motifs along the primary sequence. CC represents the 
prenylation motif.  
 
  Concerning the binding of interacting proteins, RabF motifs were proposed to be mainly 
recognized by general Rab regulators (such as GDI and REP), whereas specific interactions 
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with a certain subset of Rabs additionally require RabSF regions (e.g. most Rab-effector 
interactions and to some extent GEFs and GAPs). Confirmation of this model comes from 
several mutagenesis studies (Pereira-Leal et al., 2003) and the structure of Rab complexed to 
its effector. The structure of Rab7-RILP complex showed that RabSF1 and RabSF4 regions of 
Rab7 are important for interaction with RILP (Wu et al., 2005). However, in some cases 
different subsets of residues within the switch regions determine specificity. Rabex-5 VPS9 
domain, a RabGEF, selects for the Rab5 subfamily primarily through a strict requirement for 
a small nonacidic residue preceding the invariant phenylanaline in the switch I 
T(I/V)GA(A/S)F motif, while the selectivity for Rab21 also involves Gln53 in the TLQASF 
motif (Delprato et al., 2004; 2007). Sec2p, the specific GEF for Sec4p GTPase, discriminates 
its substrates via the switch regions (Dong et al., 2007). In contrast, MSS4, which is a less 
specific RabGEF and activates a range of Rabs, interacts with switch I, interswitch regions, 
and the N-terminus, but not with switch II (Itzen et al., 2006). Different elements contribute to 
the interacting specificity between Rab and its effectors. Furthermore, other nonconserved 
residues in Rab that alter the conformation of those conserved residues in direct effector 
contacts may also contribute to the binding specificity (Merithew et al., 2001). 
  Another important structural feature of Rab proteins was identified by Chavrier et al 
(Chavrier et al., 1991; Stenmark et al., 1994) and termed hypervariable region that comprises 
about 35 amino acid residues in the C-terminal region (Figure 1.3D). This region is presumed 
to serve as a targeting signal for the subcellular localization of Rab proteins and is at least in 
some cases subject to additional regulation. For example, phosphorylation within the 
hypervariable region of Rab4 during mitosis was shown to prevent membrane recruitment 
leading to accumulation of Rab4 in the cytosol (Vandersluijs et al., 1992; Ayad et al., 1997).   
At or near the C-terminus, the conserved cysteine(s) in the Rab prenylation motif (CC, CXC, 
CCX, CCXX, CCXXX and CAAX) are post-translationally modified by geranylgeranyl 
group(s) (Kinsella et al., 1991). This hydrophobic modification mediates the reversible 
attachement of Rab proteins to membranes and is essential for proper Rab functioning 
(Newman et al., 1992).   
1.1.3. Rab geranylgeranylation 
  Geranylgeranylation of Rab proteins is a posttranslational process catalyzed by 
geranylgeranyltransferase type II (GGTase-II or RabGGTase), which transfers geranylgeranyl 
moieties from geranylgeranylpyrophosphate (GGPP) to C-terminal cysteine residues linking 
them via stable thioether bonds (Figure 1.4) (Moores et al., 1991). GGTase-II belongs to the 
family of protein prenyltransferases together with Farnesyltransferase (FTase) and GGTase-I, 
which act on Ras and Rac/Rho GTPases, respectively (Casey et al., 1996). FTase and 
GGTase-I are also known as CaaX prenyltransferases. The term refers to the short C-terminal 
substrate sequences recognized by both enzymes, where ‘C’ stands for the cysteine that is to 
be modified, ‘a’ designates an aliphatic residue and the identity of ‘X’ determines whether ‘C’ 
will be farnesylated by FTase (X = Ala, Gln, Met, Ser) or geranylgeranylated by GGTase-I 
(X = Leu) (Moores et al., 1991; Caplin et al., 1994; Roskoski, et al., 1998). In contrast, Rab 
prenylation motifs are more heterogenic including terminal CXC, CC, CCX, CCXX and 
CCXXX sequences (Khosravifar et al., 1991; Kinsella et al., 1992), where both cysteines are 
modified by GGTaseII (Farnsworth et al., 1994). Rabs terminating with CXC sequences are 
additionally methyl esterified by a S-adenosylmethionine (SAM) dependant enzyme activity 
following the prenylation reaction (Smeland et al., 1994).  
 
Figure 1.4. GGTase-II catalyzed geranylgeranylation of Rab proteins. Rab-GDP, REP-1 and 
GGTase-II form a ternary complex (Wu et al., 2009). Prenyl groups are transferred in two 
consecutive reactions from GGPP to Rab. Structure of the complex GGTase-II (α and β 
subunits are colored gray and green, respectively), REP-1 (blue) and Rab7 (organe) based on 
structures of prenylated Rab7:REP complex (PDB code, 1VG0) and REP-1:RabGGTase 
(PDB code, 1LTX). The farnesyl group is show in stick representation in red, and Zn2+ as a 
turquoise ball in cyan. 
  
  GGTase-II consists of two subunits (α and β) forming a heterodimer of ca. 100 kDa that 
requires Zn2+ and Mg2+ for activity (Figure 1.4) (Seabra et al., 1992). In contrast to the other 
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prenyltransferases, GGTase-II additionally requires a protein cofactor, originally termed 
component A, which was later identified as the product of the choroideremia (CHM) gene and 
eventually renamed as rab escort protein (REP) (Andres et al., 1993). REP associates with the 
unprenylated Rab protein preferentially in its GDP bound form (Seabra, 1996) and facilitates 
its recognition by the catalytic GGTase α/β-heterodimer (Alexandrov et al., 1999). Upon 
ternary complex formation, GGTase-II transfers both isoprenoids in two independent, 
consecutive reactions, with the monoprenylated intermediate being strongly bound to the 
enzyme (Thoma et al., 2001).  
  Elucidation of the RabGGTase reaction mechanism was carried out by the combination of 
classical biochemical and spectroscopic methods that utilized isoprenoid and protein-based 
fluorescent probes (Anant et al., 1998; Dursina et al., 2006; Alexandrov et al., 2002; Durek et 
al., 2004; Wu et al., 2006). Detailed biophysical information generated by these studies 
promoted structure solution of the complexes between RabGGTase and REP-1, as well as 
between Rab7 and REP-1 (Pylypenko et al., 2003; Rak et al., 2004). Although the structure of 
the catalytic ternary complex has not been solved, it was computationally modeled and 
biochemically validated by using structural information from the binary complexes (Figure 
1.4) (Wu et al., 2009). It transpires from the model that the main specificity and affinity 
determinant is conferred by the interaction of the Switch I and II regions of the Rab GTPase 
domain with the Rab binding platform (RBP). An additional determinant of Rab:REP 
complex formation and prenylation is the interaction of a hydrophobic patch on the surface of 
REP, which is referred to as the C-terminal binding region (CBR), with the CBR binding 
motif (CIM) within the Rab C terminus (Rak et al., 2004; Wu et al., 2009). In most Rab 
sequences, the CIM consists of two large hydrophobic residues flanking a more polar residue.  
  Computational modeling of the catalytic ternary complex suggests that its assembly 
proceeds sequentially, starting from the recognition of the Rab GTPase domain by the RBP of 
REP, thus leading to a low- to intermediate-affinity complex (Nguyen et al., 2010) (Figure 
1.5). The affinity of the complex is further increased by an order of magnitude through 
association of CBR with CIM; this targets the Rab C terminus towards the REP-associated 
RabGGTase. The cysteines that contain part of the C terminus bind to the active site of 
RabGGTase through a series of weak interactions. One consequence of this arrangement is 
that the protein substrate specificity does not need to be encoded in the prenylatable C 
terminus, that is, both the enzyme and the Rab GTPases “outsource” their specificity for each 
other to the accessory protein REP. This sequential complex assembly, engaging 
progressively weaker and smaller binding interfaces, enables any cysteine residue near the C 
terminus to be prenylated by RabGGTase. This arrangement also enables multiple prenylation 
events on a single substrate of arbitrary sequence, a feature that is uncommon in protein-
modifying enzymes.  
 
 
Figure 1.5. Mechanistic model of RabGGTase-mediated protein prenylation. REP: Rab escort 
protein, CIM: C terminus interacting motif, RBP: Rab binding platform, CBR: C terminus 
binding region. (The picture is from ChemBioChem, 2010, 11, 1194) 
 
Following double prenylation, binding of another GGPP molecule triggers release of the 
prenylated Rab:REP complex (Thoma et al., 2001), and Rab is delivered to the membrane 
with assistance of REP (Figure 1-5) (Alexandrov et al., 1994). Two ubiquitiously expressed 
isoforms of REP have been identified in mammalian cells (REP-1 and REP-2) (Cremers et al., 
1994), whereas only a single protein named Mrs6p mediates Rab prenylation in yeast 
(Fujimura et al., 1994). Loss of REP-1 function has been linked to CHM, an X-linked 
inherited disease characterized by progressive retinal degeneration leading to complete 
blindness in adults (Seabra et al., 1993). The molecular mechanism underlying CHM was 
proposed to involve inefficient prenylation of certain Rabs (such as Rab27) due to 
malfunctioning of REP-1, which cannot be compensated by the REP-2 isoform. The 
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consequence of this accumulation of unfinished Rab27 proteins is a massive apoptosis of 
retinal cells, which leads to a progressive degeneration of the retina. 
  Interestingly, REP and RabGDI (see above) share approximately 30 % sequence identity and 
are structurally and functionally related (Seabra et al., 1992). Both proteins form the 
RabGDI/CHM family (Wu et al., 1996) can bind prenylated Rabs preferentially in their GDP 
bound state, inhibit GDP release from the GTPase domain and can deliver the Rab proteins to 
their proper membrane site. However, RabGDI cannot replace REP in the prenylation reaction 
due to its low affinity for unprenylated Rabs (Araki et al., 1991, Wu et al., 2007), whereas 
REP cannot functionally replace RabGDI´s ability to extract Rab proteins from membranes. 
Consequently, both proteins are not functionally interchangeable as was demonstrated by 
complementation experiments performed in yeast (Garrett et al., 1994) and by semisynthesis 
of Rab protein probes (Wu et al., 2007).   
  In summary, geranylgeranylation is believed to be crucial for the proper functioning of all 
Rab proteins. On a molecular level the role of the lipids seems to be at least two-fold: Firstly, 
the geranylgeranyl groups are integral components of Rab interactions with other regulatory 
proteins. Currently several factors are known, that require prenylation for productive binding 
to Rab proteins: RabGDI (Araki et al., 1991), several members of the Yip family (Calero et 
al., 2002; Figueroa et al., 2001), Rab3GAP (Fukui et al., 1997) and Rab3-GEF (Wada et al., 
1997). Secondly, the hydrophobic isoprenoids mediate the essential membrane attachment of 
Rab proteins, probably by inserting into the lipid bilayer. Unprenylated Rabs cannot associate 
with membranes and are intracellularly restricted to the cytosol where they cannot fulfill their 
biological role. Recent studies suggest that double prenylation is required for correct 
localization of Rab proteins to their characteristic subcellular target membrane, whereas 
single prenylated Rabs are mistargeted and appeared to be non-functional (Gomes et al., 
2003; Calero et al., 2003).  
1.1.4. Rab targeting 
  More than 60 Rab proteins have been described in humans, some of which are ubiquitous 
while others are subject to tissue specific and developmentally regulated expression (Pereira-
Leal et al., 2001; Seabra et al., 2002). Each Rab shows a characteristic subcellular 
distribution. In fact, Rabs may serve as important determinants of organelle identity and 
membrane organization (Munro, 2002; Seabra et al., 2004). Through the recruitment of 
specific effector molecules, Rabs can give rise to membrane subdomains within a 
compartment. Rab5a and Rab4, although both localized to early endosomes, are largely 
present on distinct domains (De Renzis et al., 2002; Sonnichsen et al., 2000). Similarly, Rab7 
and Rab9 occupy separate domains within late endosomal membranes (Barbero et al., 2002). 
Surprisingly, the molecular mechanisms regulating the specific association of Rabs with 
cellular membranes remain obscure. Though geranylgeranylation of Rab proteins is essential 
for their correct intracellular localization (Calero et al., 2003; Gomes et al., 2003), it is a 
common feature of all Rabs and thus cannot in itself account for their organelle-specific 
targeting. The C-terminal hypervariable region of about 35 amino acids shows the highest 
level of sequence divergence between Rab family members, and was postulated to act as a 
signal for subcellular targeting (Chavrier et al., 1991). Over a decade ago, Zerial and co-
workers showed that replacing the C-terminal 35 residues of Rab5 with the equivalent C-
terminal region of Rab7 resulted in re-localization of the hybrid Rab to Rab7-positive late 
endosomal structures. Targeting of Rab proteins via the hypervariable region is a widely 
accepted model, but the underlying molecular mechanisms have not been elucidated further. 
Despite the attractiveness of this proposal, recent studies indicated that this is not the case for 
several Rabs. Replacing the hypervariable domain of Rab5a with that of Rab1a, Rab2a, Rab7 
and Rab27a had no effect on its localization to early endosomes or its function in endosomal 
fusion activity (Ali et al., 2004). However, replacing the hypervariable domain of Rab27a 
with that of Rab1 or Rab5a failed to re-target the hybrid proteins away from melanosomes in 
melanocytes and the hybrid proteins reversed the Rab27a null phenotype (melanosomes 
clustering) in ashen cells indicating preservation of function despite exchanging the 
hypervariable domain (Ali et al., 2004).   
  The first step of the molecular mechanisms for Rab targeting should be the dissociation of 
the tight binding GDI-Rab complex. Based on this point, several mechanisms for Rab 
membrane targeting are proposed.  
  Delivery of Rab proteins to membranes by Rab GDF: The binding affinity of prenylated 
Rab proteins to RabGDI is relatively high with the dissociation constant (Kd) of 4.5 nM for 
GDP-bound Rab7 (Wu et al., 2010). This high affinity led to the proposal that the dissociation 
of Rab proteins from GDI and their subsequent association to membranes requires a 
displacement factor, named GDF (Figure 1.6) (Dirac-Svejstrup et al., 1997). Attempts to 
purify this GDF activity from membranes proved extremely difficult, but Pfeffer et al. used a 
candidate-screening approach to show that human Yip3 exhibits GDF activity towards the 
prenylated endosomal Rab protein Rab9 and to a lesser extent towards Rab5 (Sivars et al., 
2003). Prenyl Rab9–GDI complexes were used to test whether purified human Yip3 could 
dissociate Rab–GDI complexes as monitored by an increase in the rate of 35S-GTPγS binding. 
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Once released from GDI, a Rab will exchange bound GDP for GTPγS and then be incapable 
of rebinding GDI. Yip3 catalytically stimulated GTP[S] nucleotide binding to Rab9, thus 
implying the dissociation of the Rab protein from GDI, as this is a prerequisite for GTP[S] 
binding. This activity was reconstituted by using liposomes and is distinct from GEF activity 
because Yip3 failed to stimulate the intrinsic nucleotide exchange of the endosomal Rab 
proteins. Yip3 was specific to endosomal Rabs, Rab9 and Rab5, and failed to act on Rab1 or 
Rab2. Yip3 remains the only GDF identified thus far and other members of the Yip family 
(Ypt interacting proteins) have been assigned other functions. For example, despite the ability 
of Yip1 and Yif1 to interact with Rab proteins, the disruption of either of the two proteins did 
not result in Ypt1 mislocalization or dysfunction (Barrowman et al., 2003; Heidtman et al., 
2003). More examples of the involvement of Yip protein family members as GDFs are 
needed before a generalization of their function as GDFs can be confirmed. 
  
Figure 1.6. Models of modulation of Rab targeting of Rabs to membranes by the state of 
bound nucleotide. In model I, GDF-facilitated GDI dissociation is followed by membrane 
attachment and GEF-mediated nucleotide exchange. In a variant of this model that has not yet 
been discussed specifically here or elsewhere, the complex between Rab and GDF would be 
directly available for GEF action and exchange would occur before membrane attachment. In 
the other models for GEF-mediated insertion, either there is direct interaction of GEF with the 
Rab–GDI complex, leading to nucleotide exchange and Rab dissociation (model II), or 
spontaneous dissociation is rendered effectively irreversible by GEF activity and membrane 
attachment. (The picture is from Nat. Chem. Biol. 2010, 6, 534) 
  Delivery of Rab proteins to membranes by nucleotide exchange factors (GEF): It is an 
accepted notion that once a Rab protein has been deposited on to the target cellular 
membrane, it is activated by its nucleotide exchange factor (GEF). However, only a few Rab 
GEFs have been identified thus far. Some GEFs have been shown to consist of multisubunit 
protein complexes. For example, the Rabex5–rabaptin complex is GEF for Rab5 and the 
TRAPP complex for Ypt1 (Rab1 in Saccharomyces cerevisiae). An interesting observation is 
the finding that the activation of one Rab protein is a prerequisite for the targeting and 
recruitment of another. For example, activation of Ypt31/Ypt32 results in the recruitment of 
Sec2, a GEF for Sec4, which is the Rab downstream of Ypt31/Ypt32 in yeast secretory 
pathway (Ortiz et al., 2002). This provided the basis for the cascade model, where the 
activation of one Rab would trigger the recruitment and activation of the following Rab, a 
process mediated by a common protein complex being an effector for one Rab and a GEF for 
the other. Like Rab proteins, GEFs generally have exquisite localization within the cell and 
therefore it has been postulated that GEFs might be the receptors or the targeting determinants 
of their client Rab proteins (Figure 1.6).  
  Delivery of Rab proteins to membranes by GEFs is further proved by recent research of the 
DrrA protein in Goody’s group. The Legionella pneumophila protein DrrA displaces GDI 
from Rab1:GDI complexes, incorporating Rab1 into Legionella-containing vacuoles and 
activating Rab1 by exchanging GDP for GTP (Ingmundson et al., 2007; Machner et al., 
2007). DrrA efficiently catalyzes nucleotide exchange and mimics the general nucleotide 
exchange mechanism of mammalian GEFs for Ras-like GTPases. The GEF activity of DrrA is 
sufficient to displace prenylated Rab1 from the Rab1:GDI complex (Stefan et al., 2009; Wu et 
al., 2010). Thus, GEFs are necessary and sufficient for membrane targeting of GTPases and 
that the previously proposed GDFs are not thermodynamically required for this process (Wu 
et al., 2010). 
  Retrieval of Rab proteins from membranes mediated by Rab recycling factor: Once the 
Rab protein completes its designated function on the membrane, it becomes inactivated by 
hydrolyzing the bound GTP to GDP. This is usually accelerated and regulated by GAP. As 
has already been mentioned, inactive (GDP-bound) Rab proteins are removed from the 
membranes by GDI. Similar to the delivery process, it is thought that protein factors on the 
membrane are needed for the efficient and regulated extraction process. A fraction of the 
synaptic membrane-associated GDI is in complex with a chaperone complex containing 
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Hsp90, Hsc70 and cysteine string protein (Sakisaka et al., 2002). The ability of GDI to 
recycle Rab3A from membranes was enhanced by Hsp90 and inhibited by geldanamycin, an 
Hsp90 inhibitor. Similarly, neurotransmitter release was affected in a similar manner. These 
results led to the conclusion that Hsp90 chaperone complex is a Rab recycling factor. It will 
be interesting to see if Hsp90 plays a similar role for other Rabs and cell systems other than 
neuronal cells. Curiously, Hsp90 was co-immunoprecipitated with REP from brain cytosol 
and enhanced the REP-mediated Rab prenylation in vitro. However, the physiological 
significance of this interaction is still unclear (Ali et al., 2005). 
  Targeting plasma membrane with a polybasic-prenyl motif: Rab35 protein has to be 
localized to the plasma membrane (PM) in order to carry out its function. The C-terminal 
sequence (KLTKNSKRKKRCC) of Rab 35 contains a cluster of positively charged amino 
acids. To test whether this polybasic cluster binds negatively charged phosphatidylinositol 
4,5-bisphosphate [PI(4,5)P2] lipids, Meyer et al. developed a chemical phosphatase activation 
method to deplete PM PI(4,5)P2 (Heo et al., 2006). Unexpectedly, proteins with polybasic 
clusters dissociated from the PM only when both PI(4,5)P2 and phosphatidylinositol 3,4,5-
trisphosphate [PI(3,4,5)P3] were depleted, arguing that both lipid second messengers jointly 
regulate PM targeting. The polybasic-prenyl PM-targeting motif includes proteins such as K-
Ras for which a 20–amino acid tail sequence (Prior et al., 2011) is sufficient for farnesylation 
and PM targeting, as well as Rab35 for which an intact GTPase domain is required for 
geranylgeranylation and a polybasic sequence for PM targeting. They further compared the 
roles of farnesylation and geranylgeranylation by creating a Rab35 mutant with a consensus 
CAAX farnesylation sequence in place of the geranylgeranylation sequence (Heo et al., 
2006). This mutant showed PM localization indistinguishable from that of the 
geranylgeranylated Rab35. They reported that the polybasic-geranylgeranyl motifs of Rab35 
can be equally effective in PM targeting as the polybasic-farnesyl motif of K-Ras, which 
supports the notion that both types of prenylation motifs can be grouped into a single 
polybasic-prenyl PM-targeting motif.  
   Post-translational modifications of Rab proteins contributing to membrane targeting: 
In order to allow the necessary recruitment of the Rab to its specific target membrane, it is 
necessary to efficiently replace GDI from the Rab:GDP:GDI complex by GDF or GEF (such 
as DrrA). It is reported that posttranslational modifications of Rabs can also modulate the 
affinity for GDI and thus cause effective displacement of GDI from Rab:GDI complexes 
(Oesterlin et al., 2012). These activities have been found associated with the 
phosphocholination and adenylylation activities of the enzymes AnkX and DrrA/SidM, 
respectively, from the pathogenic bacterium Legionella pneumophila (Mukherjee et al., 2011; 
Müller et al., 2010). Both modifications occur after spontaneous dissociation of Rab:GDI 
complexes within their natural equilibrium. Therefore, the effective GDI displacement that is 
observed is caused by inhibition of reformation of Rab:GDI complexes. Interestingly, in 
contrast to adenylylation by DrrA, AnkX can covalently modify inactive Rabs with high 
catalytic efficiency even when GDP is bound to the GTPase and hence can inhibit binding of 
GDI to Rab:GDP complexes. They further speculate that human cells could employ similar 
mechanisms in the absence of infection to effectively displace Rabs from GDI. 
  In summary, membrane targeting mechanism of Rab GTPases remains not totally clear. 
Several factors including GDF, GEF and posttranslational protein modification are reported to 
release GDI from the tight complex Rab:GDP:GDI, which should be responsible for Rab 
targeting. Considering the fact that more than 60 Rab proteins show their specially 
characteristic subcellular distribution (Pereira-Leal et al., 2001), we still need to do much 
work to understand Rab targeting at molecular level. 
1.2. Orthogonal reactions for protein chemistry 
  The investigation of biological processes by chemical methods, commonly referred as 
chemical biology, often requires chemical access to biologically relevant macromolecules 
such as peptides and proteins. Chemoselective reactions are employed for this purpose. 
Chemoselective reactions in biological systems, also known as bioorthogonal reactions, are 
defined as functional groups that react rapidly and selectively with each other under 
physiological conditions in the presence of biological-relative groups. For example, a variety 
of bioorthogonal chemical reactions, such as the Cu(I)-catalyzed [3+2] azide-alkyne 
cycloaddition (Lin et al., 2006; Gauchet et al., 2006; Seo et al., 2011), the native chemical 
ligation (Dawson et al., 1994; Girish et al., 2005; Camarero et al., 2004),  the Staudinger 
ligation (Soellner et al., 2003; Watzke et al., 2006), the Diels-Alder cycloaddition (de Araujo 
et al., 2005; Pauloehrl et al., 2012), the oxime ligation (Christman et al., 2007; Lempens et al., 
2009; Dettin et al., 2011), the click sulfonamide reaction (Govindaraju et al., 2008) and the 
photochemical thiol-ene reaction (Jonkheijm et al., 2008; Weinrich et al., 2010) have been 
successfully applied for site-specific protein modification and immobilization. The oxime 
ligation, the native chemical ligation and the click ligation are employed in this project and 
highlighted as follow.  
1.2.1. Oxime ligation 
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  The reaction between oxyamines and aldehydes or ketones yields an oxime adduct (Figure 
1.7). Because this reaction is mild, the oxime ligation finds wide use in a variety of 
bioconjugation applications, including site-specific protein labeling in vitro (Cornish et al., 
1996), labeling of proteins on the bacterial cell surface (Zhang et al., 2003), and metabolic 
labeling of glycans on the mammalian cell surface (Mahal et al., 1997). 
 
Figure 1.7. Aniline catalysis of oxime ligations. The uncatalyzed oxime ligation begins with 
addition of an aminooxy reagent to a ketone, forming a carbinolamine. This initial step is 
slow because it requires protonation of the ketone, but not the aminooxy group. Next, the 
carbinolamine undergoes dehydration to form the oxime ligation product. The oxime ligation 
can be catalyzed by excess aniline, which reacts with the ketone to form an imine. The aniline 
imine is readily protonated, enabling it to react with aminooxy reagent. Subsequent loss of 
aniline leads to formation of the stable oxime product. 
  The ability of ketones and aldehydes to participate in chemoselective reactions offers a 
conceptually simple way to selectively tag these functional groups. But, in practice, the 
chemistry of the reaction imposes limitations. The reaction between a ketone and the nitrogen 
present in an aminooxy group is optimal under slightly acidic conditions (pH 5–6) and even 
then, proceeds at only a modest rate. The slow reaction kinetics can be partially overcome by 
using high concentrations of the aminooxy, but quantitative labeling remains elusive. The 
sluggish kinetics and pH dependence of these reactions result from the requirement for 
protonation of the carbonyl oxygen (Rosenberg et al., 1974; Sayer et al., 1974). Lowering the 
pH of the reaction mixture increases the concentration of protonated carbonyl, but 
simultaneously decreases the reactivity of the aminooxy nucleophile by protonating that 
molecule as well, so it is difficult to achieve rapid kinetics at any pH. The ingredient that has 
been lacking in these reactions is an appropriate nucleophilic catalyst. 
  Aniline has the unique ability to fill this role. Aniline catalyzes oxime ligations through a 
transimination mechanism (Figure 1.7). Like α-effect nitrogens, aniline reacts with protonated 
carbonyls to form imines, but the pKa of these aniline imines is such that they are significantly 
protonated at the pH of the reaction mixture. Thus, the protonated aniline Schiff base is 
poised to react rapidly with an aminooxy reagent, forming an oxime product that does not 
readily re-react with aniline. The ability of aniline to function as a catalyst in these types of 
reactions was first reported in 1961 (Cordes et al., 1962), but has only recently been applied 
to bioconjugation reactions (Dirksen et al., 2006; Yi et al., 2010). The addition of aniline 
results in a ten-fold increase in ligation efficiency, and transforms a mediocre labeling 
reaction into highly effective one. 
1.2.2. Click ligation 
  The reaction of alkynes with organoazides has been known as a valuable method for triazole 
synthesis for more than a century (Michael, 1893). It is a typical example of a Huisgen-type 
1,3-dipolar cycloaddition (Huisgen, 1963). However, the high reaction temperatures limited 
the biological application of this reaction. However, the groups of Meldal and of Sharpless 
reported an ideal regio-specifity and an extreme rate enhancement in the reaction of terminal 
alkynes with azides in the presence of copper(I) catalysis at room temperature (Sharpless, et 
al., 2001; Berry et al., 2010). Such a discovery dramatically changed the scope of its 
application in chemical biology.  
  This Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition reaction is commonly known as 
“click” reaction (Sharpless, et al., 2001). A stepwise pathway with copper(I) acetylide 
catalysts and a copper(I) triazolide intermediate is generally assumed (Figure 1.8) (Nolte et 
al., 2007). The rate-limiting step apparently changes from the protonation of the triazolide 
complex (H2O or alkyne as proton source) to the alkyne deprotonation–cycloaddition 
sequence (excess of acetic acid). Direct evidence of this mechanism was proven by the 
isolation of the copper(I)-triazolide complex (Nolte et al., 2007). Though the click reaction is 
accelerated by approximately 7 orders of magnitude compared to the uncatalyzed version, the 
catalytic copper(I) is not much stable in aqueous solution. As a ligand-assisted process, the 
reaction is further accelerated by Cu(I)-stabilizing ligand tris[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]amine (Chan et al., 2004). Due to these fast reaction kinetics and exquisite 
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selectivity, this click reaction has gained widespread utilization in chemical biology and 
materials science. 
 
Figure 1.8. Proposed mechanism in the alkyne–azide click reaction; [Cu] represents either 
mononuclear or dinuclear copper(I) complex fragments. (Angew. Chem. Int. Ed. 2007, 46, 
2101) 
 
 
1.2.3. Native chemical ligation 
Chemical synthesis is an attractive alternative to biological methods for protein production. 
Synthetic chemistry provides almost unlimited modulation of the structure of a polypeptide 
chain in order to understand the protein function. However, since proteins are large 
molecules, applying chemical synthesis to them is a considerable challenge. In 1994, Kent 
and coworkers introduced the approach of native chemical ligation (NCL), which is now a 
general method in chemical protein synthesis (Dawson et al., 1994) and protein modification. 
In this method, two unprotected synthetic peptide fragments are joined together in neutral 
aqueous conditions with the formation of a native peptide bond at the ligation site. The 
principle of NCL is depicted in Figure 1.9.  
    The approach is based on the chemoselective reaction between a peptide containing a C-
terminal thioester and another peptide containing an N-terminal cysteine. The initial 
chemoselective transthioesterification in NCL is essentially reversible, whereas the 
subsequent S→N acyl shift is spontaneous and irreversible. Thus, the reaction is driven to 
form an amide bond specifically at the ligation site, even in the presence of unprotected 
internal cysteine residues. NCL has been widely used in the total chemical synthesis of small 
proteins and protein domains, with a number of refinements in ligation methodology and 
strategy, such as auxiliary group-facilitated ligation (Offer et al., 2002; Meutermans et al., 
1999), catalytic thiol cofactors (Johnson and Kent, 2006; Dawson et al., 1997b), kinetically 
controlled ligation (KCL) (Bang et al., 2006), and convergent chemical protein synthesis 
(Durek et al., 2007). The utility of NCL was significantly broadened by the demonstration 
that both essential components (C-terminal thioester and N-terminal cysteine residue 
containing fragments) can be produced recombinantly.  
 
Figure 1.9. Principle of native chemical ligation. Both peptide fragments are fully 
unprotected and the reaction proceeds in aqueous and neutral conditions, given that one 
contains a C-terminal α-thioester and the other contains N-terminal cysteine (Dr. Thomas 
Durek’s PhD thesis, 2004). 
 
1.2.4. Expression protein ligation  
Expressed protein ligation (EPL) is a variation of NCL in which one or more of the peptide 
segments used to assemble a protein is produced recombinantly, permitting synthetic peptides 
to be chemo- and regioselectively coupled to recombinant proteins (Muir et al., 1998) by the 
NCL reaction. EPL combines the structural flexibility of chemical (peptide) synthesis with the 
ability of recombinant DNA methodologies to generate large polypeptides (proteins), thereby 
enabling the semi-synthesis of much larger proteins.  
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Figure 1.10. Basic concept of EPL. Recombinantly expressed proteins bearing a C-terminal 
thioester or an N-terminal cysteine can be prepared by fusion to and subsequent cleavage of 
engineered inteins. The isolated fragments are ligated in a manner similar to NCL. 
     
  As shown in Figure 1.10, α-thioester derivatives of recombinant proteins can be prepared by 
thiolysis of mutated intein fusions. In this case the target protein is fused to the N-terminus of 
a modified intein, which cannot undergo C-terminal cleavage. The intein catalyzes an NÆS 
acyl shift leading to a linear thioester linked intermediate, which can be cleaved by 
transthioesterification with thiols, liberating the α-thioester tagged protein. Commercially 
available systems additionally use affinity tags (mainly chitin-binding domain (CBD)), which 
allow facile affinity purification and inducible self-cleavage of expressed proteins. In contrast, 
preparation of recombinant proteins bearing an N-terminal cysteine is often more complicated 
and always involves specific removal of an N-terminal leader sequence from a precursor 
protein. Proteolytic cleavage of an expressed protein precursor with the cysteine residue 
adjacent to a protease cleavage site was demonstrated by in vitro processing with tobacco etch 
virus (TEV) protease (Tolbert et al., 2002) and Factor Xa protease (Erlanson et al., 1996; 
Chytil et al., 1998), as well as in vivo, utilizing endogenous methionylaminopeptidase 
(MetAp) (Iwai et al., 1999). In summary, protein splicing and its modulation provide the 
means for site-specific and genetically codeable labeling of recombinant proteins, which can 
be further exploited by EPL or other techniques. 
  Since its introduction, EPL has been applied to many different proteins (Muir, 2003). One of 
the most important advantages of EPL is that it allows the creating essential tools for the 
exploration of important functional questions. Most applications aim at modifications located 
within ~ 50 residues of the N- or C-terminus, which allows target molecule assembly from 
two fragments, one synthetic and one recombinant. Furthermore, sequential EPL strategies 
(i.e. the ligation of three or more fragments) offer the possibility to modify any residue within 
the entire primary protein sequence (Cotton et al., 1999, 2000).  
1.3. Lipoprotein synthesis 
  Lipidation of proteins is an important mechanism to regulate protein trafficking, localization 
and activity in cell and tissues. The targeting of proteins to membranes by lipidation plays key 
roles in many physiological processes and when not regulated properly can lead to cancer and 
neurological disorders. Dissecting the precise roles of protein lipidation in physiology and 
disease is a major challenge. The biochemical generation of fully functionalized and modified 
lipidated proteins is difficult, time consuming, and in the case of S-palmitoylation, leads to 
heterogeneous mixtures and is therefore in most cases not practical or applicable. 
 
Figure 1.11. Semi-synthetic synthesis of lipidated proteins. (a) Conjugation of proteins with 
lipidated and/or fluorescently tagged peptides by MIC ligation on cysteine residues. (b) 
Lipidation by sortase-mediated trans-peptidation. (c) Lipidation and/or fluorescent tagging of 
proteins by EPL. 
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  In contrast, chemical-biological approaches have been developed in the last years, giving 
access to the fully functional lipidated proteins bearing natural and non-natural modifications, 
thereby enabling the study of the complete functional proteins. This was achieved through 
two techniques that were developed more or less in parallel: 1) protein ligation and chemical 
synthesis of proteins (Muir, 2003; Kent, 2009) and 2) lipidated peptide synthesis, both in 
solution and on solid support. Notably, the development of solid-phase synthesis methods for 
generation of fatty-acylated and prenylated peptides has provided key tools to characterize 
these proteins (Brunsveld et al., 2006).   
  For example, the conjugation of fluorescent lipopeptides to proteins bearing C-terminal 
cysteines by maleimidocaproyl (MIC) ligation afforded fluorescent Ras lipoprotein variants to 
interrogate their partitioning into membranes in vitro (Weise et al., 2009; Nicolini et al., 2006; 
Bader et al., 2000) and trafficking in living cells (Rocks et al., 2005) (Figure 1.11a). The 
analysis of S-palmitoylated and non-hydrolyzable thioether analogs of lipidated Ras 
demonstrated that dynamic S-palmitoylation of proteins is an important feature for the 
distribution and trafficking of lipidated proteins in cells (Rocks et al., 2005). Photo-
crosslinkers such as the benzophenone group can also be installed via MIC ligations to 
investigate lipidated protein–protein interactions (Alexander et al., 2009; Volkert et al., 2003). 
In addition to isoprenoid and fatty acid analogs, other lipids such as cholesterol can be 
conjugated to proteins by MIC ligation (Peters et al., 2004). 
  Sortase-catalyzed transpeptidation provides an alternative method for the semisynthesis of 
C-terminal lipid-modified proteins (Antos et al., 2008) (Figure 1.11b). While these methods 
have provided access to fully unmodified lipoproteins, both approaches introduce non-native 
peptide linkages that may have an effect on protein structure or activity.  
  Expressed protein ligation (EPL) has emerged as a powerful method for the semisynthesis of 
proteins bearing various posttranslational modifications linked to the protein through native 
peptide bonds (Muir, 2003) (Figure 1.11c). Indeed, EPL has enabled the production of various 
lipidated protein constructs for biochemical and biophysical studies (Gottlieb et al., 2006; 
Alexandrov et al., 2002; Becker et al., 2008; Paulick et al., 2007). Of note, the semisynthesis 
of fluorescently modified and prenylated isoforms of Rab7, a member of the RabGTPase 
family of proteins involved in vesicular transport and membrane fusion, has revealed 
geranylgeranylation dependent protein–protein interactions (Wu et al., 2007). For example, 
synthetic unmodified or monogeranylgeranylated Rab7 binds to REP for further RabGGTase-
mediated geranylgeranylation and subsequent membrane targeting, whereas GDP dissociation 
inhibitor (GDI) preferentially binds mono-geranylgeranylated and dually geranylgeranylated 
Rab7 to modulate RabGTPase membrane activity (Wu et al., 2007). These biochemical 
studies provide important mechanistic insight into the cyclic regulation of RabGTPases, 
which are further supported by structural analysis of a monoprenylated Rab protein, Ypt1 also 
generated by EPL, in complex with GDI (Rak et al., 2003).  
 
Figure 1.12. a) Farnesyltransferase (FTase) catalyzed protein modification. The native 
activity of FTase is to attach farnesyl isoprenoid group to a Cys residue of the modified 
protein. b) Isoprenoid analogs functionalized with fluorophore, photo-crosslinker, biotin, 
azide or alkyne group for in vitro protein S-prenylation studies.  
  Chemoenzymatic methods can complement semisynthetic approaches for generating 
functionalized lipoproteins. For example, fluorescent nitrobenzoxadiazole (NBD) analogs of 
farnesyl and geranylgeranyl pyrophosphates were shown to be efficient in vitro substrates for 
FTase, and GGTase I/II, respectively (Dursina et al., 2006; Wu et al., 2006) (Figure 1.12). 
These fluorescent substrates provide a rapid non-radioactive assay for protein prenylation in 
vitro that facilitated the high-throughput screening of selective FTase and RabGGTase 
inhibitors (Guo et al., 2008). Prenyl pyrophosphate analogs bearing photoaffinity crosslinkers 
such as arylazides can also be enzymatically installed by FTase to map interactions of 
prenylated proteins with other proteins and membranes (Katadae et al., 2008) (Figure 1.12). 
In addition, a biotinylated geranyl pyrophosphate (BGPP) derivative can be utilized by 
RabGGTase for the site-specific modification of recombinant proteins with an affinity tag 
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(Nguyen et al., 2007, 2009). While BGPP is not a substrate for wild-type FTase or GTTase I, 
mutants of both enzymes have been identified that can utilize this biotinylated isoprenoid 
analog. Alternatively, lipid analogs bearing smaller chemical tags (azide or alkyne) can serve 
as substrates of protein lipidation enzymes and subsequently functionalized with fluorophores 
or affinity tags by click chemistry (Rostovtsev et al., 2002). 
  Chemical approaches have provided very important insight into the biosynthesis and 
functions of protein lipidation in biology (Rak et al., 2003; Rocks et al., 2010). The advances 
in the semisynthesis of lipidated peptides and proteins have yielded homogeneous materials 
for fundamental biochemical and cellular studies. These new chemical tools (semi-synthetic 
protein probes) should help to dissect the functions of protein lipidation in physiology and 
disease as well as to facilitate the development of effective therapeutics for cancer and 
neurological disorders.  
 
 
 
 
 
 
2. Aims of the project 
 
 
 
 
“Truth in science can be defined as the working hypothesis best suited to open the way to 
the next better one.” 
 
Konrad Zacharias Lorenz 
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2. Aims of the project 
  The recent advances in the field of protein chemistry paved the way for the application of 
methods of synthetic organic chemistry to the modification of large proteins. Such a 
symbiosis of chemistry and biology can be considered to be extremely useful in various 
fields, including the development of new methods for protein labeling and immobilization, the 
semi-synthesis of lipoproteins and the generation of synthetic protein probes for biological 
studies.  
  In order to generate homogeneous protein layers (also as protein microarray) as well as to 
maintain the native structure and bioactivity of the immobilized proteins, site-specific protein 
immobilization methods are advantageous, as opposed to random attachment. Moreover, to 
attain high linkage stability, covalent protein immobilization is preferable to non-covalent 
methods. The development of operationally simple and practical, mild and general techniques 
for immobilization of functional proteins on solid supports remains a central challenge. In 
particular, the development of methods that enable the direct immobilization of expressed 
proteins from cellular lysates is of great value since it streamlines the entire process of protein 
microarray fabrication and greatly enhances practicability and efficiency. We aim to develop 
a facile, efficient and mild strategy for the site-specific immobilization of proteins on surfaces 
by means of oxyamine ligation to generate protein microarrays. Furthermore, this strategy 
should enable the direct immobilization of expressed proteins from crude cellular lysates 
without prior purification. The produced protein biochips can be used for the study of protein-
protein interactions. The work should expand the repertoire of protein immobilization 
methods and provides an alternative means to meet the various requirements for protein 
immobilization. 
  Multi-color labeling is a valuable technique for the characterization of proteins with respect 
to their structure, folding, and interactions both as single molecules and in cellular 
investigations. The key technique for such studies is based on fluorescence resonance energy 
transfer (FRET). FRET applications require the attachment of donor and acceptor molecules 
to specific sites of a given protein or proteins. Such labeling is typically achieved through 
conjugation at cysteine residues or amino groups or by genetic fusion to different fluorescent 
proteins. However, site-specific incorporation of multiple fluorophores into a single protein 
remains a considerable challenge. Herein, we aim to develop a general, facile and efficient 
method for one-pot dual-labeling of a protein based on two chemoselective reactions. The 
produced dual-labeling protein probes should be used for studying protein-protein interactions 
and protein refolding. 
 
 
Figure 2.1. Overview of the project. The combination of organic synthesis and molecular 
biology produced modified proteins. The lower part of the figure shows some applications of 
such modified proteins, which were explored in this study.  
 
  The GTPase cycle is strictly regulated by GEFs that mediates GDP/GTP exchange. GEFs are 
often multidomain proteins or members of large protein complexes, which activate GTPases 
at specific subcellular sites. GEFs have been considered as promising therapeutic targets, due 
to their function in regulating disease-relevant GTPase signaling. Investigation of GEF 
mechanisms and identification of GEF inhibitors require appropriate assays for the GEF 
activity. The frequently used method for monitoring GEF activity is based on the intrinsic 
fluorescence of the protein or that of GDP/GTP analogues labeled with an environmentally 
sensitive fluorophore, such as N-methylanthraniloyl (mant). Though mant is a small 
fluorescent group, mant-GDP or -GTP might not behave identically to the native nucleotides. 
Thus, kinetic parameters obtained using mant-GDP/GTP are not identical to those of native 
nucleotides. An assay using radio-labeled GDP/GTP is not appropriate for monitoring fast 
kinetics of GEF-mediated nucleotide exchange. We aim to develop a sensitive and versatile 
assay based on intermolecular FRET between GEF and GTPase for monitoring GEF-
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mediated nucleotide exchange. Transient kinetic studies based on the FRET signal changes 
can be used to monitor the GEF activity and inhibition. This strategy may open up a new 
avenue for the identification of GEF inhibitors and for studying GEF mechanisms. 
  Tools for generating protein-lipid conjugates are valuable for studying the role of post-
translational lipid modification in controlling protein function and localization. However, 
recombinant production of post-translationally modified proteins is usually challenging in 
terms of homogeneity and output. The site-specific attachment of lipids to proteins remains a 
significant challenge in bioconjugation. Only a relatively limited set of chemical and 
chemoenzymatic strategies are available for this purpose. We aim to develop a general and 
fast ligation strategy for preparing lipid-protein conjugates based on tandem EPL and click 
chemistry. The lipid-protein bioconjugate should be quantitative, which can make the 
purification of ligated protein much facile. The ligation strategy may open up a new avenue 
for production of lipoproteins that are used in various biological studies. 
  In order to further understand the mechanism of Rab prenylation, we want to know whether 
there is nothing required for Rab C-terminal sequence and to what extent the Rab prenylation 
machinery could tolerate the change in the Rab C-terminal sequence. We also hope to use 
chemical-biological tools to probe whether the C-terminal hypervariable region of Rabs 
contains a general targeting signal for Rab localization. We aim to replace Rab C-terminal 
sequence and cysteines with unnatural linkers (such as a polyethylenglycol (PEG) linker) and 
thiols, respectively. The produced protein probes can be used to elucidate the mechanism of 
Rab prenylation. A further aim of this work was to provide sufficient amounts of PEGylated 
Rab protein probes for intracellular localization.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Results and Discussion 
 
 
 
 
 
 
“Things should be made as simple as possible, but not any simpler.” 
 
Albert Einstein 
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3.1. Development of a universal strategy for C-terminal protein 
modification and immobilization  
3.1.1. Introduction  
  Site-specific protein modification can facilitate the characterization of proteins with respect 
to their structure, folding, and interaction with other proteins both in biochemical and in 
cellular investigations. Although many chemical reactions are applicable in principle, 
methods for site-specific modification of proteins remain in high demand and there is a 
requirement for readily available ligation reagents (Hackenberger et al., 2008; Kurpiers et al., 
2009). Moreover, the structural sensitivity of proteins calls for chemical transformations that 
proceed under mild conditions (room temperature, neutral pH) and are compatible with all 
functional groups present in proteins. Oxime-based reactions have found wide application in 
the conjugation of biomolecules due to the absence of oxyamine groups in proteins and their 
orthogonal reactivity with ketones to give stable oximes (Sohma et al., 2009; Muralidharan et 
al., 2006; Kalia et al., 2010; Sletten et al., 2009; Lim et al., 2010; Zeng et al., 2009; Dirksen et 
al. 2006; Huang et al., 2010). The oxime reaction has been exploited in protein modification 
mainly via incorporating ketone groups into proteins by various chemical (Geoghegan et al., 
1992), enzymatic (Lee et al., 2010) and molecular biological methods (Cornish et al., 1996; 
Brustad et al., 2008). To expand the application of this efficient methodology to protein 
ligation, we planned the development of a simple and general method to incorporate 
oxyamine groups into proteins and its further reaction with ketone-containing molecules as an 
alternative method for protein modification.  
    It is well known that hydroxyamine of thioesters can lead to expose the free thiol groups 
(Figure 3.1a). On the other hand, it was shown that during NCL the nitrogen atom of 
oxyamines can react with a thioester group intramolecularly (Figure 3.1b) (Canne et al., 1996). 
Therefore, we reasoned that in theory, highly nucleophilic oxyamines could also selectively 
react intermolecularly with a C-terminal thioester of a protein. If this reaction would be 
performed with a linker carrying two oxyamine groups, one oxyamine could form a 
hydroxamic acid with the protein and the second oxyamine still would be available for a 
subsequent ligation reaction (Figure 3.1c). This project describes how a bis(oxyamine) 
molecule 1 was first incorporated at a protein C-termini to produce oxyamine-modified 
proteins, and how the subsequent efficient and specific reaction of the second oxyamine group 
with ketones was achieved to modify/immobilize proteins site-specifically under mild 
conditions. The labeling strategy has been commercialized for a wide application by Jena 
Bioscience (http://www.jenabioscience.com).  
 
Figure 3.1. a) Intermolecular aminolysis of thioester by oxyamine. b) Intramolecular 
aminolysis of thioester by oxyamine. c) A strategy for production of an oxyamine-modified 
protein. 
3.1.2. Preparation of oxyamine-modified proteins    
  The bacterial expression strategy for the generation of protein C-terminal thioesters is shown 
in Figure 3.2. This requires the truncated target protein gene to be inserted upstream of an 
intein-chitin-binding-domain (CBD) or intein-His-tag construct. Following expression and 
affinity purification of the three-part fusion protein, the protein of interest is precisely cleaved 
from the intein as a C-terminal α-thioester. Several E. coli expression vectors are now 
commercially available that allow the target DNA to be easily subcloned in frame of various 
engineered inteins (Xu et al., 2000). These vectors utilize the T7/lac promoter to provide 
stringent control of fusion protein expression and a CBD from Bacillus circulans. The 
pTWIN1 vector that was frequently used in this study is depicted in Figure 3.2a. Another 
pTWIN1-His vector whose CBD is replaced by His-tag was also used (Figure 3.2b).  
  All protein thioesters in this thesis were expressed as C-terminal intein fusions using 
pTWIN1 or pTWIN1-His expression vectors. Vectors were prepared by using standard PCR 
subcloning procedures employing in most cases ligation sites recommended by New England 
Biolabs. The various expression vectors were then transformed into BL21(DE3) cells and a 
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series of preliminary studies were undertaken to identify optimal expression conditions (IPTG 
concentration, induction time and temperature were varied). For soluble fusion protein 
expression the induction temperature had to be lowered to 18-22 °C in all cases examined so 
far. Purification of the fusion proteins from crude cell extracts employing chitin agarose beads 
or Ni-NTA (nitrilotriacetic acid) column was straightforward. However, starting with crude 
cell lysate the whole procedure should reach the thiol induced cleavage stage within 4-6 hours. 
Cleavage was in all cases performed in the presence of 500 mM 2-mercaptoethanesulfonic 
acid (MESNA) at room temperature for 12-16 h. Incubation of the intein-fusion protein with 
such high concentrations of MESNA (0.5 M) resulted in almost quantitative cleavage. Firstly, 
Rab1-thioester as a model protein was generated through intein-mediated partial protein 
splicing. The successful expression and purification of Rab1 were indicated by SDS-PAGE 
(Figure 3.2), with typical yield of 5-10 mg per liter of bacterial culture in excellent purity 
(> 90 %). 
 
Figure 3.2. a) The pTWIN1 vector utilizes two mini-inteins. Depending on the cloning 
strategy, target proteins can be fused C- and/or N-terminally to the inteins. b) The pTWIN1-
His vector employs the His-tag instead of CBD in a). MCS = multiple cloning site. c) 
Expression and purification of Rab1-thioester. Lane 1: Marker, Lane 3: cell lysate before 
induction, lane 4: cell lysate after induction with IPTG overnight (o/n), lane 5: pellet of the 
cell lysate, lane 6: flow-through from the chitin column, lanes 2 and 7: chitin beads after 
washing, lane 8: fraction of the eluted protein after an overnight incubation with 0.5 M 
MESNA at 20 °C, lane 9: chitin beads after the cleavage; d) Further purification by gel 
filtration assay, Lane 1: Marker, Lanes 2-5: fractions before gel filtration, Lanes 6-9: fractions 
after gel filtration. 
  The synthesis of bis(oxyamine)·2HCl (1·2HCl) started from the commercially available and 
inexpensive reagent N-hydroxyphthalimide and 1,2-dibromoethane (Figure 3.3) (Bauer et al., 
1963). The economic yielded 1·2HCl in a convenient manner without chromatography (yield 
> 20% over two steps; for details see experimental part) is important for the wide use of the 
method developed herein. The resulting white solid 1·2HCl was dissolved in a 2 M NaOH 
solution to prepare a 1-2 M stock solution with a pH around 7.5. This stock solution 1 is 
stable at 4 °C for at least two years. It should be noted that compound 1 (rather than its HCl 
salt) is liquid and readily explosive. However, the stock solution is safe enough for common 
protein ligation operations.  
 
Figure 3.3. a) Synthesis of bis(oxyamine) 1 and the generation of Rab-ONH2. b) and c) ESI-
MS spectra of Rab1-thioester (Mcalc. = 22380) and Rab1-ONH2 (Mcalc. = 22330), respectively. 
(Rab1-thioester is a gift from Nathalie Bleimling) 
  Once bis(oxyamine) 1 was prepared, its use for protein modification was investigated. In 
order to introduce an oxyamine group into a protein, the reaction of Rab1-thioester and 1 was 
performed on ice for 4 h. As shown in Figure 3.3, ESI-MS analysis revealed that the main 
protein peak had a mass of 22329 Da (expected mass 22330 Da), implying that most of the 
Rab1 protein was modified with the oxyamine moiety. The bis(oxyamine) could react directly 
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with the thioester group to form a stable O-alkyl hydroxamic acid bond. It should be noted 
that there is no sign of bis(oxyamine) bridged proteins as indicated by SDS-PAGE. There was 
also no detectable thioester hydrolysis during this reaction. Excess of 1 in the Rab1-ONH2 
preparation was removed by simple dialysis against sodium phosphate buffer (pH 7.5). Under 
neutral conditions oxyamine-modified protein could be stored at -80 °C for more than two 
years, generally without any detectable decomposition or loss of oxime ligation efficiency. 
This strategy should be general for preparation of oxyamine-modified proteins.  
3.1.3. Optimization of the oxyamine ligation conditions  
  The reactivity of the oxyamino group on proteins was first tested using acetone. After simple 
incubation of Rab1-ONH2 (1 mg/mL, ESI-MS 22330) and acetone (10 mM) at pH 5.5 on ice, 
the reaction was finished within 20 minutes (ESI-MS 22371), indicating that the reaction was 
rapid and generated a protein carrying a single acetone modification. In order to achieve 
fluorescent labeling of proteins, the same reaction was investigated with a ketone-containing 
fluorophore. Keto-coumarin was chosen firstly, since this fluorophore has good water-
solubility and an excellent quantum yield, and is easy to synthesize (Sethna et al., 1945). On 
incubation of keto-coumarin 2 and Rab1Δ3-ONH2 on ice for four hours, full conversion of the 
oxyamine to an oxime was achieved (Figure 3.4b). Unreacted small molecules were then 
removed by passing the reaction mixture over a PD-10 desalting column pre-equilibrated with 
30 mM sodium phosphate buffer (pH 7.5, 50 mM NaCl, 1 mM MgCl2, 10 µM GDP, and 5 
mM DTE). Excitation/emission scans of a solution of Rab1-coumarin revealed that, as 
expected from the reporter group used, the fluorescence spectrum has an excitation maximum 
at 332 nm and an emission maximum at 412 nm (Figure 3.4c).  
  In order to further examine the fluorescent labeling efficiency of the protein by SDS-PAGE, 
keto-fluorescein 3 was synthesized and incubated with Rab1Δ3-ONH2 on ice for various 
reaction times. The fluorescence gel image (Figure 3.4d) showed that the reaction was rapid 
and complete within 2 h on ice at pH 5.5. Rab1-thioester did not show any detectable labeling 
with 3, further confirming that the reaction was chemoselective. The labeling reaction 
appeared to be highly efficient, since the starting Rab1-ONH2 was not detected by ESI-MS 
(Figure 3.4e). 
  To further validate this ligation method as a general method for protein C terminal 
modification, it was also applied to an enhanced yellow fluorescent protein (EYFP). As for 
Rab1, the EYFP thioester was generated from an intein fusion protein, which was further 
modified with the oxyamine group by direct incubation of protein and 1 in buffer. The 
obtained oxyamine-modified protein EYFP-ONH2 was then incubated with 3 for different 
times on ice. The fluorescence intensity of the band corresponding to the product increased 
with time, and was essentially complete within 2 h at pH 5.5 (Yi et al., 2010). Formation of 
the product with the expected mass was detected by ESI-MS. These results indicate that the 
C-terminal modification strategy is general and efficient. 
 
Figure 3.4. a) C-terminal fluorescence labeling by oxyamine-ketone ligation with different 
keto-fluorophores. b) ESI-MS spectrum of the reaction product between Rab1-ONH2 and 2 
(Mcalc. = 22516). c) Emission spectra of Rab1-ONH2 (1 µM) and Rab1-coumarin (1 µM) 
excited by 332 nm. d) Fluorescence (left) and Coomassie staining (right) images of a gel 
loaded with Rab1-ONH2 labeled with keto-fluorescein 3 (M, marker of 97, 66, 45, 30, 20.1, 
14.4 KD; Lane 1, Rab1-ONH2; Lane 2, Rab1-thioester and 3 for 30 min incubation on ice; 
Lanes 3-5, reaction between Rab1-ONH2 and 3 for 30 min, 1 h and 2 h at pH 5.5 on ice, 
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respectively.) e) ESI-MS spectrum of the ligation product of Rab1-ONH2 and 3 (Mcalc. = 
22771). 
 
Figure 3.5. Reaction kinetics of 1 mg/mL Rab1-ONH2 and 1 mM 3 through incubation on ice 
in sodium phosphate buffer (30 mM). a) Typical ESI peaks of the reaction mixture through 
incubation on ice at pH 6.5 for 4 hours, which shows both ligated and unligated proteins. b) 
Deconvolution mass spectra for that in a). c) and d) Ligation yield versus reaction time at pH 
6.5 and 7.0, respectively. The ligation yield was calculated based on the ratio of the spectral 
integration values of the peaks of ligated and unligated proteins. The solid lines show a first-
order reaction fit giving half-live value of 7.1 h, 15.1 h and 2.8 h for that at pH 6.5, pH 7.0 
without and with 100 mM aniline, respectively. 
  ESI-MS analysis is an excellent tool to detect the protein ligation efficiency, and can be used 
to monitor the reaction kinetics in this work. Further experiments showed that the oxime 
reaction of 1 mg/mL Rab1Δ3-ONH2 and 1 mM keto-fluorescein 3 could be achieved 
quantitatively at pH 6.5 (Figure 3.5c). The reaction is about ten-time slower than that at pH 
5.5. Surprisingly, the protein ligation could be accomplished efficiently at pH 7.0 within 2 
days (Figure 3.5d). Aniline can catalyze the oxime ligation in neutral buffer (Dirksen et al., 
2006), and in our case the ligation rate can be further improved (by about fivefold) in the 
presence of 100 mM aniline at pH 7.0 (Figure 3.5d). Therefore, we can achieve quantitative 
labeling of oxyamine-modified proteins at pH 7.0 by incubation the reaction on ice overnight.  
  The oxime ligation normally cannot proceed efficient at neutral pH value. It is plausible that 
the particular functional moiety introduced at the protein C terminus might contribute to the 
fast oxime ligation kinetics in this work. Kinetic studies based on the model molecule 4 where 
the same bis(oxyamine) function was added to Fmoc-lysine compared to O-
benzylhydroxylamine 5, were performed at pH 7.0 buffer in pseudo-first-order reaction 
conditions (Figure 3.6). The oxime reaction of 3 with 4 was about tenfold faster than that for 5, 
implying that our bisoxyamine is a particularly effective nucleophile for rapid reactions with 
ketones in protein modification, and may be the responsibility of the increase in efficiency.  
 
Figure 3.6. a) Chemical structures of 4 and 5. b) HPLC traces for the reaction of 1 mM 3 and 
10 mM 4 at pH 7.0 buffer at different time (0, 5, 11, 41 minutes). c) Mass spectrum of the 
peak 1 in b) at retention time of around 6.7 min. The calculated [M+H]+ mass for 6+H of the 
oxime product of 3 and 4 is 884.35. d)  HPLC traces for the reaction of 1 mM 3 and 10 mM 5 
at pH 7.0 buffer at different time (0, 11, 41, 71, 116 minutes). e) Mass spectrum of the peak3 
in d) at retention time of around 8.3 min. The calculated [M+H]+ mass for 7+H of the oxime 
product of 3 and 5 is 565.20. f) Reaction kinetics of 5 (○) and a model molecule 6 (□) with 3. 
The reaction yield was calculated based on the ratio of the integrated peaks values of reacted 
and unreacted fluorescein in HPLC traces. The solid lines show a first-order reaction fit 
giving half-life values of 7.3 and 70.7 min. for 4 and 5, respectively. 
  To test the oxime-bond stability, the oxime-bond-containing Rab1-fluorescein protein (about 
45 μM) was dialyzed against 1 L sodium phosphate buffer (50 mM, pH 7.4) at 4 ºC and 
analyzed by LC-MS after 4 h, 1 day and 2 days. No hydrolyzed protein was detected 
according to the mass spectra. We also mixed 1 mM 5 and 1 mg/mL Rab1-fluorescein (about 
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45 μM) in sodium phosphate buffer (50 mM, pH 7.4) and incubation on ice for three days. We 
found no evidence by mass spectrometry for replacement of the bisoxyamino moiety by 5 or 
for hydrolysis under these conditions. The oxime protein can be kept at -80 ºC for at least 3 
months without hydrolysis. These results indicate that the oxime bond was stable enough at 
neutral pH to allow typical applications in biochemical experiments. Thus, the fast oxime 
ligation under mild conditions to form a stable oxime bond should provide a potentially 
general method for C-terminal modification of proteins. 
  The unique position and chemistry of protein C termini has stimulated efforts to target this 
site for selective protein modification. In one approach, a protein tag is appended to a target 
protein, and an enzymatic reaction is used to covalently introduce a C-terminal modification 
onto a protein (Antos et al., 2009; Tsukiji et al., 2009; Keppler et al., 2002; Chen et al., 2005). 
However, the protein tag is still retained in the labeled protein, which may interfere with 
protein function. An intein-based protein cleavage reaction has generated very useful 
approaches to protein C-terminal modification (Blaschke et al., 2000), mainly based on 
thioester-mediated ligation chemistry (Dawson et al., 1994; Lue et al., 2004; Watzke et al., 
2006). A limitation of this method is that it generally leads to introduction of a cysteine 
residue into the target protein, regardless of whether this corresponds to the native structure or 
not. In addition, the thioester could undergo potential hydrolysis during the ligation reaction. 
Recently, it was reported that the C-terminal carboxylate can also be transformed into a 
thioacid, followed by protein C-terminal modification via thioacid/azide amidation in the 
presence of 6 M G.-HCl and 3 mM 2,6-lutidine (Zhang et al., 2009). However, these 
conditions are too harsh to maintain the proper folding of a protein. Moreover, the thioacid 
group is prone to hydrolysis under such conditions. In contrast to these methods, we could 
introduce an oxyamine group into the C-terminus of protein in mild conditions, and this can 
subsequently undergo fast and chemoselective oxime ligation on ice for site-specific protein 
labeling. No hydrolysis of thioester bonds is found in the reaction.  
  
3.1.4. Functional characterization of the labeled proteins  
  In order to determine whether proteins still retain their activity after fluorescent labeling, we 
chose another Rab GTPase, Rab7, which binds to Rab escort protein (REP-1) with nanomolar 
affinity (Alexandrov et al., 1999). Fluorescence labeling of Rab7Δ2 was performed as for 
Rab1 with keto-coumarin. ESI-MS of the protein peaks gave masses of Rab7Δ2-ONH2 and 
Rab7-coumarin of 23273 and 23458 Da, respectively, consistent with the expected values of 
23275 and 23459 Da. Rab7Δ2-coumarin and REP-1 were incubated on ice for 1 hour, 
separated by gel filtration and analyzed by SDS-PAGE (Yi et al., 2010). It is clear that Rab7-
coumarin and REP-1 form a complex, implying that the modification of coumarin at the C-
terminus did not significantly perturb the Rab7:REP-1 interaction (Wu et al., 2007; 
Sidorovitch et al., 2002). 
  To assess whether this method can be used for studying protein-protein interactions, we 
attached an environmentally sensitive fluorophore dansyl group to the protein C-terminus by 
the oxime ligation (keto-dansyl 8). When the synthetic Rab7Δ7-dansyl protein probe was 
titrated with REP-1, a dose-dependent and saturatable increase of the fluorescence emission 
signal was observed when excited at 340 nm (Figure 3.7a).  
  Titration data could be fitted using a quadratic equation describing the binding curve and 
were consistent with 1:1 stoichiometry. The Kd value obtained (2.6 nM) is close to the one 
determined previously using mant-GDP-bound Rab7 (1 nM) (Alexandrov et al., 1998). Our 
results demonstrate that the oxyamine-ketone ligation offers an advantageous and novel 
approach for the site-selective functionalization and labeling of proteins for protein-protein 
interaction studies. 
 
Figure 3.7. a) Schematic drawing of dansyl-modified Rab probe for Rab:REP interaction. b) 
Titration of REP-1 (10.5, 26.2, 47.2, 89.2, 126, 231, 283.5, 598.5, 861 nM) to a nominal 
concentration of 140 nM Rab7Δ7-dansyl using direct fuorescence as a signal for binding 
(excitation wavelength 340 nm). c) The emission intensity at 500 nm was fitted by using a 
quadratic equation to give 2.6 nM for the Kd.  
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  In a further application of the method, we applied it to the generation of a dual-color labeled 
Rab. Dual-color protein labeling is a valuable tool for fluorescence resonance energy transfer 
(FRET) studies of dynamic biomolecular dynamics and associations (Joo et al., 2008). We 
expressed the protein mCherry-Rab7Δ3-intein, since mCherry is a FRET acceptor for 
fluorescein. After performing the labeling reaction of mCherry-Rab7Δ3-ONH2 with 3 as 
described above, fluorescent imaging of the protein bands on the gel displays green and red 
fluorescence (Yi et al., 2010). Figure 3.8 shows that FRET occurred within the mCherry-
Rab7Δ3-fluorescein molecule, since a strong fluorescent signal at 610 nm could be observed 
when mCherry-Rab7Δ3-fluorescein was excited at 490 nm (excitation wavelength for 
fluorescein). Compared with mCherry-Rab7Δ3-ONH2 at the same concentration and excited 
at the same wavelength, this represents ca. 6 fold signal increase due to FRET. In contrast, 
denatured mCherry-Ypt7Δ3-fluorescein only displayed a strong signal of fluorescein 
fluorescence at emission wavelength 510 nm, suggesting that the FRET disappeared due to 
unfolding of the protein. FRET signal could be used to test the folding state of the construct 
under the ligation conditions (i.e. at pH 5.5). Thus, storing mCherry-Rab7Δ3-fluorescein in 
the ligation buffer for one week on ice did not lead to significant change in the fluorescent 
spectra, further suggesting that the ligation conditions are mild for Rab protein modification, 
although this remains to be tested in further individual cases. 
 
Figure 3.8. a) Schematic representation of generation of a dual-color protein showing FRET 
between fluorescein and mCherry. b) Emission spectra of mCherry-Rab7Δ3-fluorescein 
showing a FRET effect, while the denatured protein just shows the emission band of 
fluorescein. 
 
3.1.5. Immobilization of oxyamine-modified proteins  
  The immobilization of proteins on surfaces plays an important role in various field of the life 
sciences, such as quick and comprehensive biomarker detection in clinical samples 
(Knickerbocker et al., 2011; Lee et al., 2008), proteome-wide interaction screens (MacBeath 
et al., 2000), and applications in drug discovery (Terstappen et al., 2007; Yu et al., 2011; 
Lynch et al., 2004), which could facilitate systematic understanding of biological phenomena 
at the molecular level (Phizicky et al., 2003; Weinrich et al., 2009). In order to generate 
homogeneous protein layers as well as to maintain the native structure and bioactivity of the 
immobilized proteins, site-specific protein immobilization methods are superior to random 
attachment (Jonkheijm et al., 2008; Lin et al., 2010; Wong et al., 2009). Moreover, in terms of 
linkage stability, covalent protein immobilization methods are particularly preferable. A 
variety of bioorthogonal chemical transformations have been successfully applied for site-
specific protein immobilization (Jonkheijm et al., 2008). Each of them have their own 
advantages and limitations. However, the development of operationally simple and practical, 
mild and general techniques for immobilization of functional proteins on solid supports 
remains a central challenge. Furthermore, the development of methods that enable the direct 
immobilization of expressed proteins from cellular lysates would be of great value (Weinrich 
et al., 2010; Sielaff et al., 2006). To address this issue, this work aims to develop a new 
strategy for the immobilization of proteins equipped with oxyamine groups at the C-terminus 
on ketone-coated surfaces to generate protein microarrays, which can be further used to study 
protein-protein interactions (Figure 3.9).  
 
Figure 3.9. Schematic illustration of the immobilization of proteins equipped with oxyamine 
groups at the C-terminus on ketone-coated surfaces and its use for the detection of protein-
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protein interactions. Su = succinimide. (This work is in close cooperation with Dr. Yong-
Xiang Chen in Prof. Waldmann’s group) 
    To establish the method, glass slides activated with N-hydroxysuccinimide (NHS) esters 
(SCHOTT NEXTERION® Slide P) were firstly coated with a linker incorporating a 5-amino-
2-pentanone ethylene ketal 9, and then blocked with ethanolamine (Figure 3. 9). After the 
deprotection of the ketone by treatment with a 1% HCl solution, the ketone-coated slides were 
ready for protein immobilization via the oxyamine ligation.  
  To this end, an enhanced green fluorescent protein tagged Rab7 protein equipped with an 
oxyamine group at the C-terminus (EGFP-Rab7Δ15-ONH2) was prepared by EPL approach 
as previously described. EGFP-Rab7Δ15-ONH2 and EGFP-Rab7Δ15-thioester (negative 
control) in neutral buffer (pH 7.0) were spotted on a ketone-functionalized slide and incubated 
in a humidity chamber at room temperature. After washing out non-reacting proteins, the 
protein immobilization efficiency can be demonstrated by quantifying the fluorescence 
intensity of protein spots on the slides. The preliminary experiments showed that 
immobilization of EGFP-Rab7Δ15-ONH2 gave intense fluorescence signals, whereas almost 
no signal was observable for EGFP-Rab7 thioester (Figure 3.10a). The ratio of average 
fluorescence intensity between these two proteins was 478:1, indicating that the oxyamine 
proteins could be selectively and efficiently immobilized on the ketone-coated slides by the 
oxyamine ligation.  
  Aniline can catalyze the oxime ligation in neutral buffer (Dirksen et al., 2006; Yi et al., 
2010). However, when a 100 mM solution of aniline was included in the protein solution, the 
immobilization efficiency improved only moderately (Figure 3.10b, ratio of average 
fluorescence intensity 1:1.8). Considering the need of an organic cosolvent to solubilize 
aniline (see experimental part for detail) and the potentially negative effect of organic solvents 
on protein samples, we decided to investigate an aniline-free oxyamine ligation for 
preparation of protein biochips.  
  In order to optimize the conditions for protein immobilization, EGFP-Rab7-ONH2 was 
incubated with ketone-coated slides for different time frames at room temperature after 
spotting. The time-dependent immobilization efficiencies were reflected by average 
fluorescence intensities (Figure 3.10c), and incubation for 6 hours appeared to be an optimal 
condition. Therefore, six hours was selected as general incubation time for immobilizing 
oxyamine-modified proteins on ketone-coated slides.  
 
Figure 3.10. Optimization of the immobilization conditions for EGFP-Rab7-ONH2 on the 
ketone-coated slides. a) Fluorescence image of the slide with EGFP-Rab7-ONH2 without and 
with 100 mM aniline and the control EGFP-Rab7-COSR at pH 7.0 for 6 hours b) Quantified 
relative fluorescence intensities after immobilization of proteins at pH 7.0 for 6 hours. c) 
Time-dependent immobilization efficiency of EGFP-Rab7-ONH2 under neutral condition 
reflected by relative fluorescence intensity. d) Relative fluorescence intensity of the 
immobilization of EGFP-Rab7-ONH2 at different pH values. 
 
The oxime ligation normally proceeds much faster at lower pH (4.5) than at pH 7.0 (Dirksen 
et al. 2006). The oxime ligation has been used previously for site-specific protein 
immobilization on oxyamine-coated surfaces under weakly acidic conditions, which employ 
proteins equipped with ketone groups (Christman et al., 2007). Hence, we probed the 
immobilization of EGFP-Rab7-ONH2 at different pH values. The quantification of 
fluorescence intensities (Figure 3.10d) indicated that the immobilization of EGFP-Rab7-
ONH2 at pH 7.0 and 6.5 proceeded with similar efficiency whereas almost no signal was 
observable for the protein at pH 6.0, probably due to the instability of EGFP-Rab7-ONH2 on 
the slides at lower pH value.  Similar results were obtained for oxyamine-modified mCherry-
Rab7 (Figure 3.11). Immobilization of mCherry-Rab7-ONH2 at pH 7.0 gave intense 
fluorescence signals, whereas almost no signal was observable for mCherry-Rab7 thioester or 
for the oxyamine-modified protein at pH lower than 6.5 (Figure 3.11), again implying that our 
oxyamine ligation strategy is general and efficient for protein immobilization. Moreover, 
since most proteins are more stable under neutral conditions than under weakly acidic 
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conditions, the use of neutral pH for protein immobilization renders the oxyamine ligation a 
more general method for protein immobilization. 
 
Figure 3.11. Immobilization of mCherry-Rab7-COSR and mCherry-Rab7-ONH2 on ketone-
coated slides at different pH values with and without aniline catalysis. The slides were 
incubated with the protein solution at room temperature for 4 hours.  
 
3.1.6. Chip-based protein-protein interactions  
The generated protein biochips should be valuable tools for the study of protein-protein 
interactions. To investigate this possibility, we used the EGFP-Rab7 protein microarray for 
the analysis of a protein-protein interaction (Figure 3.12). Hence, the slides with immobilized 
EGFP-Rab7 were treated with a 200 nM solution of a Cy3-labeled Rab escort protein 1 (Cy3-
REP-1) and with a 1 µM solution of Cy3-labeled Rab GDP dissociation inhibitor (Cy3-
RabGDI), respectively. REP-1 has high binding affinities (nM) for unprenylated Rab proteins. 
In contrast, RabGDI binds unprenylated Rab proteins with micromolar or even lower affinity 
(Wu et al., 2007). After treatment of the slide with Cy3-REP-1, clear fluorescence signals 
were detected, which indicated the recognition of EGFP-Rab7 by Cy3-REP-1. For Cy3-
RabGDI (1 μM), almost no fluorescence signal was detected, indicating no interaction 
between immobilized EGFP-Rab7 and Cy3-RabGDI at this concentration (Figure 3.12b). We 
further employed protein kinase A α-subunit (PKA) for protein immobilization and used a 
fluorescein-labeled PKA antibody for detection. As shown in Figure 3.12c, the slide with 
immobilized PKA-ONH2 shows strong fluorescence after treatment with a FITC-labeled PKA 
antibody, while in the case of PKA-COSR the fluorescence is weak. The efficiency of the 
immobilization was investigated employing different protein concentrations. PKA-ONH2 was 
immobilized at concentrations ranging from 100 μM to 5 μM. A concentration-dependent 
signal was detected in all cases (Figure 3.12d). These results demonstrate that the 
immobilization of oxyamine-functionalized proteins on ketone-coated slides maintains the 
correct tertiary structure of the proteins, and that the generated protein chips can be used for 
the study of protein-protein and antigen-antibody interactions even at low protein 
concentrations. 
 
Figure 3.12. Interaction analysis of immobilized proteins with fluorescently-labeled 
recognizing proteins. a) Schematic showing the spotting conditions and subsequent protein-
protein interaction analysis. b) Immobilization of 50 µM EGFP-Rab7 followed by detection 
with 200 nM Cy3-REP-1 and 1 µM Cy3-RabGDI. The ratio of average fluorescence intensity 
between that of REP-1 and GDI-1 is about 20:1. c) Immobilization of 50 µM PKA followed 
by detection with 500 nM FITC-labeled PKA antibody. The ratio of average fluorescence 
intensity between that of PKA-ONH2 and PKA-COSR is about 8:1. d) Different 
concentrations of PKA-ONH2 were immobilized on ketone-coated microarray and then 
detected by incubation with a 500 nM solution of FITC-labeled antibody.   
3.1.7. Labeling and immobilization of target proteins from cell lysates  
  The selective reactivity of bis(oxyamine) towards thioester bonds at high concentrations and 
the tandem bioorthogonal oxyamine ligation should enable the direct modification and 
immobilization of expressed proteins from crude cellular lysates without further purification. 
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Figure 3.13. Proteins can be site-specific tagged with bis(oxyamine) and subsequently labeled 
with fluorophores or direct immobilized on ketone-coated surfaces. a) Schematic showing the 
principle of the method. b) SDS-PAGE analysis of E. coli lysates after treatment with 
MESNA and bis(oxyamine) followed by incubation with keto-fluorescein. Lanes 1 and 4, no 
transfection of PKA gene; lanes 2 and 5, transfection of PKA gene but without induction by 
IPTG; lanes 3 and 6, transfection with PKA gene and induction by IPTG. Lane M, maker for 
97, 66, 45, 30, 20, 14.4 KDa; lane 7, Rab7-fluorescein (Yi et al., 2011) as a fluorescent 
marker. c) Direct immobilization of cellular lysates containing expressed PKA on ketone-
coated slides followed by detection with 500 nM FITC-labeled PKA antibody. Pure 
oxyamine-modified EGFP-Rab7 protein was used as positive control. d) Direct 
immobilization of cellular lysates containing expressed GFP-Rab7 on ketone-coated slides. 
 
  To investigate this possibility we explored the selective labeling and site-specific 
immobilization of PKA from cell lysates (Figure 3.13). To this end, the PKA-intein fusion 
protein was overexpressed in E. coli and the corresponding soluble cellular fractions without 
further purification were treated overnight with a 500 mM solution of MESNA at room 
temperature followed by reaction with a 300 mM solution of bis(oxyamine) on ice for 4 hours. 
After dialysis against phosphate buffer (pH 7.5) in the presence of protein inhibitor, the 
resulting solution was incubated with keto-fluorescein for 6 h. The oxyamine-modified PKA 
was selectively labeled with keto-fluorescein as indicated by the presence of a fluorescent 
band with the correct molecular weight on SDS-PAGE (Figure 3.13b), thus demonstrating the 
successful labeling of proteins directly from E. coli expression lysates.  
  The direct immobilization of oxyamine-modified proteins was investigated by employing 
PKA expression lysates directly for spotting (Figure 3.13c). The strong fluorescence signal of 
the microarray obtained after treatment with a FITC-labeled PKA antibody proves the 
successful immobilization of oxyamine-modified PKA from E. coli lysates. Similarly, direct 
immobilization of EGFP-Rab7 in cellular lysates resulted in a strong fluorescence signal 
indicating the covalent attachment of the proteins (Figure 3.13d) and thus the selective 
immobilization of oxyamine-modified GFP-Rab7 from cellular lysates, while no signal could 
be detected when the cellular lysates were not treated with bis(oxyamine) (GFP-Rab7-COSR). 
 
3.1.8. Conclusion  
  A facile, chemoselective, efficient and potentially general strategy for C-terminal protein 
modification and immobilization has been developed. Some key points are highlighted as 
follow: 
1. For the first time, a high concentration of oxyamine is used for the selective 
aminolysis of thioester bonds in proteins. 
2. Oxyamine-modified proteins can be produced by this new chemical reaction of 
bis(oxyamine) with protein thioester at pH 7.5. 
3. The oxyamine group on protein C-terminus is efficient for oxyamine ligation both in 
solution and on solid surface at pH 7.0. 
4. The selective reactivity of bis(oxyamine) towards thioester bonds at high 
concentrations and the tandem bioorthogonal oxyamine ligation enable the direct 
modification and immobilization of expressed proteins from crude cellular lysates. 
As a useful alternative to existing approaches for protein labeling, the rapid reaction of the 
oxyamine-modified proteins with ketones under mild condition is intriguing and potentially 
advantageous for many biological applications including synthesis of Rab protein probes and 
construction of protein microarray. The produced protein probes and biochips can be used for 
the study of protein-protein interactions, as indicated by Rab-REP and PKA-antibody 
interaction studies. This strategy expands the repertoire of protein labeling and 
immobilization methods and provides an alternative means to meet the various requirements 
for protein modification and immobilization. 
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3.2. Development of universal strategies for quantitative labeling 
of N-Cys-proteins and one-pot dual-color labeling of a protein  
 
3.2.1. Introduction 
  Multi-color labeling is a valuable technique for the characterization of proteins with respect 
to their structure, folding, and interactions both as single molecules and in cellular 
investigations. The key technique for such studies is based on FRET (Giepmans et al., 2006; 
Piston et al., 2007; Roy et al., 2008; Weiss, 1999). FRET applications require the attachment 
of donor and acceptor molecules to specific sites of a given protein or proteins. Such labeling 
is typically achieved through conjugation at cysteine residues or amino groups or by genetic 
fusion to different fluorescent proteins (Hong et al., 2003; Schleifenbaum et al., 2004; Lee et 
al., 2010; Szilvay et al., 2009). However, site-specific incorporation of multiple fluorophores 
into a single protein remains a considerable challenge. Dual-labeling of a single protein has 
been achieved using multi-step reactions. For example, sortases with different substrate 
specificity were used for site-specific C- and N-terminal labeling of a single protein (Antos et 
al., 2009). The Muir lab reported a method for producing a dual-labeled protein through a 
multi-step expressed protein ligation approach (Cotton et al., 2000). Recently, Yang et al. 
used a three-step strategy based on split inteins for site-specific two-color protein labeling 
(Yang et al., 2009). This work aims to develop a facile and efficient method for dual-labeling 
of proteins based on two chemoselective reactions. 
  Frequently used chemoselective reactions include NCL, Staudinger ligation, click chemistry, 
oxime ligation, strain-promoted cycloaddition, and Diels-Alder ligation (Sletten et al., 2009). 
We reasoned that by employing two chemoselective reactions for protein labeling, it should 
be possible to obtain dual-color labeled proteins in a one-pot reaction in a straightforward 
fashion (Figure 3.14a).  
  A facile and efficient method for C-terminal modification of proteins is developed in part 3.1. 
For N-terminal labeling, a protein containing an N-terminal cysteine can undergo NCL with 
thioester probes (Dawson et al., 1994; 2000). Hence, we speculated that both NCL and oxime 
ligation could be employed for one-pot dual-color labeling of a given protein (Figure 3.14b) 
(Rose, 1994; Canne et al., 1995). Coumarin as FRET donor and fluorescein as FRET acceptor 
were chosen, considering both of which can be easily prepared from commercially available 
reagents (see experimental part for details). Herein we develop a strategy for constructing a 
dual-labeled Rab7 GTPase in a one-pot reaction with quantitative conversion and illustrate the 
use of the produced Rab probe for studying protein refolding and protein-protein interactions. 
   
Figure 3.14. a) Schematic showing the orthogonality for two chemoselective reactions and 
protein function groups. b) Strategy for preparation of a dual-color coumarin-fluorescein 
protein by one-pot oxime ligation and native chemical ligation. 
 
3.2.2. N-terminal modification of N-Cys-proteins 
  The exposure of an N-terminal cysteine can be achieved via a TEV (tobacco etch virus) 
protease cleavage. Hence, a hexahistidine-tag (His6-tag) followed by the TEV protease 
cleavage sequence was fused to the N-terminus of the target protein. A cysteine mutation was 
introduced at the P1′ position of TEV cleavage site (Figure 3.15a). The resulting plasmid was 
transformed into E. coli BL21(DE3) cells for expression of TEV-Cys-proteins. After protein 
expression and purification, the TEV protease cleavage of the His6-tagged proteins was 
carried out at room temperature (see experimental part for detail). The produced N-terminal 
cysteine proteins were purified on a Ni-NTA column to remove His6-TEV protease and 
uncleaved His-tagged proteins and characterized by SDS-PAGE (Figure 3.15c) and ESI-MS 
(Figure 3.15d). Such a general strategy for preparing N-Cys-proteins has been successfully 
applied to DrrA (GEF of Rab1) and Rcc1 (GEF of Ran). 
  Our next goal aimed to achieve quantitative conversion during the NCL-based N-terminal 
protein modification. We chose coumarin thioester 10 (quantum yield of 0.27) as FRET donor 
and keto fluorescein 3 (quantum yield of 0.97) as FRET acceptor, both of which can be easily 
prepared from commercially available reagents. A dansyl-thioester 11 was also prepared 
(from Dr. Wei Liu in Wu’s group), since that the dansyl fluorophore under UV exposure is 
much brighter than that of coumarin. The NCL reaction for N-terminal modification was not 
complete after incubation on ice for three days using MESNA as a thiol cofactor (checked by 
a) b) 
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LCMS). We then used 11 for optimization of reaction conditions on SDS-PAGE. Kent et al. 
reported that the addition of 200 mM MPAA ((4-carboxymethyl)thiophenol) can significantly 
accelerate the native chemical ligation during protein total synthesis (Johnson et al., 2006). 
Herein we tested the reaction of N-Cys-Rcc1 with 11 (Figure 3.16b,c) and found that 200 mM 
MPAA can greatly increase the protein labeling efficiency. The further reaction kinetics of N-
Cys-Rcc1 and 11 in the presence of 200 mM MPAA indicated that the half-life reaction time 
is about 24 minutes (Figure 3.16d). The reaction can be complete within 2-3 h under such 
reaction conditions. Quantitative modification of N-Cys-DrrA with 10 can also be achieved 
by similar reaction condition, as indicated by both SDS-PAGE and ESI-MS (Figure 3.16e-g).  
 
Figure 3.15. a) and b) The gene sequence around T7 promotor in the pET19TEV_N-Cys 
vector. c) SDS-PAGE analysis of Rab7 proteins. Lane 1, TEV-tag-Rab7Δ3-ONH2; Lane 2, N-
Cys-Rab7Δ3-ONH2 before removing TEV protease; Lane 3, N-Cys-Rab7Δ3-ONH2. d) ESI-
MS spectra of TEV-tag-Rab7Δ3-ONH2 (Mcalc. 25291) and N-Cys-Rab7Δ3-ONH2 (Mcalc. 
23544). 
 Figure 3.16. a) Strategy for N-terminal protein modification with thioester-containing 
fluorophores 10 and 11. b) SDS-PAGE of N-Cys-Rcc1 (50 µM) with 11 (500 µM) at room 
temperature for 2 h with fluorescence scan (up) and Coomassie staining (down). Lane 1, Rcc1 
only; lanes 2-5, the reaction with no thiol catalysis, 100 mM MESNA, 100 mM MPAA, 200 
mM MPAA, respectively. c) Relatively fluorescent intensities of labeling Rcc1 proteins in 
SDS-PAGE. d) Reaction kinetics of N-Cys-Rcc1 (50 µM) with 11 (500 µM) at room 
temperature in the presence of 200 mM MPAA revealed by relatively fluorescent intensities 
of labeling Rcc1 proteins in SDS-PAGE. e) SDS-PAGE of N-Cys-DrrA (lane 1) and N-
coumarin-DrrA (lane 2) with Coomassie staining (left) and fluorescence scan (right). f) and g) 
ESI-MS spectra of N-Cys-DrrA (Mcalcd = 22028) and coumarin-DrrA (Mcalcd = 22328), 
respectively. 
 
  There are many strategies for site-specific protein modification at the N terminus because the 
N-terminal amine of a protein has unique pH-dependent reactivity. Its decreased pKa value 
relative to amine groups on lysine side chains renders selective modification possible in the 
presence of many competing lysine side chains. For example, transamination reactions 
optimized by Francis et al. have been particularly successful for selective modification of the 
N-terminal amine (Gilmore et al., 2006). Extensive characterization revealed that the 
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transamination reaction proceeded best when Ala, Gly, Asp, Glu, or Asn occupied the N-
terminal position. This reaction also occurred with many other N-terminal residues, but the 
yields were variable (Scheck et al., 2008). Very recently, a method of highly selective N-
terminal modification of proteins (modified α-amino group/modified ε-amino group > 99:1) 
by an isolated ketene at pH 6.3 was developed by Che et al. (Chan et al., 2012). Other 
chemical methods for N-terminal modification rely on a specific residue at the N terminus. 
For example, N terminal serine and threonine residues undergo periodate oxidation to form 
glyoxylamides (Geoghegan et al., 1992). The aldehyde moiety of the glyoxylamide can then 
be modified with hydrazide or aminooxy reagents. A Pictet–Spengler reaction can selectively 
modify N-terminal tryptophan and histidine residues with aldehyde probes (Li et al., 2000). N-
Terminal cysteine residues have also been exploited in the highly successful method of 
protein modification known as native chemical ligation (Tolbert et al., 2002). In this project, I 
have developed the MPAA-catalysis NCL as a universal strategy for labeling of protein N 
terminus with advantages containing: 1) quantitative modification; 2) potentially orthogonal 
reaction with the oxyamine ligation; 3) operationally facile and practical. The reaction 
conditions were mild enough for labeling of different proteins such as Rabs, DrrA and Rcc1.  
3.2.3. N/C-terminal dual-labeling of N-Cys-Rab7Δ3-ONH2 
  To generate a doubly functionalized Rab7 protein with an N-terminal cysteine and a C-
terminal oxyamine, N-Cys-Rab7Δ3-ONH2, a TEV cleavage peptide sequence was firstly 
fused to the N terminus of the Rab7Δ3 protein as described above (part 3.2.2). Rab7Δ3 fused 
N-terminally to an engineered Mxe GyrA intein domain can undergo initial NÆS acyl 
transfer and be subsequently cleaved by thiol reagents, releasing a thioester-tagged protein. 
Subsequently, the Rab7Δ3-thioester (10 mg/mL, 400 µM) was treated with 500 mM 
bis(oxyamine) at pH 7.5 to produce the oxyamine-modified protein. After dialysis to remove 
bis(oxyamine), TEV protease was then added to cleave the N-terminal protection sequence to 
expose the N-cysteine (Figure 3.17). The produced N-Cys-Rab7Δ3-ONH2 was purified on a 
Ni-NTA column to remove His6-TEV protease and uncleaved His-tagged proteins.  
  Before performing the one-pot dual-labeling of N-Cys-Rab7Δ3-ONH2, it was necessary to 
prove that both native chemical ligation and oxime ligation are orthogonal in the labeling 
conditions.  
 
Figure 3.17. A strategy for producing of N-Cys-Rab7Δ3-ONH2. 
  In order to show the specificity of the N-terminal labeling reaction, oxyamine-tagged 
proteins without the N-terminal cysteine, TEV-Rab7Δ3-ONH2 and Rab7Δ7-ONH2, were 
chosen as controls. Under the same reaction conditions, coumarin-thioester (10) did not show 
cross reaction with oxyamine tagged proteins (Figure 3.18a), suggesting the chemoselectivity 
of the NCL reaction. This was further confirmed by evaluating the reaction using ESI-MS. A 
mixture of about 0.23 mM Rab7-ONH2 and 0.5 mM coumarin-thioester in the presence of 200 
mM MPAA was incubated on ice in the phosphate buffer (pH 7.5) for 24 h. LC-ESI-MS of 
the protein before and after reaction suggested no reaction between coumarin-thioester and 
Rab7-ONH2 under these conditions (Figure 3.18b). 
 
Figure 3.18. a) SDS-PAGE of the reaction of 10 with TEV-Rab7-ONH2 (lane 1), Rab7Δ7-
ONH2 (lane 2) and N-Cys-Rab7Δ3-ONH2 (lane 3). Fluorescence scan and Coomassie staining 
were shown in the upper and lower panel, respectively. Reaction conditions: 1 mg/mL (43 µM) 
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protein, 0.7 mM 10, 200 mM MPAA, room temperature, 3 h. b) ESI-MS spectra of Rab7-
ONH2 before (black line) and after (red line) reaction with 10. c) SDS-PAGE of the reaction 
of 3 with N-Cys-Rab7Δ3-CONHOH (lane 1) and Rab7Δ7-ONH2 (lane 2). Fluorescence scan 
and Coomassie staining were shown in the upper and the lower panel, respectively. Reaction 
conditions: 1 mg/mL (43 µM) protein, 1 mM 3, 100 mM aniline, pH 7.0, on ice for 6 h. d) 
ESI-MS spectra of N-Cys-Rab7Δ3-CONHOH before (black line) and after (red line) reaction 
with 3. 
  In order to show the specificity of the C-terminal labeling reaction, a Rab protein containing 
N-terminal cysteine, N-Cys-Rab24, was used as a control. Under the same reaction conditions, 
keto-fluorescein did not show cross reaction with N-Cys-Rab24 (Figure 3.18c), suggesting the 
chemoselectivity of the oxime ligation reaction under these conditions. This was further 
confirmed by evaluating the reaction using ESI-MS. A mixture of about 43 μM N-Cys-
Rab7Δ3- CONHOH or Rab7Δ7-ONH2 and 1 mM keto-fluorescein in the presence of 100 mM 
aniline was incubated on ice in the phosphate buffer (pH 7.0) for 6 h. LC-ESI-MS of the 
protein before and after reaction suggested no reaction between keto-fluorescein and N-Cys-
Rab7Δ3-CONHOH under these conditions (Figure 3.18d). 
 
Figure 3.19. Reaction kinetics of 40 µM N-Cys-Rab7Δ3-ONH2 protein and 160 µM 10 in the 
presence of 200 mM MPAA (a) or 0.4 mM 3 in the presence of 100 mM aniline (b) through 
incubation on ice in sodium phosphate buffer (pH 7.0) and the approximations of the first-
order reactions (solid lines) with reaction half-lives of about 2.5 and 3.5 hours, respectively. c) 
and d) The ESI-MS spectra indicated that both reactions were finished after one day 
incubation. 
  Now that the cross reaction of coumarin thioester with oxyamine tagged proteins and keto-
fluorescein with N-Cys-proteins were not observed, the next step was to optimize the 
quantitative conversion of both N- and C-terminal modification for the double-functionalized 
N-Cys-Rab7Δ3-ONH2 protein. The first-order reaction of the Rab protein and 3 or 10 was 
performed on ice in the presence of catalysis, and the extent of protein labeling was monitored 
over 20 hours by SDS-PAGE. Following protein separation on a SDS-PAGE gel, the labeled 
protein was visualized and quantified by a fluorescence gel scanner (Figure 3.19). In both 
cases, the labeling was shown to reach near completion (> 95% labeling) within 20 hours of 
the reaction. The site-specific nature of both labeling reactions was confirmed by ESI-MS 
results (Figure 3.19).  
 
Figure 3.20. a) Strategy for the preparation of a two-color Rab7 protein by two 
chemoselective reactions. b) SDS-PAGE of the dual-label proteins N-coumarin-Rab7Δ3-
fluorescein (left lane) and N-coumarin-Rab7Δ3-rhodamine (right lane). Photos from left to 
right: emission in the blue fluorescence mode with cut-off filter at 530 nm showing mainly 
fluorescein fluorescence; emission in the green fluorescence mode with cut-off filter at 605 
nm showing mainly rhodamine fluorescence; excitation with UV light and emission without 
cut-off filter; Coomassie blue staining result. c) ESI-MS spectrum of coumarin-Rab7-
fluorescein (Mcalcd = 24287). 
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  Because both labeling reactions are near quantitative and show not cross reaction under the 
reaction conditions, the tandem NCL and oxime ligation reactions could be used for 
producing two-color labeled proteins (Figure 3.20). A mixture of 3 mg/mL (130 µM) protein 
and 0.7 mM coumarin 10 in the presence of 200 mM MPAA was incubated at room 
temperature for 3 h. The resulting solution was diluted into 4 volumes of sodium acetate 
buffer (50 mM, pH 5.5) and incubated with 3 (0.5 mM) in the presence of 100 mM aniline on 
ice. The quantitative dual-labeling of Rab7 protein was confirmed by LCMS and SDS-PAGE 
after overnight reaction (Figure 3.20).  
Encouraged by these results, I next tested whether the orthogonality of the transformations 
suffices from one-pot dual-labeling of a protein. I found that the oxime ligation was not 
affected by MPAA and coumarin thioester. Further experiments showed that one-pot dual-
labeling could be achieved simply by incubation of both 0.5 mM 10 or keto-rhodamine 12 and 
0.5 mM 3 with 43 mM protein N-Cys-Rab7Δ3-ONH2 on ice for one day in the presence of 
catalysts 200 mM MPAA and 100 mM aniline. Quantitative conversion of N-Cys-Rab7Δ3-
ONH2 to the dual-labeled N-coumarin-Rab7Δ3-fluorescein and N-coumarin-Rab7Δ3-
rhodamine protein was observed by ESI-MS and fluorescent SDS-PAGE (Figure 3.20). High 
yields of fluorescent labeled proteins are very important, because poor labeling efficiency 
reduces the quality of FRET measurements or requires additional purification steps. After 
removing excess small molecules on a desalting column, the obtained dual-labeled protein 
could be used for biophysical studies. 
 
Figure 3.21. a) Emission spectra of N-coumarin-Rab7-fluorescein before (black line) and 
after (red line) subtilisin treatment. Excitation was at 400 nm. b) Schematic drawing of the 
dual-color labeling Rab7. Structures of fluorophores were generated by CHEM3D. The three-
dimensional probe structure was generated by manually attached fluorophores at N-/C-
terminus of Rab7 (PDB code, 1VG1). 
As expected, the optical properties of the dual-labeled protein N-coumarin-Rab7Δ3-
fluorescein are dominated by the acceptor chromophore (Figure 3.21a), indicating that the two 
fluorescent dyes located at the N- and C-terminus of Rab7 are close enough to produce an 
efficient FRET effect, which is consistent with the crystal structure (Figure 3.21b) (Rak et al., 
2004). Digestion of Rab7 by subtilisin protease led to loss of the FRET signal. The ratio of 
fluorescein to coumarin emission intensities (517 nm/471 nm) upon excitation at 400 nm 
changes from 1.92 to 0.84 on loss of energy transfer after proteolytic digestion (Figure 3.21a). 
These results imply that the dual-labeling protein probe has potential to monitor protease 
activity. 
  The development of methods for specific protein decoration in multiple sites shows great 
relevance and impact in many fields of life science. In previous reported methods, the 
covalent and selective modification of multiple cysteines in an expressed protein has been 
achieved, taking advantage of the different solvent accessibility and reactivity of Cys residues. 
An alternative multiple-labeling strategy involves the modification of cellular ribosomal 
machinery for the introduction of unnatural amino acids with functional properties or ability 
to react selectively with specific probes (Sletten et al., 2009). Compared with these methods, 
the present labeling strategy allows for simultaneously N- and C-terminal labeling by two 
bioorthangonal chemical reactions with nearly quantitative conversion and without obvious 
cross reaction.  
3.2.4. Application of the dual-labeling Rab probe  
 
Figure 3.22. a) Binding of dual-labeled Rab7 (100 nM) with its effectors. Change of emission 
(excitation, 400 nm) of coumarin-Rab7-fluorescein in the presence of 10 times GDI-1, REP-1 
and LidA. b) Schematic drawing of the Rab:REP interaction with the Rab C-terminal 
conformation change and Rab N-terminal interaction with REP.  
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  To demonstrate the potential use of dual-labeled protein probes for protein-protein 
interaction studies, we examined the interaction of the dual-labeled Rab7 protein with the Rab 
binding proteins GDI and REP-1. As expected, addition of GDI-1 does not perturb the FRET 
signal (Figure 3.22), since GDI binds unprenylated Rab proteins only with micromolar or 
even lower affinity (Wu et al., 2007). Addition of the tightly binding REP-1 to the labeled 
Rab led to an increase in the fluorescence intensities of both the donor and acceptor, while the 
ratio of acceptor to donor intensities decreased. From a previous structural analysis (Rak et al., 
2004), it was envisaged that the C-terminus of Rab7 interacts with REP-1 and becomes 
stretched away from the globular GTPase domain upon binding to REP-1. This would be 
expected to lead to an increase in the distance between the N- and C-termini of Rab7, in 
accordance with the decrease in FRET efficiency in the dual-labeled Rab7. The increase in 
fluorescence intensity may result from the fluorescence enhancement of the relatively 
environmentally sensitive coumarin when it binds REP-1. This was confirmed by using a 
single-labeled N-coumarin-Rab7 (Yi et al., 2011). When LidA, a Rab effector from 
Legionella pneumophila (Machner et al., 2006), was added to N-coumarin-Rab7Δ3-
fluorescein, the interaction led to a change of the emission ratio (517 nm/471 nm) from 1.92 
to 1.67, suggesting a slight conformational change when Rab7 binds to LidA. Further 
biophysical and structural biology studies are needed to investigate the interaction between 
LidA and Rab GTPases. 
 
Figure 3.23. a) Absorption (dotted line) and emission (solid line) spectra of 10 (blue) and 12 
(red) in phosphate buffer (pH 7.0). The spectra overlaps of the emission spectra of the donor 
and the absorption spectra of the acceptor are colored in orange. b) Emission spectra of N-
coumarin-Rab7Δ3-rhodamine (blue line), N-coumarin-Rab7Δ3-rhodamine after the addition 
of REP-1 (red line), N-coumarin-Rab7Δ3-ONH2 (dashed cyan line), and N-Cys-Rab7Δ3-
rhodamine (dashed pink line). Excitation was at 400 nm.  
  Another dual-labeled protein, N-coumarin-Rab7Δ3-rhodamine, was prepared using the one-
pot method with keto-rhodamine 12 instead of keto-fluorescein 3. Since there is not much 
overlap between the absorption spectrum of rhodamine and the fluorescence emission 
spectrum of coumarin (Figure 3.23a), almost no intramolecular FRET was observed for this 
protein, which is therefore suitable to study Rab-REP interactions based solely on the change 
in fluorescence intensity of coumarin (Figure 3.23b). Titration of REP-1 to 80 nM N-
coumarin-Rab7-rhodamine gives a value of 3.8 nM for the Kd (excitation was at 400 nm, 
emission was collected at 464 nm) from three independent measurements. This is close to the 
result determined previously using Rab7-dansyl (see Part 3.1). These results demonstrate that 
the dual-labeled Rab protein retains its activity for interaction with its regulator/effector, 
suggesting that the labeling strategy is mild enough for protein modification. 
  In further experiments, the use of N-coumarin-Rab7Δ3-fluorescein for protein folding 
studies was tested. The protein (20 μL, 0.1 mg/mL) in buffer A (50 mM HEPES, pH 7.2, 50 
mM NaCl, 2 mM MgCl2, 5 mM DTE) was added into 980 μl buffer A containing 0-8 M 
guanidine hydrochloride (G.HCl). Then the emission spectra (420-700 nm) with excitation at 
400 nm were recorded. The intramolecular FRET signal decreased with increasing denaturant 
concentrations from 0 to 8 M (Figure 3.24a). We observed a time-dependent decrease in the 
FRET signal in the presence of 2 M G.HCl (Figure 3.24b). This suggests the average distance 
between the two dyes increased when G.HCl was used to unfold the protein. 
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Figure 3.24. Unfolding and refolding of the dual-labeled Rab protein probe. a) Fluorescence 
spectra of N-coumarin-Rab7-fluorescein before (—) and after denaturation in 8 M G.HCl for 
30 min (- -). Excitation was at 400 nm. b) Emission spectra of N-coumarin-Rab7-fluorescein 
in 2 M G.HCl. Each spectrum was recorded at 2 min intervals. T = 0 min (black), t = 10 min 
(pink line). c) Emission spectra of the denatured Ncoumarin-Rab7-fluorescein in 6 M G.HCl 
(—) and after diluting into the refolding buffer (- -). Excitation was at 400 nm. d) The 
emission ratio of 518 nm/462 nm (excitation at 400 nm) as function of time for refolding in 
the presence of GDP (●) and GppNHp (▲).  
 
  Refolding was carried out by diluting the denatured protein into refolding buffer A. In this 
study a 1:100 dilution of the denatured protein into refolding solution was performed. Firstly, 
20 μl protein (0.1 mg/mL) was precipitated by addition of 200 μl cold methanol. Before 
starting renaturation the precipitated protein material had to be solubilized by strong 
denaturants such as 6 M G.HCl. Herein 10 μl denaturing buffer (50 mM HEPES, pH 7.2, 6 M 
G.HCl) was added to dissolve the protein pellet, and the resulted solution was added into 990 
μl buffer A containing 50 µM GDP or GppNHp (a nonhydrolysis analog of GTP). It is 
reported that the presence of cofactors or substrates (e.g. GDP or GTP) during refolding has 
been shown to dramatically increase the yields of renaturation for Rab proteins (Durek et al., 
2004). The emission ratio of 518 nm/462 nm (excitation at 400 nm) as function of time was 
recorded to monitor the refolding in real time. The protein was refolded with observed with 
refolding rate constants of 0.16 and 0.24 min-1 in the presence of 50 μM GDP and GppNHp, 
respectively (Figure 3.24c,d), suggesting similar stabilizing effects of the two nucleotides. 
This is in aggrement with the similar affinities of the nucleotides to Rab7 (Simon et al., 1996). 
Although the protein is maintained in the soluble fraction, this does not necessarily prove that 
it is correctly folded. The refolded Rab was intended for complexation with interacting 
proteins such as REP, which are expected to discriminate between the correctly folded and 
misfolded protein due to the dependence of this interaction on the integrity of the GTPase fold 
(Khosravifar et al., 1992). In this study, the refolded GDP-bound Rab7 protein is able to bind 
REP-1 and displays a similar response in the emission spectra as that of the native Rab7 
protein (Yi et al., 2011), suggesting that the protein is correctly refolded and functional.  
  It is generally assumed that the folding of a polypeptide chain is a spontaneous process 
intrinsically determined by its primary structure (i.e. amino acid sequence) and depending on 
the appropriate environment. Small single-domain proteins derived from total- or semi-
synthesis or from bacterial inclusion bodies have been refolded with excellent yields in the 
past, including small GTPases of the Ras superfamily proteins (Durek et al., 2004; Wu et al., 
2011). Based on a FRET-based protein probe in this study, we found that supplementing the 
refolding buffer with different nucleotides (GDP or GppNHp) could easily give access to 
differently nucleotide-loaded Rab proteins, which would meet the needs of various other 
applications. For example, we can prepare GppNHp-bound GTPases through this refolding 
strategy, which is indicated in the semisynthesis of GppNHp-bound RhoA GTPase.  
 3.2.5. Synthesis of RhoA-GG by refolding methods 
  Now that the protein refolding results of the FRET-based Rab probe point out a way to 
produce GppNHp-bound GTPase, we aim to semisynthesize the lipidated RhoA in both GDP- 
and GppNHp-bound forms through a refolding strategy. In mammals, Rho family consists of 
20 proteins, belonging to the superfamily of small GTPases. RhoA as one of the best 
characterized Rho GTPases was described as master regulators of the actin cytoskeleton 
(Pedersen et al., 2012). Unlike Rab GTPases, RhoA contains a polybasic sequence together 
with one GerGer group at the C-terminus. The synthesis of lipidated RhoA (RhoA-GG) was 
achieved by EPL of RhoA-thioester and a geranylgeranylated peptide 13 (Figure 3.25).  
 
Figure 3.25. a) The ligation conditions of RhoA-thioester and 13. b) SDS-PAGE of RhoA 
before (lane 1) and after (lane 2) the ligation reaction. c) ESI-MS spectra of RhoA before 
(Mcalcd = 20203) and after (Mcalcd = 21526) the ligation reaction. d) A micellar structure of 13 
is proposed in buffer during the ligation. e) Gel filtration traces of refolded GppNHp-bound 
RhoA-GG (black line) and its complex with RhoGDI (blue line) and analysis of their resulting 
fractions by SDS-PAGE of refolded GppNHp-bound RhoA-GG (f) and its complex with 
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RhoGDI (g). Compound 13 was synthesized by Dr. Debapratim Das from the Department of 
Chemical Biology, MPI Dortmund.  
    Since the GerGer-containing peptide 13 is water-soluble, the ligation between RhoA-
thioester and 13 can be performed in buffer without addition of detergents. This is different 
from what it was observed with Rab proteins, since their geranylgeranylated peptides were 
found to be essentially insoluble in pure aqueous solutions and high concentrations of the 
detergents were necessary for solubilizing the lipidated peptides for EPL (Durek et al., 2004). 
As shown in Figure 3.25, EPL for RhoA is carried out in aqueous buffers (pH 7.4) at room 
temperature with 13 in large molar excess (10 times) in the reaction mixture in order to 
improve the ligation yields. MESNA (100 mM) as catalytic thiol cofactors was added that can 
retain the cysteine side chains in the reduced state, reverse the formation of unproductive 
thioesters and activate less reactive thioesters by transthioesterification. The quantitative 
conversion was indicated by SDS-PAGE and ESI-MS after incubation of the reaction for 2 
days. After the reaction, the geranylgeranylated RhoA (RhoA-GG) precipitated from the 
ligation buffer.   
  The lipidated peptide 13 might form micellar structures in solution, e.g., the hydrophobic 
region (GerGer moiety) forms the micelle interior while the polybasic region interacts with 
thioester groups in the Stern-layer (Figure 3.25d). The relatively high charge density on the 
micelle surface could additionally contribute to the polarization of the carbonyl thioester, 
thereby enhancing its reactivity with protein-thioesters. The micellar structure may render 13 
soluble in solution. After the ligation, lipidated proteins on the micellar structure contact each 
other, resulting in protein aggregration and precipitation.   
  The RhoA-GG pellets were resolubilized in 6 M G.HCl buffer containing the reductant DTE 
and the detergent CHAPS. Renaturation of the denatured protein was achieved by pulse-
refolding approach in which the denatured protein was titrated into refolding buffer of typical 
30-fold dilution in pulses (Durek et al., 2004). It is reported that prenylated Rab proteins 
could be stabilized in solution using delipidated BSA (Dirac-Svejstrup et al., 1994), but 
required higher molar excess of the later. Herein, 10 time delipidated BSA was added into the 
refolding buffer in order to stabilize the GerGer group in RhoA. The resulting RhoA-GG 
protein remained in solution after refolding in the presence of GDP or GppNHp, which is an 
atypical behavior because the geranylgeranylated protein tends to form aggregates in buffer 
(Wu et al., 2007). The ligated protein eluted from a size exclusion column at a position 
corresponding to a molecular mass < 10 kDa, suggesting that the protein does not form 
multimers and that its migration is retarded on the column probably by hydrophobic 
interaction with the matrix. The solubility of RhoA-GG is surprising. From the SDS-PAGE 
(Figure 3.25f), RhoA-GG co-elute with small amount of BSA, which should help to stabilize 
RhoA-GG in solution. Furthermore, the ploybasic sequence at the C-terminus should also 
contribute to the water-solubility of RhoA-GG, since Rab-GG in the presence of small 
amount of BSA tends to form aggregates in buffer (Dr. Yaowen Wu, PhD thesis, 2008). 
Semisynthetic GppNHp-bound RhoA-GG was correctly folded as judged by its ability to form 
a stoichiometric complex with GDI (Figure 3.25e,g). These results imply that the refolding 
strategy for preparation of GppNHp-bound lipidated Rho GTPases is feasible, considering 
that the biochemical generation of such GppNHp-bound lipidated proteins in multi-milligram 
scale is difficult or in most cases not practical or applicable. 
 3.2.6. Conclusion 
  In summary, a universal and quantitative method for N-terminal labeling of N-Cys-proteins 
was achieved. A general, facile and efficient strategy for N- and C-terminal dual-color 
labeling of a protein was achieved by using both native chemical ligation and oxime ligation 
in an one-pot manner. The produced protein probes based on these labeling methods were 
used to study protein refolding and protein-protein interactions by FRET. It is found that both 
GDP and GppNHp can help GTPase to refold, and therefore point out a way to produce 
GppNHp-bound GTPase as indicated in the case of semisynthesis of RhoA-GG.  
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3.3. Development of a FRET-based strategy for monitoring GEF-
mediated activation of GTPases 
 
3.3.1. Introduction  
  GEFs are essential partners of GTPases involved in intracellular signal transduction and 
regulatory mechanisms (Bos et al., 2007). GEFs are often multidomain proteins or members 
of large protein complexes, which activate GTPases at specific subcellular sites (Garcia-Mata 
et al., 2007; Yoshimura et al., 2010; Quilliam et al., 2002). Thermodynamic and kinetic 
analyses of interaction of GEFs have suggested a common mechanism involving allosteric 
competition between nucleotide and GEF interacting with a GTPase (Klebe et al., 1995; 
Lenzen et al., 1998; Hutchinson et al., 2000; Gromadski et al., 2002). GEFs catalyze 
dissociation of the tightly bound nucleotide from the GTPase by reducing the affinity of the 
nucleotide, and vice versa, binding of the nucleotide decreases the affinity of GEF. As a result, 
the nucleotide is displaced and subsequently replaced by GTP due to much higher cellular 
concentration of GTP than GDP. The binding of the nucleotide consequently releases the GEF 
(Goody, 2002; Guo et al., 2005). The interactions of GEFs with GTPases have been resolved 
at the atomic level. Binding of a GEF to a GTPase induces conformational changes in switch I 
and II and the P loop, resulting in disruption of the nucleotide binding site (Vetter et al., 2001).  
  GEFs have been considered as promising therapeutic targets, due to their function in 
regulating disease-relevant GTPase signaling (Morishige et al., 2008; Gonzalez-Garcia et al., 
2005; Malliri et al., 2002; Vega et al., 2008). For example, GEP100, a GEF for Arf6, connects 
EGFR signaling to Arf6 activation and is responsible for invasive activity of breast cancer 
cells, suggesting that Arf6 and its regulator could be therapeutic targets for the prevention of 
breast cancer metastasis (Morishige et al., 2008). Tiam1 (a RacGEF) knock-out mice develop, 
grow and reproduce normally, but are resistant to the development of Ras-induced skin 
tumors (Malliri et al., 2002). This suggests that inhibition of Tiam1 may be a safe and 
efficient approach for anti-tumor therapy. GEF inhibitors have been used in chemical genetic 
studies to reveal the function of specific GEFs, such as ArfGEFs and RhoGEFs (Hafner et al., 
2006; Gao et al., 2004; Bouquier et al., 2009; Blangy et al., 2006).  
  Investigation of GEF mechanisms and identification of GEF inhibitors require appropriate 
assays for the GEF activity. The frequently used methods for monitoring GEF activity are 
based on the intrinsic fluorescence of the protein or that of GDP/GTP analogues labeled with 
an environmentally sensitive fluorophore, such as N-methylanthraniloyl (mant) (Klebe et al., 
1995). Though mant is a small fluorescent group, mant-GDP and -GTP might not behave 
identically to the native nucleotides. Thus, kinetic parameters obtained using mant-GDP/GTP 
are not identical to those of native nucleotides (Schoebel et al., 2009; Itzen et al., 2007). An 
assay using radio-labeled GDP/GTP is not appropriate for monitoring fast kinetics of GEF-
mediated nucleotide exchange. The specific binding of an effector domain with a GTP-bound 
protein has been used as a sensor for the activation of GTPases in vitro and in vivo (Kraynov 
et al., 2000; Mochizuki et al., 2001; Galperin et al., 2003). Such interactions can be detected 
by FRET and pull-down assays (Bill et al., 2011; Knaus et al., 2007; Niebel et al., 2011). 
Although the activation-dependent interaction assay reports the extent of GTPase activation, it 
could not be used to visualize the interaction of GEFs in real time. Furthermore, these probes 
require a tedious search for an appropriate effector domain (Nakamura, 2005). These 
prompted us to develop a sensitive and versatile assay based on intermolecular FRET between 
GEF and GTPase (Figure 3.26). FRET-based detection produces large Stokes shift together 
with a dual-wavelength readout that provides an internal normalization (Förster, 1946). The 
development of FRET probes has significantly facilitated the analysis of enzyme activity, the 
elucidation of structures and conformational changes of biomolecules, and the detection of 
biomolecular interactions involved in various biological events (Sapsford et al., 2006). In this 
work, FRET is employed to analyze protein-protein and protein-ligand interactions.  
 
Figure 3.26. A FRET strategy for monitoring GEF mechanism. G = GTPase, GXP = 
GDP/GTP. 
3.3.2. Construction of FRET-based GEF sensors  
  The construction of a FRET system based on the interaction between GEF and GTPase 
requires the specific attachment of donor and acceptor fluorophores to the proteins (Figure 
3.26). Methods for facile, specific and efficient modification at the C- and N-termini of 
proteins were established by using chemoselective reactions under mild conditions (see part 
3.1 and 3.2). In this work we further employ these methods to label both GTPases and their 
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GEFs with FRET dyes coumarin and fluorescein. As a proof of principle, we chose Rab1 
GTPase and its GEF from Legionella pneumophilathe, DrrA, of which the GEF domain (340-
533) was used (we refer to it as DrrA hereinafter) (Schoebel et al., 2009), and Ran GTPase 
and its GEF, RCC1 (Klebe et al., 1995). To generate GEF with an N-terminal cysteine, we 
fused a peptide sequence containing a TEV cleavage site (ENLYFQ¦C; dotted line indicates 
the cleavage site) to the N-terminus of the GEF protein. TEV protease was then added to 
expose the N-terminal cysteine, resulting in N-Cys-DrrA and N-Cys-Rcc1 that can 
subsequently undergo NCL with coumarin-thioester (Figure 3.27). GTPases were fused C-
terminally to an intein domain and were subsequently cleaved by MESNA to release the α-
thioester-tagged proteins. The resulting proteins were treated with a high concentration of 
bis(oxyamine) at pH 7.5 to produce the oxyamine-modified proteins that were subject to 
oxime ligation with keto-fluorescein (Figure 3.27). All labeled proteins were characterized by 
mass spectra and SDS-PAGE.  
  It is noted that the C-terminal hypervariable region of Rab1 together with prenylatable 
cysteines are deleted, since they are not involved in interactions with RabGEF (Schoebel et al., 
2009). However, GDP-bound Ran1-178 without the C-terminal region is very unstable during 
protein purification. This point is consistent with a previous crystal structural analyisis that 
the C-terminal sequence of Ran is involved in nucleotide binding (Scheffzek et al., 1995). The 
full-length Ran1-205 is enough stable and choosen in this study.  
  
Figure 3.27. Site-specific labeling of DrrA and Rab1b (left) to form a coumarin-DrrA:Rab1b-
fluorescein complex and its gel filtration trace at 280 nm (right). The fractions 8-15 were 
analyzed by SDS-PAGE as shown in the lower panel. 
  With fluorophore-modified proteins in hand, we prepared the DrrA:Rab1b and Rcc1:Ran 
complexes by mixing stoichiometric amounts of the proteins with 10-fold excess of EDTA 
(ethylene diamine tetra acetic acid) over Mg2+ (Figure 3.27). The coordination of Mg2+ by 
EDTA can greatly reduce the GDP-binding ability of GTPases, and therefore is beneficial for 
the replacement of GDP by GEF. After run a gel filtration in nucleotide-free buffer, the 1:1 
GEF:GTPase protein complex eluted out in the position with correct molecular weight. SDS-
PAGE was further employed to indicate the formation of the 1:1 GEF:GTPase complex. Such 
labeling strategy could also be successfully applied to a Rho GTPase, Cdc42, and its GEF, 
Dock9.  
 
Figure 3.28. a) Emission spectra of coumarin-DrrA:Rab1b-fluorescein complex before (green 
line) and after GDP treatment (red line) or after buffer treatment (black dotted line). Inset: 
photographs of coumarin-DrrA:Rab1b-fluorescein complex before (left) and after GTP 
treatment (right) under a UV lamp. b) Emission spectra of coumarin-Dock9:Cdc42-
fluorescein complex before (red line) and after GTP treatment (blank line). c) Emission 
spectra of coumarin-Rcc1:Ran-fluorescein complex before (gray line) and after GTP 
treatment (blank line). All spectra were excited at 400 nm. 
  The coumarin-DrrA:Rab1b-fluorescein complex displayed green fluorescence under a UV 
lamp, while addition of 100-fold excess of GTP led to cyan fluorescence. This color change 
can be observed by the naked eye (Figure 3.28). Upon excitation of coumarin (FRET donor) 
at 400 nm, two emission peaks at 471 nm (coumarin) and 517 nm (fluorescein) were observed, 
indicating an efficient FRET effect. Addition of GDP or GTP into the complex led to loss of 
the FRET signal, with a change in the ratio of fluorescein to coumarin emission intensities 
(517 nm/471 nm) from 1.04 to 0.41 (Figure 3.28a). In contrast, the FRET signal (I517 nm/471 nm) 
of the protein complex remained constant upon buffer dilution or AMP treatment. These 
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results show that the association of GDP/GTP with DrrA:Rab1b complex displaced DrrA. 
This process can be monitored by the significant decrease of the FRET signal (FRET-off 
signal). We also observe such FRET-off signal in other GTPase:GEF pairs including 
Cdc42:Dock9 and Ran:Rcc1 (Figure 3.28). As expected, the ratio of fluorescein to coumarin 
emission intensities (517 nm/471 nm) decrease from 1.00 to 0.54 and from 0.78 to 0.44 for 
Dock9:Cdc42 and Ran:Rcc1, respectively. These results imply that the association of 
GDP/GTP with GEF:GTPase complexes displaced GEF (Figure 3.29). This process can be 
monitored by the significant decrease of the FRET-off signal.  
 
Figure 3.29. Kinetics and equilibria of the reversible GEF:GTPase:GXP interaction cycle. 
The parameters shown in black are for DrrA and Rab1b and red for RCC1 and Ran.   
3.3.3. Kinetics for monitoring the dissociation of the GEF:GTPase complex  
  In order to answer the question whether the kinetics of association of GDP or GTP to the 
GTPase:GEF complex are different, we performed the transient kinetic experiment in the 
reverse direction under pseudo first order conditions. Firstly, the transient kinetics of the 
reaction were examined in stopped flow experiments in which a 1:1 complex of DrrA:Rab1b 
was mixed rapidly with varying concentrations of GDP or GTP. The FRET-off signal on 
displacement of DrrA from Rab1b by GDP or GTP was a pseudo-first-order process (Figure 
3.30a). The observed rate constants for the displacement showed a hyperbolic dependence on 
nucleotide concentration, indicating a two-step reaction (Figure 3.30b,d). These hyperbolic 
dependence curves allow the determination of Kd4 and k-3 (Figure 3.29) through the following 
relationship:  
 
The affinity of GDP for the DrrA:Rab1b complex was 8-fold higher than that of GTP, with a 
Kd4 value of 89.5 µM for GDP or 761 µM for GTP (Figure 3.29). The Kd4 value for GDP was 
comparable with the previously determined value using tryptophan fluorescence as the 
binding signal (Schoebel et al., 2009). Although the affinity of GTP with the GEF:GTPase 
complex is relatively low, the higher concentration of GTP (up to 1 mM) in cells (Kleinecke 
et al., 1979) allows efficient GTP binding with the complex to achieve nucleotide exchange. 
The result also implies that the DrrA:Rab1b complex does not have much selectivity towards 
GDP or GTP, namely, GDP or GTP is an allosteric competitive factor in the GEF-catalyzed 
reaction (Goody, 2002).   
 
Figure 3.30. a) Stopped-flow traces of the dissociation of the coumarin-DrrA:Rab1b-
fluorescein complex by addition of GDP of 15 µM (red line) and 150 µM (green line). The 
black line represents the control on mixing the protein complex and buffer. The final 
concentration of coumarin-DrrA:Rab1b-fluorescein is 50 nM. b) Hyperbolic dependence of 
the observed rate constant for FRET-off signal change from the coumarin-DrrA:Rab1b-
fluorescein complex on various concentrations of GDP or GTP. The time-courses of the 
FRET-off signal were fitted to a single exponential function, and the resulting rate constants 
(kobs) were plotted against GDP or GTP concentration. The hyperbolic fittings (solid lines) 
gave Kd4 values of GDP/ GTP with the DrrA:Rab1b complex and the dissociation rate 
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constant (k-3) of DrrA from Rab1b:GDP or GTP complex as shown in Figure 3.29. c) 
Stopped-flow traces of the dissociation of the coumarin-Rcc1:Ran-fluorescein complex (500 
nM) by addition of GDP of 3 µM (red line) and 15 µM (black line). The green line represents 
the control on mixing the protein complex and buffer. d) The hyperbolic fittings (solid lines) 
gave Kd4 values of GDP/GTP with the Rcc1:Ran complex and k-3 of Rcc1 from Ran:GDP or 
GTP complex similar with that in the Rab1b:DrrA complex. 
 
  We also employed the Ran:Rcc1 pair to study the association of GDP or GTP to the 
GTPase:GEF complex. Using identical nucleotide concentrations, we find that the association 
of GTP to Ran-RCC1 is slower than that of GDP. Quantitative evaluation of the two reaction 
steps was performed as that of the DrrA:Rab1 pair by hyperbolically fitting the secondary plot 
of kobs against GXP concentration (Figure 3.30d). The affinity of GDP for the Rcc1:Ran 
complex was about 5-fold higher than that of GTP, with a Kd4 value of 5.8 µM for GDP or 
31.5 µM for GTP. These Kd4 values were comparable with the previously determined value 
using tryptophan fluorescence as the binding signal (Klebe et al., 1995).  
  Using mdGTP, we cannot obtain the reaction rate at saturating nucleotide concentrations due 
to the high background signal at these concentrations. The present strategy will not have this 
problem. While using the change of intrinsic tryptophan fluorescence as a signal (Klebe et al., 
1995), one could observe single exponential time traces with rate constants similar with that 
in Figure 3.30d. However, the present strategy allows direct measurement of the displacement 
of GEF with unlabeled nucleotide, and, is thus superior to the approach using Mant-GDP/GTP 
or tryptophan fluorescence, which only provides the information on nucleotide association. 
  It was interesting to observe whether ATP could disrupt the DrrA:Rab1b binary complex, 
especially since an equivalent experiment cannot be performed using fluorescent nucleotides. 
To this end, the FRET-off signal of the coumarin-DrrA:Rab1b-fluorescein complex was 
monitored by addition of 1 mM ATP or GTP. The results showed that association of ATP 
with DrrA:Rab1b complex is three orders of magnitude slower than that of GTP (Figure 3.31). 
The kinetics imply that GEF:GTPase complex binds with GTP rather than ATP in vivo. From 
the thermodynamic view point, GTPases bind to ATP with a 106 lower affinity than GTP 
(John et al., 1990; Simon et al., 1996).  
 Figure 3.31. Time-dependent decrease of the FRET-off signal of the 50 nM coumarin-
DrrA:Rab1b-fluorescein complex by treatment with 1 mM ATP or GTP (inset). The traces 
were fitted to a single exponential function to give kobs value of 0.076 s-1 for ATP and 67.14 s-
1 for GTP. 
  The dissociation of the GEF:GTPase complex could be monitored by displacing labeled 
GEF  with excess of non-labeled GEF (Figure 3.32a). This dissociation caused a significant 
decrease of the FRET signal (Figure 3.32b,c). Single exponential fitting of the trace gave the 
dissociation constants for DrrA:Rab1b (koff = 0.011 s-1) and RCC1:Ran (koff = 0.0035 s-1), 
indicating a tightly bound GEF:GTPase complex. It is noted that this kind of the rate 
constants could not be determined directly in earlier studies, indicating the advantage of our 
FRET-based strategy. For the first time, we could directly monitor the dissociation of the 
GEF:GTPase complex in this work.  
 
Figure 3.32. a) A FRET-based strategy to monitor the dissociation of GEF from the 
GEF:GTPase complex. b) Dissociation kinetics of 50 nM coumarin-DrrA:Rab1b-fluorescein 
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complex on addition of 1 µM non-labeled DrrA. The red line represents a fit to a single 
exponential function to give a kobs value of 0.011 s-1. Inset: the emission spectra of the sample 
before addition non-labeled DrrA (black line) and after reaction for 500 s (red line). c) 
Dissociation kinetics of 500 nM coumarin-Rcc1:Ran-fluorescein complex on addition of 10 
µM non-labeled Rcc1. A fit (red line) to a single exponential function gives a kobs value of 
0.0035 s-1. 
3.3.4. Kinetics for monitoring protein-protein interactions 
  We next examined the association of coumarin-GEF with GDP:GTPase-fluorescein. GEF 
can displace GDP from GTPase to form the GEF:GTPase complex, which can be monitored 
by the increase of the FRET signal (FRET-on signal) (Figure 3.33). The observed first-order 
rate constant showed a linear dependence on GEF concentration in the concentration range we 
have used. This suggests that the affinity of GEF with GTPase:GDP is low, i.e. Kd3 is high, 
which is in line with the previously determined Kd3 of 10-40 µM (Schoebel et al., 2009). The 
plots indicated that the exchange rate constant k-4 for GDP was higher than the one 
determined using mant-GDP (k-4 of 7.6 s-1 for DrrA and 21 s-1 for RCC1) (Schoebel et al., 
2009; Klebe et al., 1995). The slope in Figure 3.33a of the linear fit provides an estimation of 
the GEF catalytic efficiency of DrrA (kcat/KM = 1.5 × 106 M-1s-1), which is comparable with 
the reported value of 0.91 × 106 M-1s-1 (Suh et al., 2010). These results demonstrate that the 
FRET strategy can be used to monitor GEF activity.  
 
Figure 3.33. Characterization of the GEF activity using FRET-on signal. a) 50 nM 
GDP:Rab1b-fluorescein was rapidly mixed with varying concentrations of DrrA. The time-
courses of FRET-on signal were fitted to a single exponential function, and the resulting rate 
constants (kobs) were plotted against DrrA concentration. Inset: time-dependent increase of 
FRET signal at different concentrations of DrrA. b) 500 nM GDP:Ran-fluorescein was rapidly 
mixed with varying concentrations of Rcc1. The time-courses of FRET-on signal were fitted 
to a double exponential function, and the resulting rate constants (kobs) were plotted against 
Rcc1 concentration.  
3.3.5. Conclusion  
  In summary, we have presented the general principle of a FRET-based strategy for 
monitoring GEF-mediated nucleotide exchange using site-specifically labeled GEF and 
GTPase proteins. Using NCL and oxime ligation, we prepared N-terminal coumarin-labeled 
GEFs and C-terminal fluorescein-labeled GTPases. We constructed two pairs of coumarin-
GEF:GTPase-fluorescein complexes, which showed a significant intermolecular FRET effect. 
The FRET signal was disrupted by binding of GDP or GTP and allowed direct detection of 
the GEF:GTPase interaction. Transient kinetic studies based on the FRET signal changes 
were used to monitor the GEF activity and nucleotide binding. The studies led to a consistent 
conclusion on the GEF mechanism involving allosteric competition between GDP/GTP and 
GEF’s interaction with a GTPase. The strategy presented here could be a general method that 
is applicable to other GEFs and GTPases, and may open up a new avenue for the 
identification of GEF inhibitors and for studying GEF mechanisms. 
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3.4. Development of a general strategy for preparation of lipid-
protein conjugates   
 
3.4.1. Introduction  
  Post-translational modification of proteins with lipids (e.g. fatty acids, isoprenoids) is an 
essential biological process in eukaryotic cells. Tools for generating protein-lipid conjugates 
are valuable for studying the role of post-translational lipid modification in controlling protein 
function and localization. However, recombinant production of post-translationally modified 
proteins is usually challenging in terms of homogeneity and output. The site-specific 
attachment of lipids to proteins remains a challenge in bioconjugation. Only a relatively 
limited set of chemical (Brunsveld et al., 2006; Kadereit et al., 2000; Grogan et al., 2005; 
Alexandrov et al., 2002) and chemoenzymatic (Owen et al., 1999; Mcgeady et al., 1995; 
Antos et al., 2008) strategies are available for this purpose. EPL has proven to be a 
chemoselective and efficient method for construction of lipidated Rab GTPases (Durek et al., 
2004). Herein we aim to develop a general and quantitative bioconjugate method as an 
alternative strategy for preparing lipid-protein conjugates. 
  In this work Rab proteins were chosen as model proteins, since they have single or double 
modification of geranylgeranyl isoprenoids at the C terminus. Studies of Rab protein function 
as well as the mechanism of Rab prenylation require methods that allow for generating 
enough amounts of prenylated Rab proteins with new functionalities such as fluorophores, 
photoreactivity, and isoprenoid groups at non-native positions. Herein we employed the click 
reaction to construct lipid-protein conjugates because: 1) the formed 1,2,3-triazole has only a 
low steric demand and is also regarded as a peptide-bond mimetic (Tron et al., 2008); 2) the 
reaction confers superior efficiency (high reaction rate) and selectivity (Rostovtsev et al., 
2002; Berry et al., 2010); 3) the quantitative click ligation would enable to make pure 
lipidated proteins. This is particularly important, since the separation of modified protein from 
unmodified one may be highly problematic. Recently, the strategy where a protein or peptide 
equipped with an alkyne or azide moiety undergo rapid click reaction has been widely 
employed in protein/peptide modifications (Yi et al., 2009; Weikart et al., 2010; Xiao et al., 
2009; Flavell et al., 2008; Binda et al., 2011; Wang et al., 2011; Cai et al., 2011). In this work, 
we firstly incorporated an azide group into the C-terminus of Rab proteins based on EPL and 
subsequently ligated alkyne-modified prenylated peptides or lipidated molecules to the 
proteins using click reaction (Figure 3.34). Using this approach we can generate prenylated 
Rab proteins that form complexes with their natural chaperones REP-1 and GDI-1, which 
were used to study Rab prenylation in vitro.  
 
Figure 3.34. Strategy for the semi-synthesis of geranylgeranylated Rab proteins. Firstly, an 
azide group is introduced into protein C-terminus by NCL, and then the Click reaction 
between an alkyne-containing lipid and the resulted azide-modified protein produces a lipid-
modified protein bioconjugate. 
3.4.2. Preparation of azide-modified proteins  
  In order to incooperate an azide moiety into a protein in a site-specific fashion and using the 
EPL reaction, compound 14 was designed and synthesized (Figure 3.35). The synthesis of 14 
starts from Fmoc-Cys(StBu)OH and 2-azidoethanamine (see experimental part for details). 
The cysteine moiety in 14 is protected by t-butylthio (StBu), which can be easily removed by 
treatment with high concentration of thiol additives during EPL. The co-existence of thiol and 
azide groups in one molecule is stable (Riedrich et al., 2007), however, the azide group in 14 
can be reduced to an amino group by high concentration of thiols. We finally found that 100-
150 mM MESNA can efficiently remove the StBu group in buffer without reducing the azide 
group.    
 
Figure 3.35. Synthesis of CysN3 14. 
   
83 
 
  The reaction of 14 and Rab-thioesters in the presence of 150 mM MESNA resulted in azide-
modified proteins, and then the mixture was dialyzed to remove excess of 14. In the optimized 
conditions (Figure 3.36), the thioester proteins were quantitatively converted to azide-
modified proteins as indicated by LCMS. Partial dimerization of the azide-modified proteins 
was observed during the storage at -80 °C probably due to the disulfide cross-linking of C-
terminal cysteines. However, protein cross-linking did not influence the subsequent click 
ligation (see following results). Though the azide groups in protein can be significantly 
reduced to amino groups in the presence of 500 mM MESNA, the azide-modified proteins are 
stable in the buffer for click ligation. 
 
Figure 3.36.  a) An optimized ligation conditions for preparation of azide-modified proteins. 
b) and c) ESI-MS spectra of Rab7Δ7 thioester proteins (Mcalcd = 22842) and azide-modified 
proteins (Mcalcd = 22892), respectively. 
3.4.3. Synthesis of alkyne-containing lipid molecules     
  The GerGer-containing peptides were synthesized based on solid-phase lipidated peptide 
synthesis (SPPS) developed by Waldmann et al. (Gottlieb et al., 2006). The GerGer group 
was firstly incorporated into cysteine to produce the building block Fmoc-Cys(GerGer)OH 
(Brown et al., 1991). It is noted that the reaction intermediate, Cys(GerGer)OH, has relatively 
low solubility in CH2Cl2. If small amount CH3OH (0.5%) is added during the reaction, the 
yield (from GerGerOH) can be greatly improved to reach more than 80% (Figure 3.37), which 
is important because the commercial available GerGerOH is expensive. 
 
Figure 3.37. synthesis of the lipid building block 18. 
 
Figure 3.38. Solid-phase peptide synthesis of the geranylgeranylated peptides with N-
terminal alkyne moieties.  
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  The lipid building block was loaded onto 2-chlorotrityl chloride (2-Cl-Trt) resin or linked to 
peptide by standard Fmoc technique (Figure 3.38). The coupling of propiolic acid 
encountered the problem of precipitation upon addition of N,N-diisopropylethylamine 
(DIPEA) (Neukamm et al., 2008). Eventually I found that the mixture of 3 eq. (equivalent) 
propiolic acid and 3 eq. N,N'-diisopropylcarbodiimide (DIC) in cold CH2Cl2 can react with 
the resin at 0 °C. Though this reaction was performed in weak acid condition, no significant 
lipidated peptides were cleaved from resin during the couple reaction. The mono-
geranylgeranylated fluorescently labeled peptides 19-21 were obtained after cleavage from 
the 2-Cl-Trt resin using a standard procedure. The peptides were purified by flash 
chromatography with about 50% yield and characterized by MALDI-TOF and high resolution 
ESI mass spectra (HRMS).  
3.4.4. Click ligation for lipid-protein conjugate 
 
Figure 3.39. SDS-PAGE shows the fluorescent labeling of protein by click reaction. Lane 1, 
azide-modified Rab7; Lanes 2-4, click reaction of azide-modified Rab7 and the fluorescent 
peptide with reaction time of 15, 30, 60 minutes, respectively. 
  With both azide-modified proteins and alkyne-modified peptides in hand, we next aimed to 
perform the click ligation in buffer without protein precipitate and decomposition. In the first 
tests, I found that Rab proteins were totally decomposed in the presence of copper. It was 
reported that the reactive oxygen species produced by Cu(I) can damage biomacromolecules 
(Devaraj et al., 2005). The ligand tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amin) (TBTA) 
is reported to greatly increase the click reaction rate and to reduce protein decomposition 
during the Click reaction. A dansyl-containing fluorescent peptide 22 (Figure 3.39) was 
employed to optimize the protein ligation. This fluorescently labeled peptide permits easy 
detection of protein ligation products by means of SDS-PAGE when the unstained gel is 
exposed to UV light. In such a case, appearance of a fluorescent band in the 20-30 kDa 
molecular weight region indicates the formation of the ligation product. Firstly, a 10 × click 
catalysis was prepared as: 10 mM CuSO4 (from 100 mM stock solution), 10 mM TBTA 
ligand (from 20 mM methanol stock solution), 20 mM sodium ascorbate (from 200 mM 
freshly stock solution) were mixed and incubated at room temperature for 5 minutes. Then the 
catalysis solution was added into a mixture of azide-modified Rab7 (1 mg/mL) and 22 (1 mM) 
at pH 7.4 buffer. After the reaction, the solution was centrifuged and 1 mM EDTA was added 
to quench the reaction. Based on SDS-PAGE, I found that the Rab protein was highly 
efficient modified within 15 minutes without obvious protein decomposition, implying that 
this copper-catalyzed click ligation is very fast as expected. 
 
Figure 3.40. a) The click protocol for semisynthesis of geranylgeranylated Rab GTPases. b) 
SDS-PAGE of the ligated product of Rab1 with peptide 20 before (lane 1) and after (lane 2) 
purification. Lane M, molecular marker. The gel was photographed both in the UV light to 
show fluorescence (right) and in the visible light after Coomassie blue staining (left). c) ESI-
MS spectrum of the ligation product of Rab1 and peptide 20 (Mcalcd = 22965 Da). d) HPLC-
MS profiles of Rab1-N3 (black line) and the ligation product with prenylated peptide (red 
line). The elution condition: buffer A, 0.1% HCOOH in H2O; buffer B, 0.1% HCOOH in 
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CH3CN; flow rate of 1 mL/min for RP-C4 column; 0-5 min, 80% buffer A; 5-15 min, 80-
30% buffer A with gradient mode; 15-17 min, 30-10% buffer A; 17-19 min, 10-80% buffer A; 
then keep in 80% buffer A. The ESI-MS spectra between 12-15 min further indicated the 
quantitative conversion from Rab1-N3 to Rab1-G.  
 
 
  Encouraged by these results, we tested the click reaction of azide-modified Rab with alkyne-
containing lipidated peptides. Not surprisingly, the geranylgeranylated peptides 19-21 are 
very hydrophobic, which are insoluble in 30% methanol or 50 mM CHAPS-containing buffer. 
In previous studies, it was found that cetyltrimethylammonium bromide (CTAB) can 
efficiently solubilize the GerGer-containing peptides in buffer (Durek et al., 2004). In this 
study, the click reaction of prenylated peptides and azide-modified Rab proteins proceeded 
rapidly in the presence of CTAB. The appearance of fluorescent bands of 24 kDa in SDS-
PAGE indicated the formation of the ligated product Rab1-G (Figure 3.40b). LC-MS analysis 
further indicated the quantitative ligation of Rab1 with prenylated peptides (Figure 3.40c). 
The HPLC traces of Rab1 before and after ligation with lipopeptide (Figure 3.40d) indicated 
the click reaction can be finished within 30 minutes. 
 
Figure 3.41. The chemical structure of 23 and ESI-MS spectra of Rab7-N3 and the ligation 
product with 23. 
 
  We further used an alkyne-containing hexadecyl chain 23 (a palmitoyl analogue, Figure 
3.41) for lipid–protein bioconjugation. The click reaction between azide-modified Rab7 and 
23 was complete within 30 min in the optimized click ligation protocol, as indicated by LC-
MS. These results suggested that the click ligation strategy is general applicable for the 
generation of lipidated proteins. 
  EPL has successfully enabled the production of various lipidated Rab protein constructs for 
biochemical and biophysical studies (Thomas Durek PhD thesis, 2004; Yao-Wen Wu PhD 
thesis, 2008). It is proposed that the high charge density on the micelle surface (Figure 3.42) 
could additionally contribute to the polarization of the carbonyl thioester, thereby enhancing 
its reactivity. However, such effect leads to unavoidable hydrolysis of thioesters in CTAB 
buffer. Using two-step ligation strategy here, we can achieve the quantitative lipid-protein 
bioconjugate. The first-step of EPL is quantitative, since the ligation of 14 and thioester 
proteins can proceed smoothly without addition of CTAB. Now that the thioester groups have 
been transferred into azide groups, no hydrolysis will happen in this case (Figure 3.42). The 
tandem Click ligation is highly efficient to achieve quantitative conversion of azide-modified 
proteins into lipidated proteins. 
 
Figure 3.42. Hypothetical model of the micelle catalysis effect of CTAB for EPL (left) and 
Click ligation (right). Rab thioester is colored red and the geranylgeranylated peptide is 
shown in blue.  
3.4.5. Development of a purification strategy    
  Upon completion of the click reaction, ligated proteins must be purified from contaminating 
lipidated peptides, and detergent (CTAB) or additive (MESNA), which unexpectedly turned 
out to be highly problematic. To this end, the reaction mixture was treated with ice-cold 
acetone or methanol (at least 10-fold volume), which resulted in fully protein precipitation 
and partly extraction of unligated peptide into the organic phase (Figure 3.43). It appeared 
that the geranylgeranylated Rab tightly associates with the prenylated peptide and CTAB, 
which is presumably due to the result of strong hydrophobic interactions. Therefore, the 
protein pellet was washed with organic solvents such as methanol and dichloromethane and 
then with water to remove unreacted prenylated peptides and detergents. Using this approach 
peptide free ligation proteins could be obtained.  
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Figure 3.43. a) Photograph showing the general purification protocol for semisynthetic 
prenylated proteins. b) Gel filtration chromatography of Rab1C(G)C:REP-1 complex and 
REP-1. c) SDS-PAGE analysis of the resulting fractions of the Rab1C(G)C:REP-1 complex 
from 12 to 21 min (elution time) as resolved in lane 1-10, respectively. The gel was 
photographed both in the UV light (up) and the visible light after Coomassie blue staining 
(down).   
  The renaturation step is necessary to achieve functional lipidated proteins. The protein pellet 
was firstly dissolved in 8 M guanidinium-HCl containing 500 mM MESNA that successfully 
disrupted the disulfide crosslinking and the protecting group StBu of the C-terminal cysteine. 
The resulting protein was refolded by pulse dilution into refolding buffer. To stabilize the 
lipidated protein after removal of the detergent, Rab chaperones such as REP-1 or GDI-1 were 
added. After renaturation of the lipid-modified Rab protein further purifications turned out to 
be straightforward using standard biochemical procedures including dialysis and gel filtration 
(Figure 3.43). The large volumes of very dilute protein solutions had to be concentrated 
before gel filtration. The yield of proteins from this refolding procedure is about 40% (based 
on azide-modified proteins).  
  Based on the present method, we constructed prenylated Rab1 proteins and REP-1 
complexes arising from the ligation of Rab1 with peptide 20 and 21, termed Rab1-CC(G) and 
Rab1-C(G)C, respectively. The prenylated Rab1 (Rab1-G):REP-1 complexes were subject to 
size-exclusion chromatography. A single protein peak eluted earlier than the REP-1 peak 
contained both prenylated Rab1 and REP-1 proteins as indicated by SDS-PAGE of the eluted 
fractions (Figure 3.43), suggesting that prenylated Rab1 form a tight complex with REP-1 
(Alexandrov et al., 1999).    
3.4.6. In vitro protein prenylation of lipoproteins 
  The binding activity of the semi-synthetic Rab1-G protein with REP-1 implies its 
functionality. This prompted us to ask whether the obtained mono-geranylgeranylated Rab 
protein could function as a prenyl acceptor in the prenylation reaction meditated by 
RabGGTase. Using NBD-farnesyl pyrophosphate (NBD-FPP) (Wu et al., 2006), a fluorescent 
analogue of geranylgeranyl pyrophosphate (GGPP), we performed an in vitro prenylation 
assay in which the Rab1-G:REP complex was incubated with RabGGTase and NBD-FPP. As 
shown in Figure 3.44a, incorporation of NBD-isoprenoids to Rab1-G proteins was observed 
(Figure 3.44a, Lane 6 and 7), while no incorporation was observed when RabGGTase was 
omitted (Figure 3.44a, Lane 4 and 5). This suggests that the semi-synthetic Rab1-G can accept 
another prenyl group through the prenylation reaction. This result indicated that the 
semisynthetic lipidated proteins were correctly refolded and functional.  
  We further used the fluorescence change of the C-terminal dansyl group upon prenylation to 
monitor the prenylation of both mono-geranylgeranylated Rab intermediates. The time course 
of fluorescence decrease could be fitted with a double-exponential function (Figure 3.44b). 
The observation of non-single exponential reaction kinetics is probably due to a 
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conformational change following the chemical step. This is not surprising, since diprenylated 
C-terminus has to move out of the active site of RabGGTase and associates with the lipid 
binding site on the REP molecule (Thomä et al., 2001; Pylypenko et al., 2006; Wu et al., 
2009). Prenylation of Rab1-C(G)C (k1 = 0.002 s-1) is slightly faster than that of Rab1-CC(G) 
(k1 = 0.0015 s-1), suggesting that the protein with the first prenyl group at the N-terminal 
cysteine may adapt more favourable conformation for the second prenyl transfer. Thus, we 
conclude that the N-terminal cysteine of Rab1 is preferred for the first round of prenylation. 
This is consistent with the previous finding that the prenylation of Rab1-CS is slightly faster 
than that of Rab1-SC (Shen et al., 1996). In contrast, in the case of Rab7 with CXC C-
terminal motif the upstream cysteine is preferred for the first prenyl transfer (Durek et al., 
2004; Thomä et al., 2001). It is conceivable that C-terminal motif (CC or CXC) of Rab 
proteins might determine which cysteine is preferred for the first prenyl transfer. These 
scenarios could be explained by the fact that Rab C-terminus is flexible and adapts a variety 
of conformations during prenylation (Wu et al., 2009). Nevertheless, the order of cysteine 
residues does not appear to significantly affect the extent of Rab protein prenylation in vitro 
(Farnsworth et al., 1994), and both C-terminal cysteines of Rabs were geranylgeranylated. 
However, the biological role of ordered digeranylgeranylation remains elusive.  
 
Figure 3.44. The activity of Rab1-G in complex with REP-1 was confirmed by in vitro 
prenylation assay. A) Incorporation of NBD-FPP to Rab1-G upon in vitro prenylation 
resolved by SDS-PAGE (top: Coomassie blue staining; middle: scan of NBD fluorescence 
(ex: 488 nm); bottom: scan of dansyl fluorescence in UV light. Lane 1: Rab1Δ5-thioester, 
Lanes 2: Rab1-C(G)C:REP-1 complex, Lane 3: Rab1-CC(G):REP-1 complex. Lanes 6 and 7, 
prenylation of the Rab1-C(G)C (lane 6) and Rab1-CC(G) (lane 7) in complex with REP-1 in 
the presence of RabGGTase and NBD-FPP for 1 h at room temperature. Lanes 4 and 5: the 
same reactions as shown in lane 6 and 7 in the absence of RabGGTase. It is noted that there 
was no crosstalk between dansyl and NBD fluorescence under these conditions. B) 
Prenylation reactions of semisynthetic Rab1-G. 75 nM Rab1-G:REP complex was incubated 
with 75 nM RabGGTase, and 30 µM GGPP was added at the point indicated by arrows. The 
solid lines represent fits to a double-exponential equation for Rab1-CC(G) in red (k1 = 0.0015 
s-1 and k2 = 0.00016 s-1) and Rab1-C(G)C in blue (k1 = 0.002 s-1 and k2 = 0.0003 s-1).    
 
4.4.7. Conclusion 
  In summary, we have presented a new strategy using tandem EPL and click chemistry to 
site-specifically install hydrophobic lipids into proteins. The two-step ligation reaction is 
quantitative, which makes the purification of ligated protein much facile. The approach 
yielded correctly folded and functional geranylgeranylated Rab GTPases, as could be inferred 
by their ability to interact with REP/GDI as well as to accept the second prenyl group in 
prenylation. The ligation strategy may open up a new avenue for the production of lipidated 
proteins that are used in various biological studies. What is more, the replacement of Rab C-
terminal sequence with unnatural triazole moiety did not influence Rab prenylation, which 
encourages further modifications at the Rab C-terminus for the investigation of Rab GTPases 
functions. Based on this study, we aim to use chemical linkers to replace the C-terminal 
hypervariable region of about 35 amino acids of Rabs to probe Rab prenylation and 
subcellular localization mechanism in following studies. 
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3.5. Semisynthesis of PEGylated proteins for probing Rab 
prenylation and localization mechanism   
 
3.5.1. Introduction  
  Rab proteins require a posttranslational modification that is conferred by RabGGTase 
together with an additional factor REP, which attaches geranylgeranyl moieties onto (usually) 
two cysteines at their C-terminus. Rab prenylation requires the formation of a catalytic Rab-
REP-RabGTPase ternary complex (Alexandrov et al., 1999). Although the structure of the 
ternary complex is not available, a model of the complex has been established based on the 
crystal structures of Rab-REP and REP-RabGGTase binary complexes (Pylypenko et al., 
2003; Rak et al., 2004; Wu et al., 2009). Structure and interaction analysis suggest that three 
binding interfaces contributed from 1) the GTPase domain; 2) C-terminal interacting motif 
(CIM) of Rab with REP; 3) RabGGTase with REP confer the establishment of the ternary 
complex (Guo et al., 2008; Wu et al., 2009). Computational simulation of the disordered Rab 
C-terminal peptide in the ternary complex and biochemical validation suggest that the flexible 
C terminus of Rab substrate forms a series of weaker and less specific interactions that 
channel it into the active site of RabGGTase. In order to further understand the mechanism of 
Rab prenylation, we want to know whether there is anything required for Rab C-terminal 
sequence and to what extent the Rab prenylation machinery could tolerate the change in the 
Rab C-terminal sequence. We speculated that the assembly of Rab prenylation machinery 
could allow any C-terminal cysteine residue that is presented into the active site of 
RabGGTase to undergo prenylation, and therefore, if we replace the Rab C-terminal sequence 
with a non-native peptide chain such as a polyethylenglycol (PEG) linker, Rab could still be 
prenylated. 
  On the other hand, the C-terminal hypervariable region of 35 to 40 amino acids shows the 
highest level of sequence divergence between Rab family members, and was postulated to act 
as a signal for subcellular targeting. Zerial and co-workers showed that replacing the C-
terminal 35 residues of Rab5 with the equivalent C-terminal region of Rab7 resulted in re-
localization of the hybrid Rab to Rab7-positive late endosomal structures (Chavrier et al., 
1991). Targeting of Rab proteins via the hypervariable region is a widely accepted model, but 
the underlying molecular mechanisms have not been elucidated further. Despite the 
attractiveness of this proposal, recent studies indicated that this is not the case for several 
Rabs. We reason that if we replace the C-terminal hypervariable region of Rabs with a non-
native peptide chemical linker, the result protein probes could be used for studying Rab 
localization mechanism.   
  In this work, we semisynthesized a series of Rab probes that the C-terminal hypervariable 
region and prenylatable cysteines are replaced by PEG linkers and thiols, respectively. 
Biochemical analysis suggested that the resulting PEGylated Rab probes were prenylated as 
efficiently as the wild type Rab proteins. Using the EGFP-tagged Rab probes, we found that 
the flexible C-terminal sequences of some Rabs (such as Rab1 and Rab5) have no 
contribution for their cellar localization.  
3.5.2. Replace the peptide after CIM by a chemical linker   
  Firstly, we chose a well-characterized Rab7 protein as the model protein. We aimed to 
replace the peptide after the essential CIM motif by a PEG linker. Since the length of the 
linker is critical for Rab prenylation (Wu et al., 2009), we sought to produce a PEGylated 
Rab7 protein conjugate that has a similar C-terminal length as that of the wild type protein 
(Figure 3.45a). To this end, we truncated the amino acid residues after the CIM motif of Rab7 
protein and cloned the truncated Rab7 gene in an intein vector (pTWIN1). Rab7Δ15-thioester 
protein was produced through intein-medicated protein splicing using MESNA as the thiol 
reagent. Subsequently, Rab7Δ15-thioester was treated with bis(oxyamine) at pH 7.5 on ice for 
4 h to achieve oxyamine-modified protein, Rab7Δ15-ONH2, which is competent for oxime 
ligation with a chemical linker containing a ketone moiety (see part 3.1 for details). 
  As shown in Figure 3.45, we designed a chemical linker 24 containing a ketone group for 
oxime ligation, a PEG linker, and two prenylatable cysteines. This linker was synthesized by 
stepwise solid-phase synthesis using Fmoc-Cys(StBu), (4,7,10)-trioxa-1,13-tridecanediamine 
(TTD), succinic anhydride, and 3-(2-methyl-1,3-dioxolan-2-yl)propan-1-amine as building 
blocks (Figure 3.45b). Firstly, Fmoc-Cys(StBu) was loading on 2-Cl-Trt resin with loading 
efficiency of 0.4-0.5 mmol/g. After deprotection of the Fmoc group, the linker was extended 
by standard coupling protocols (see synthesis details in the experimental part). It is noted that 
after the coupling of TTD, the coupling reaction on resin became inefficiency, probably due 
to the long and flexible structure of this TTD linker. Finally, the linker was cleaved from the 
resin by treatment with 5% TFA in CH2Cl2, and in this case the protection group of ketone 
was also cleaved. The result crude product was purified by prep-HPLC with the final yield of 
about 8%.  
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Figure 3.45. A) Chemical structures of the C-terminus of Rab7 wild type and the design 
bioconjugate Rab7-PEG-CC. B) Synthesis route for the chemical linker 24. 
  The PEG-1 linker 24 contains two cysteines protected with StBu groups, which can be 
removed by the treatment with reducing reagents after protein ligation. Incubation of 24 and 
Rab7Δ15-ONH2 on ice overnight resulted in full conversion of the oxyamine to an oxime 
adduct, Rab7-PEG-1, as shown by SDS-PAGE (Figure 3.46). It is noted that because 24 has 
little water-soluble, 10% methanol had to been added into the ligation buffer to keep 24 
soluble. Though organic solvents have the potentially negative effect on protein samples, I 
found that reaction at the low-temperature (protein ligation on ice) is enough mild to keep 
protein stable under these conditions. The overall yield of the semisynthesis protein is larger 
than 90%, implying that the ligation conditions are mild and efficient. After the oxime 
ligation, the unreacted linker 24 can be easily removed by a desalting column.  The StBu 
groups in the semisynthesis Rab7-PEG-1 cannot be removed efficiently by treatment with 200 
mM DTE overnight (data not shown). I speculate that the steric effect of two StBu groups 
from two neighbor cysteines may be responsible for this slow reaction kinetics. A smaller 
thiol reagent instead of DTE may be more efficient for this cleavage. Finally, we found that 
500 mM MESNA can be used to cleave both StBu groups fast and completely, as indicated by 
LCMS (Figure 3.46c), to achieve thiol-free protein Rab7-PEG-1-CC. 
 
Figure 3.46. A) Semisynthesis of Rab7-PEG-CC. B) SDS-PAGE analysis of Rab7Δ15-
thioester (lane 1), Rab7Δ15-ONH2 (lane 2) and Rab7-PEG-CC (lane 3). C) ESI-MS spectrum 
of Rab7-PEG-CC (Mcalcd = 22613). 
  The obtained Rab7-PEG-1-CC was subjected to in vitro prenylation assay using substrates 
NBD-FPP and GGPP. The prenylation reaction was allowed to proceed for 1 h at 37 °C and 
was quenched by addition of SDS-PAGE sample buffer, after which the samples were 
resolved on a 15% SDSPAGE gel and scanned for fluorescence using a laser fluorescent 
image reader followed by Coomassie blue staining. As shown in Figure 3.47, Rab7-PEG-1-
CC displays nearly identical prenylation efficiency to that of the wild type Rab7 protein. The 
prenylation kinetics at room temperature further supported that Rab7-PEG-1-CC can be 
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prenylated as efficient as that of wide-type Rab7. Prenylation of Rab7-PEG-CC using GGPP 
also led to the doubly geranylgeranylated protein as shown by ESI-MS. These results suggest 
that, as expected, replacing the peptide between the CIM motif and the prenylatable cysteines 
with a non-peptidic PEG linker does not affect Rab prenylation, and the Rab protein substrate 
specificity is not encoded in this C-terminal region. 
 
Figure 3.47. a) The activity of semisynthesis protein probe Rab7-PEG-1-CC was confirmed 
by in vitro prenylation reaction through incorporation of NBD-FPP to Rab resolved by SDS-
PAGE (left: scan from a laser fluorescent image reader excitation at 473 nm; right: 
photograph in visible light after Coomassie blue staining). Lane 1: Rab7Δ15-ONH2; Lane 2: 
Rab7CSS; Lane 3: Rab7 wide type; Lane 4: Rab7-PEG-1-CC. b) The relative fluorescence 
intensity of the Rab bands in a). c) Reaction kinetics of the in vitro prenylation by an end-
point assay based on NBD-FPP for Rab7-PEG-1-CC. d) LCMS spectra of the prenylation 
reaction in the presence of the RabGGTase substrate GGPP (Mcalcd = 23157 Da). Reaction 
condition: 6 µM PEGylated Rab7, 10 µM REP, and 6 µM RabGGTase were mixed with 100 
µM GGPP in prenylation buffer and incubated for 1 h at 37 °C. Before reaction, the Rab 
protein eluted at about 12.7 min, while after geranylgeranylated reaction, the protein eluted at 
about 17 min, and the prenylation reaction was clearly shown by the change of mass spectra. 
 
 
4.5.3. Replace prenylatable cysteines with a thiol group   
 
Figure 3.48. a) Chemical structures of the C-terminus of Rab7 wild type and the design 
bioconjugate Rab7-PEG-2-SH. b) Synthesis route for the chemical linker 25. 
  From above studies, we know that the Rab7 C-terminus downstream the conserved CIM 
motif does not encode specificity for Rab prenylation. We hope to further probe whether the 
prenylatable cysteines can be replaced by thiols. A chemical linker PEG-2 25 was designed 
(Figure 3.48), which contains a ketone group for protein ligation, a (PEG)8 linker and a 
prenylatable thiol linked by disulfide bond, which can be easily cleaved by using 5 mM DTE 
during protein ligation. 
  Unlike PEG-1 24, the PEG-2 25 is water-soluble. So we can perform the oxime ligation of 
25 and Rab7Δ15-ONH2 in buffer without addition of methanol co-solvent. The LCMS 
spectrum indicated the successful protein ligation to give a protein peak at 22508 (Figure 
3.49). The result bioconjugate Rab7-PEG-2-SH can be prenylated by RabGGTase (Figure 
3.49b-d). Using NBD-FPP, Rab7-PEG-2-SH displays faster prenylation efficiency than that of 
the wild type Rab7 protein. This is reasonable considering that there is only one thiol in the 
semisynthesis protein rather than two cysteines in wide-type protein. Prenylation of Rab7-
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PEG-2-SH using GGPP led to the geranylgeranylated protein (Figure 3.49d). These results 
imply that the thiol group in Rab7-PEG-SH can be prenylated as efficient as cysteines at the 
Rab C-terminus, suggesting a flexibility within RabGGTase prenylation machine!  
 
Figure 3.49. a) LCMS spectrum of the Rab7-PEG-2-SH protein. b) The relative fluorescence 
intensity of the Rab bands in in vitro prenylation reaction through incorporation of NBD-FPP 
to Rab resolved by SDS-PAGE. c) Reaction kinetics of the in vitro prenylation by an end-
point assay based on NBD-FPP. d) LCMS spectra of the prenylation reaction in the presence 
of the RabGGTase substrate GGPP (Mcalcd = 22780 Da). Reaction condition: 6 µM PEGylated 
Rab7, 10 µM REP, and 6 µM RabGGTase were mixed with 100 µM GGPP in prenylation 
buffer and incubated for 1 h at 37 °C.  
4.5.4. Replace the C-terminal hypervariable region with chemical linkers   
  Considering the fact that the C-terminal hypervariable region of about 30-40 amino acids 
shows the highest level of sequence divergence between Rab family members, we further 
argue that whether the C-terminal hypervariable region before the CIM motif contributes to 
Rab prenylation. In order to answer this question, we firstly designed and synthesized a very 
long PEGylated chemical linker PEG-3 (Figure 3.50) to try to replace the Rab7 C-terminal 
hypervariable region of 34 amino acids. It is noted that the CIM motif, which is necessary for 
the Rab:REP interaction, must be kept in the linker.  
 Figure 3.50. a) The design of PEG-3 linker based on wide-type Rab7. b) The synthesis route 
for the linkers 36 and 37. DCC: dicyclohexylcarbodiimide. NHS: N-hydroxysuccinimide.  
  As shown in Figure 3.50a, the C-terminal sequence before the IKL motif is replaced by a 
ketone-containing (PEG)8 fraction. Considering the facile synthesis for PEG-3 liker, we 
replace lysine in the IKL motif as alanine. The amino acids after the IKL motif were replaced 
by a PEG12 fraction. One or two cysteines were appended at the C-terminus of the linker for 
prenylation.    
  The synthesis of PEG-3 36 and 37 were achieved by the combination of SPPS and solution 
synthesis (Figure 3.50b). Firstly, the tripeptide IAL was prepared in SPPS. Cleavage of 
peptide 26 at weak acid condition (1% TFA) is mild enough for keeping the Boc group. The 
selective coupling between 26 and an amino group in PEG12 was achieved by firstly 
preactivating 26 with DCC and NHS, and then reacting with the amine group in the presence 
of carboxylate group (Brunsveld et al., 2005). Such a two-step strategy is efficient (normally 
yield > 80%) for following coupling reactions. Finally, the Boc group was deprotected to give 
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30 and 31 for subsequent coupling reaction. An N-terminal fragment 33 was prepared 
separately. The coupling of 33 and 30 or 31 gave the final linkers with protected ketones. 
Surprisingly, the deprotection of ketones in 34 or 35 becomes more difficult than that in 24 or 
25. I could not remove the protection group in normal condition (5% TFA in CH2Cl2). Finally, 
the deprotection condition was optimized as 50% TFA in CH2Cl2 for overnight reaction. The 
ketone group in these long and flexible PEG-3 linkers (36, 37) could be schielded from the 
deprotection reaction, and this point is further supported by their very slow oxime ligation.  
 
Figure 3.51. a) Design of Rab7-GGS-PEG1-CC. b) and c) LCMS spectra of the 
semisynthesis protein probe and its prenylation product based on GGPP. The prenylation 
condition was similar with that for Rab7-PEG1-CC. d) Reaction kinetics of the in vitro 
prenylation by an end-point assay based on NBD-FPP. 
  The oxime ligation between oxyamine-modified proteins and 36 or 37 cannot be achieved 
based on the establishment ligation conditions (data not shown). On the other hand, the 
protein expression and purification of Rab7Δ34-thioester were highly problematic. Though 
the Rab7Δ34-intein protein was soluble, the Rab7Δ34-thioester was unstable and precipitated 
during purification procedures. I have met a similar case in the protein purification of Ran1-178, 
a C-terminal deleted construct of Ran. The C-terminal amino acids of Rab GTPases could 
contribute to the protein stability. We then re-consider the experimental design, since it looks 
very difficult to achieve the ligation of Rab7Δ34 and PEG-3 linkers.  
  Consequently, we try to use a non-specific sequence linker (Pedersen, et al., 1998), (GGS)n, 
to replace the C-terminal hypervariable region before the CIM motif. As shown in Figure 
3.52a, we aim to use (GGS)n-VKL-PEG1-CC to replace the C-terminal 35 amine acids of 
Rab7 and other Rabs. The successful semisynthesis of the protein probe Rab7Δ34-(GGS)n-
VKL-PEG1-CC is indicated by LCMS (Figure 3.51b) and SDS-PAGE. Prenylation of 
Rab7Δ34-(GGS)n-VKL-PEG1-CC using GGPP led to the double-geranylgeranylated protein 
as indicated by LCMS result (Figure 3.51c). Using NBD-FPP, this protein probe displayed a 
little faster prenylation efficiency than that of the wild type Rab7. These results imply that the 
Rab C-terminal hypervariable region besides CIM motif does not encode Rab prenylation 
signal specificity. 
  The study presented here further elaborated the model for Rab prenylation. The specificity of 
Rab prenylation machinery is conferred by three binding interfaces, including GTPase domain 
and CIM of Rab with REP and RabGGTase with REP. Once the ternary protein complex is 
established, Rab C-terminus is concentrated within the micro-environment of the ternary 
complex, thus, enhances the chances of C-terminal cysteines or even thiols reaching the active 
site of RabGGTase. Rab C-terminal hypervariable sequence upstream and downstream the 
CIM does not contribute specificity and binding energy to the assembly of ternary protein 
complex. As a consequence, Rab protein substrate specificity does not need to be encoded in 
the prenylatable C-terminus. The model is consistent with the fact that RabGGTase has 
essentially no sequence preference for the context of the prenylatable cysteines, and the C-
terminal sequences occurring in Rab GTPases include CC, CXC, CCX, CCXX, CCXXX, and 
CXXX (Pereira-Leal et al., 2001). Hence any cysteine-containing fragment, even any thiol-
containing fragment, which can properly present the thiols into the active site of RabGGTase, 
is able to undergo prenylation. This point is proved by our results that Rab C terminus 
replaced by a thiol-containing chemical linker did not affect its in vitro prenylation efficiency. 
The very flexible prenylation ability of RabGGTase prenylation machine allows it to process 
a family of over 60 Rab proteins with hypervariable C-terminal sequences, a feature that is 
uncommon in protein-modifying enzymes. In this study, we further find that using (GGS)n-
VKL-PEG1-CC to replace the C-terminal 35 amino acids of Rab7 did not influence 
prenylation by RabGGTase. Therefore, the unique feature of Rab prenylation machinery 
enables it to process unnatural Rab C-terminal moieties that contain cysteines or thiols. Based 
on this study, it is also possible to produce di-gernaylgeranyled peptides by using a cleavable 
linker at the Rab C-terminus.  
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3.5.5. Synthesis of GFP-tagged Rab probes for studying membrane 
targeting   
  The next question we are interested in is whether the C-terminal hypervariable region of Rab 
proteins contributes to Rab subcellular localization. We intended to use the semisynthesis 
protein probes to address this point. EGFP is tagged to Rab N-terminus as a fluorescent 
indicator, since it is reported that such tagging do not interfere Rab localization and function 
in living cells (Ali et al., 2004). In this work, we produced a series of EGFP-tagged Rab 
proteins (Rab1, Rab5, Rab7, Rab8, Rab35) without the flexible C-terminal sequence. The 
expressed Rab proteins were ligated with chemical linkers 24 and 25 as described above 
(Figure 3.52a-c). All semisynthesis proteins were characterized by LCMS spectra (Table 3.1) 
and SDS-PAGE, indicating the successful preparation of these protein probes. 
Table 3.1. LCMS results of Rab protein probes used in this study. (calculation mass) 
Protein (P) P-COSR P-ONH2 P-PEG1 P-PEG1-CC P-PEG1-
C(GG)C(GG) 
P-PEG2-SH P-PEG2-
S(GG) 
Rab7Δ15 
 
21974 
(21972) 
21926 
(21922) 
22792 
(22789) 
22617 
(22613) 
23162 
(23157) 
22508 
(22500) 
22777 
(22772) 
EGFP-Rab1 Δ13 49732 
(49752) 
49683 
(49702) 
50553 
(50569) 
50378 
(50393) 
 50271 
(50280) 
 
EGFP-Rab5 Δ14 50001 
(50019) 
49954 
(49969) 
   50545 
(50547) 
 
EGFP-Rab5-Q79L-Δ14 49988 
(50004) 
49943 
(49954) 
50798 
(50821) 
  50520 
(50532) 
 
EGFP-Rab7 Δ15 50889 
(50905) 
50836 
(50855) 
51707 
(51722) 
51532 
(51546) 
 51459 
(51433) 
 
EGFP-Rab8 Δ13 49659 
(49652) 
49602 
(49602) 
   50168 
(50180) 
 
EGFP-Rab35 Δ11 50527 
(50542) 
50481 
(50492) 
51346 
(51359) 
51170 
(51183) 
   
Rab7Δ34-(GGS)n-
VKL-GG 
 
21135 
(21131) 
21086 
(21081) 
21954 
(21948) 
21779 
(21772) 
22321 
(22316) 
  
EGFP-Rab1 Δ31-
(GGS)n-VKL-GG 
49122 
(49134) 
49078 
(49084) 
49938 
(49951) 
49775 
(49975) 
   
EGFP-Rab5-Q79L-Δ35-
(GGS)n-VKL-GG 
49186 
(49191) 
49150 
(49140) 
50007 
(50007) 
49834 
(49834) 
   
EGFP-Rab7 Δ34-
(GGS)n-VKL-GG 
49025 
(49037) 
48977 
(48987) 
49841 
(49855) 
49678 
(49679) 
   
 
  All EGFP-tagged Rab probes were tested for in vitro prenylation reaction through 
incorporation of NBD-FPP to Rabs resolved by SDS-PAGE. As shown in Figure 3.52d, 
strong fluorescence of the semisynthesis Rab probes can be observed in SDS-PAGE, while in 
the case of pure EGFP-tagged Rabs, only weak fluorescence is indicated by the fluorophore of 
EGFP. All Rab probes can be prenylated based this fluorescence assay. These results imply 
that Rab probes were efficiently prenylated in vitro, and again indicate that the RabGGTase 
machine is indeed very flexible for protein prenylation.  
  
Figure 3.52. a)-c) Design of EGFP-tagged Rab probes. d) The activity of semisynthesis 
protein probes EGFP-Rab-(GGS)n-PEG-1-CC were confirmed by in vitro prenylation 
reaction through incorporation of NBD-FPP to Rab resolved by SDS-PAGE (left: scan from a 
laser fluorescent image reader excitation at 473 nm; right: photograph in visible light after 
Coomassie blue staining). Lanes 1, 3, 5: pure Rab1, Rab5, Rab7 proteins as negative control; 
Lanes 2, 4, 6: prenylation reaction samples of Rab1, Rab5, Rab7 proteins, respectively; Lane 
7, prenylation reaction sample of Rab7 wide type; Lane M: marker 97, 66, 45, 30, 20.1, 14.4 
KD. 
  These semisynthetic Rab probes were further microinjected into living HeLa cells for in vivo 
prenylation and localization studies (Figure 3.53, this work was performed by Fu Li in Wu’s 
group). The plasmids of cherry-tagged wide-type Rab proteins were transfected as positive 
control. The steady-state localization of the microinjected proteins was determined by means 
of confocal fluorescence microscopy and compared to the localization of transfected cherry-
tagged Rabs. The co-localization results are Rab-dependent.  
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Figure 3.53. Subcellular distribution of various Rab family small GTPases in HeLa cells 
(provided by Fu Li in Wu’s group). Semisynthesis protein represents EGFP-Rab-PEG1-CC or 
EGFP-Rab-PEG2-SH (Rab8); wide-type protein represents transfected mCherry-Rab.      
  A steady-state distribution comparable to native Rab1 protein could be observed for the 
EGFP-Rab1-PEG1-CC probe, which localize with wild type at the Golgi apparatus. This 
result implies that the C-terminal hypervariable region of Rab1 do not encode membrane-
targeting signal. The recent research in Goody’s group indicates that a RabGEF DrrA can 
dissociate Rab1:GDP:GDI complex efficiently (Schoebel et al., 2009), suggesting that 
RabGEF may play a key role in Rab1 membrane targeting. This point is consistent with our 
finding that the semisynthetic Rab1 probes can co-localize with wide-type Rab1, namely, the 
Rab1 localization is determined by RabGEF rather then Rab C-terminal sequence. The 
successful co-localization of semisynthetic protein probes and wide-type proteins also implies 
that these protein probes can be prenylated in vivo, considering the fact that Rab proteins 
without C-terminal prenylation cannot target to membranes (Gomes et al., 2003; Calero et al., 
2003). 
  For further functional studies, a Rab5Q79L mutant was selected because this Q79L mutant 
was found mainly in the GTP-bound form in vivo (Stenmark et al., 1994). Expression of 
Rab5Q79L is known to cause formation of enlarged early endosomes. Therefore, this 
phenotype can be used to indicate the biological activity of semisynthetic Rab probes. We 
found that EGFP-Rab5Q79L-PEG-CC probe could co-localize with mCherry-Rab5Q79L and 
induce appearance of unusually large early endocytic structures (Figure 3.53). The 
replacement of flexible C-terminus of Rab5 with chemical linkers did not perturb Rab 
functionality in living cells.  
  However, while in the case of Rab7, Rab8 and Rab35, the semisynthesis Rab probes and 
wide-type proteins have different distribution in cells (Figure 3.53). For Rab35, replacement 
of the polybasic sequence with the PEG linker may disrupt the electrostatic interaction with 
the PIPs lipids on the PM, leading to mistargeting of Rab35 from the PM to the Golgi (Heo et 
al., 2006). For Rab7, we found that the C-terminal hypervariable sequence before CIM is 
essential for targeting to late endosome or lysoyomes (from Fu Li’s data in Wu’s group). 
Further study is needed to fully understand the contribution of C-terminal sequence of Rab7 
and Rab8 for membrane targeting.  
3.5.6. Conclusion    
  In conclusion, we have used a facile method of oxime ligation to produce a series of 
PEGylated Rab protein probes for prenylation and localization studies. The replacement of 
Rab C-terminal peptide with an unnatural PEG moiety did not perturb Rab prenylation in 
vitro and in vivo. These results further elucidated the mechanism of Rab prenylation, i.e. there 
is no specificity required in Rab C-terminus hypervariable regions before and after the CIM 
motif for Rab prenylation. Using these Rab probes, we further investigated the issue that 
whether the C-terminal hypervariable region contributes to Rab targeting. We found that the 
membrane targeting mechanisms for Rab-family proteins are more complex than previous 
proposal. For several Rab proteins, the C-terminal hypervariable regions do not contribute to 
the membrane targeting. However, the replacement of C-terminal sequence with chemical 
linkers in several Rab proteins disrupted Rab membrane targeting, implying that in these Rab 
proteins the C-terminal sequence is important for biological function. Further work is needed 
to fully understand membrane targeting mechanisms of various Rab proteins. 
 
   
107 
 
 
 
 
4. Summary  
 
 
 
 
 
 
 
“An expert is a man who has made all the mistakes which can be made, 
 in a narrow field.” 
 
Niels Bohr 
 
 
 
 
4.  Summary  
  The development of methods for the chemical ligation of synthetic small molecules or 
peptides to proteins is a current frontier in chemical biology. Expressed protein ligation (EPL) 
has been extremely useful for the synthesis of various proteins in the past. In particular the 
concept of EPL elegantly demonstrates the usefulness of combining the fields of synthetic 
organic chemistry and molecular biology in order to address complex physiological and 
biochemical questions. The present study aimed at two facets: 1) establish several universal 
strategies to extend the EPL technology for site-specific protein modification and 
immobilization; 2) adapt the EPL methodology to the semi-synthesis of Rab proteins probes, 
which exert many important functions during vesicular transport in eukaryotic cells.  
  Firstly, we developed a facile, efficient and mild strategy for the site-specific immobilization 
of proteins on surfaces by means of oxyamine ligation to generate protein microarrays. In our 
strategy the proteins are first readily modified with oxyamine groups at the C-terminus and 
then immobilized on ketone-coated slides. This immobilization strategy proceeds efficiently 
at neutral conditions (pH 7.0), and is exceptionally mild for protein immobilization in 
comparison to other methods. Furthermore, this strategy enables the direct immobilization of 
expressed proteins from crude cellular lysates without prior purification. The produced 
protein biochips can be used for the study of protein-protein interactions, as indicated by Rab-
REP and PKA-antibody interaction studies. Our strategy expands the repertoire of protein 
immobilization methods and provides an alternative means to meet the various requirements 
for protein immobilization. 
  Secondly, we presented the principle of using two chemoselective reactions to site-
specifically label a single protein in a one-pot reaction. We developed a general, facile and 
efficient strategy for N- and C-terminal dual-color labeling exemplified for the Rab7 protein 
using native chemical ligation and oxime ligation. The method is low in cost and easy to carry 
out. The reaction conditions are biocompatible and mild enough for protein modifications. 
The strategy presented here could be a general method for generating dual-labeled proteins, 
which could also have a wide range of applications for studying protein functions at the single 
molecule and cellular level. We have shown the the produced protein probe can be used to 
study protein refolding and protein-protein interactions by FRET studies. This study leads to 
the finding that both GDP and GppNHp can help GTPase to refold, and therefore point out a 
way to produce GppNHp-bound GTPase as indicated by successful semisynthesis of a RhoA-
GG protein. 
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  Thirdly, we presented the principle of a FRET strategy for monitoring GEF-mediated 
nucleotide exchange using site-specifically labeled GEF and GTPase proteins. Using NCL 
and oxime ligation, we prepared N-terminal coumarin-labeled GEFs and C-terminal 
fluorescein-labeled GTPases. We constructed the coumarin-GEF:GTPase-fluorescein 
complex, which showed a significant intermolecular FRET effect. The FRET signal was 
disrupted by binding of GDP or GTP and allowed direct detection of the GEF:GTPase 
interaction. Transient kinetic studies based on the FRET signal change were used to monitor 
the GEF activity and nucleotide binding. The studies led to a consistent conclusion on the 
GEF mechanism involving allosteric competition between GDP/GTP and GEF’s interaction 
with a GTPase. The strategy presented here could be a general method that is applicable to 
other GEFs and GTPases, and may open up a new avenue for the identification of GEF 
inhibitors and for studying GEF mechanisms. 
  Fourthly, we presented a general strategy using tandem EPL and click chemistry to site-
specifically install hydrophobic GerGer modifications into proteins. The two-step ligation is 
quantitative, which makes the purification of ligated protein much facile. The approach 
yielded correctly folded and functional geranylgeranylated Rab GTPases, as could be inferred 
by their ability to interact with REP as well as to accept the second GerGer group in 
prenylation. The ligation strategy may open up a new avenue for production of lipoproteins 
that are used in various biological studies. 
  Finally, we have used a facile method of oxime ligation to produce a series of PEGylated 
Rab protein probes for prenylation and localization studies. The replacement of Rab C-
terminal region with an unnatural PEG moiety did not perturb Rab prenylation in vitro and in 
vivo. These results further elucidated the mechanism of Rab prenylation, i.e. there is no 
specificity required in Rab C-terminus hypervariable regions before and after the CIM motif 
for Rab prenylation. Using this series of Rab probes, we further investigated the issue that 
whether the C-terminal hypervariable region contributes to Rab targeting. We found that the 
membrane targeting mechanisms for Rab-family proteins are more complex then previous 
propose. For Rab1 and Rab5, the C-terminal hypervariable regions do not contribute to the 
membrane targeting. However, the replacement of C-terminal sequence with chemical linkers 
in several Rab proteins indeed disrupt their membrane targeting, implying that in these Rab 
proteins the C-terminal hypervariable region is important for biological function. This work 
provides an example of chemical tools can be used to challenge native biomolecular functions, 
leading to better understanding the Rab prenylation and targeting mechanisms.  
4.  Summary (german) 
Die Entwicklung von Methoden für die chemische Ligation von synthetischen kleinen 
Molekülen oder Peptiden, Proteinen ist eine aktuelle Grenze in der chemischen Biologie. 
Exprimierte Protein-Ligation (EPL) war äußerst nützlich für die Synthese von verschiedenen 
Proteinen in der Vergangenheit. Insbesondere das Konzept der EPL elegant zeigt den Nutzen 
der Kombination der Felder der synthetischen organischen Chemie und Molekularbiologie, 
um komplexe physiologische und biochemische Fragen anzugehen. Die vorliegende Studie an 
zwei Facetten einzuführen: 1) herzustellen mehrere universale Strategien, um die EPL-
Technologie für eine ortsspezifische Proteinmodifikation und Immobilisierung erstrecken; 2) 
Anpassung der EPL Methodik auf die Halbsynthese Rab Proteine Sonden, die mehrere 
wichtige Funktionen ausüben während vesikulären Transport in eukaryotischen Zellen. 
  Erstens haben wir eine einfache, effiziente und leichte Strategie für die ortsspezifische 
Immobilisierung von Proteinen an Oberflächen durch Ligation an Oxyamingruppe 
Proteinmikroarrays erzeugen. In unserer Strategie die Proteine werden zunächst leicht mit 
Oxyamingruppe Gruppen am C-Terminus modifiziert und anschließend immobilisiert auf 
Keton-beschichtete Objektträger. Diese Immobilisierung Strategie effizient verläuft bei 
neutralen Bedingungen (pH 7,0), und ist besonders mild zur Immobilisierung von Proteinen 
im Vergleich zu anderen Methoden. Darüber hinaus ermöglicht diese Strategie die direkte 
Immobilisierung von exprimierten Proteinen aus rohem Zelllysaten ohne vorherige Reinigung. 
Die produzierten Protein Biochips können für die Untersuchung von Protein-Protein-
Wechselwirkungen, wie durch Rab-REP und PKA-Antikörper-Wechselwirkung Studien 
gezeigt verwendet werden. Unsere Strategie erweitert das Repertoire der Immobilisierung von 
Proteinen Methoden und bietet eine alternative Möglichkeit, um die verschiedenen 
Anforderungen für die Immobilisierung von Proteinen erfüllen. 
  Zweitens haben wir das Prinzip der Verwendung von zwei chemoselektive Reaktionen auf 
ortsspezifisch kennzeichnen ein einzelnes Protein in einer Eintopfreaktion. Wir entwickelten 
einen allgemeinen, einfache und effiziente Strategie für die N-und C-terminalen zweifarbige 
Kennzeichnung für das Protein unter Verwendung Rab7 native chemische Ligation und Oxim 
veranschaulicht. Das Verfahren ist kostengünstig und einfach durchzuführen. Die 
Reaktionsbedingungen sind biokompatibel und mild genug für die Protein-Modifikationen. 
Die Strategie hier vorgestellte könnte ein allgemeines Verfahren zur Erzeugung doppelt 
markierte Proteine, die ebenfalls könnte eine Vielzahl von Anwendungen zum Studium 
Proteinfunktionen am einzigen Molekül und zellulärer Ebene. Wir haben gezeigt, das das 
gebildete Protein-Sonde verwendet werden, um Protein-Umfaltung und Protein-Protein-
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Wechselwirkungen durch FRET-Untersuchungen zu untersuchen. Diese Studie führt zu der 
Erkenntnis, dass sowohl BIP als auch GppNHp kann GTPase helfen, falten, und deshalb 
darauf, einen Weg zu GppNHp-gebundenen GTPase, wie sie durch erfolgreiche Semisynthese 
eines RhoA-GG Protein angegeben. 
  Drittens haben wir das Prinzip einer FRET-Strategie für die Überwachung GEF-vermittelten 
Nukleotid-Austausch mit Website-spezifisch markierten GEF und GTPase-Proteine. 
Verwendung NCL und Oxim bereiteten wir N-terminalen Cumarin-markierten GEFs und C-
terminalen fluoresceinmarkierten GTPasen. Wir konstruierten die Cumarin-GEF:GTPase-
Fluorescein-Komplex, der eine signifikante intermolekulare FRET-Effekt zeigte. GTPase 
Interaktion: das FRET-Signal wurde durch Bindung von GDP oder GTP und erlaubt den 
direkten Nachweis des GEF gestört. Transient kinetische Studien zur FRET Signaländerung 
bezogen wurden verwendet, um die Aktivität und GEF Nukleotidbindung überwachen. Die 
Untersuchungen führten zu einer konsistenten Rückschluss auf die GEF Mechanismus mit 
allosterischen Wettbewerb zwischen GDP / GTP und GEF die Interaktion mit einer GTPase. 
Die vorgestellte Strategie könnte hier eine allgemeine Methode, die für andere GEFs und 
GTPasen ist, und kann eröffnen einen neuen Weg für die Identifizierung von GEF-Inhibitoren 
und für das Studium GEF-Mechanismen. 
  Viertens stellten wir eine allgemeine Strategie mit Tandem EPL und klicken Chemie 
ortsspezifisch installiert hydrophoben Gerger Modifikationen in Proteine. Das zweistufige 
Ligation ist quantitativ, wodurch die Reinigung des Proteins wesentlich ligierten facile. Der 
Ansatz ergab korrekt gefaltete und funktionelle geranylgeranyliert Rab GTPasen, wie durch 
ihre Fähigkeit, mit REP sowie interagieren, um die zweite Gruppe in Gerger Prenylierung 
akzeptieren abgeleitet werden könnten. Die Ligation kann eröffnen einen neuen Weg zur 
Herstellung von Lipoproteinen, die in verschiedenen biologischen Studien verwendet werden. 
  Schließlich haben wir ein einfaches Verfahren von Oxim Ligierung, um eine Reihe von 
PEGyliertem Rab-Protein-Sonden für Prenylierung und Lokalisationsstudien produzieren. Der 
Ersatz von Rab C-terminalen Region mit einer unnatürlichen PEG-Gruppierung nicht stören 
Rab Prenylierung in vitro und in vivo. Diese Ergebnisse den Mechanismus aufgeklärt Rab 
Prenylierung, dh es besteht keine Spezifität in Rab C-Terminus hypervariablen Regionen vor 
und nach dem Motiv für CIM Rab Prenylierung erforderlich. Mit diesen Reihe von Sonden 
Rab wir weiter untersucht, ob das Problem, dass die C-terminalen hypervariablen Bereich 
nach Rab Targeting beiträgt. Wir fanden, dass die Membran Targeting-Mechanismen für die 
Rab-Proteine Familie komplizierter als in früheren schlagen sind. Für Rab1 und Rab5, werden 
die C-terminalen hypervariablen Regionen nicht an die Membran-Targeting beitragen. 
Allerdings ist die Ersetzung der C-terminalen Sequenz mit chemischen Linker in mehreren 
Rab Proteine tatsächlich stören ihrer Membran-Targeting, was bedeutet, dass in diesen Rab-
Proteine der C-terminalen hypervariablen Region ist wichtig für biologische Funktion. Diese 
Arbeit stellt ein Beispiel für chemische Werkzeuge verwendet werden, um einheimische 
biomolekularen Funktionen anzufechten, was zu einem besseren Verständnis der Rab 
Prenylierung und Targeting-Mechanismen. 
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5. Materials and Methods 
 
 
 
 
 
“Scientific knowledge aims at being wholly impersonal.” 
 
Bertrand Russell 
 
 
  
 
5. Materials and Methods 
5.1. General methods 
Silica gel flash liquid chromatography: 
Purifications were performed using silica gel from J. T. Baker or Merck (particle size 40-60 
μm) under approximately 0.5 bar pressure. 
Nuclear magnetic resonance spectroscopy (NMR): 
1H- and 13C-NMR spectra were recorded using a Varian Mercury 400 spectrometer (400 
MHz, 1H and 100 MHz, 13C). Chemical shifts are expressed in parts per million (ppm) from 
internal deuterated solvent standard (CDCl3: δH = 7.26 ppm, δC = 77.0 ppm; CD3OD: δH = 
4.84 ppm, δC = 49.05 ppm; d6DMSO: δH = 2.50 ppm, δC = 39.43 ppm; D2O: δH = 4.79 ppm). 
Coupling constants (J) are given in Hertz (Hz) and the following notations indicate the 
multiplicity of the signals: s (singlet), d (doublet), t (triplet), dd (doublet of doublet), m 
(multiplet), br (broad signal). 
Electronspray ionization mass spectrometry (ESI-MS): 
Electrospray mass spectrometric analyses (ESI-MS) were performed on a Finnigan LCQ 
spectrometer. Calculated masses were obtained using the software ChemDraw Ultra 
(CambridgeSoft Corporation) or Xcalibur. 
Reversed-phase liquid chromatography-ESI (LCMS) for small molecules: 
LCMS measurements were carried out on a Hewlett Packard HPLC 1100/Finnigan LCQ mass 
spectrometer system using Nucleodur C18 Gravity, Nucleosyl 100-5 C18 Nautilus (Macherey-
Nagel) or Jupiter C4 (Phenomenex) columns and detection at 215 and 254 nm. 
Method A: Positive linear gradients of solvent B (0.1% formic acid in acetonitrile) and 
solvent A (0.1% formic acid in water) were used at 1 mL/min flow rate. 
Method B: Negative linear gradients of solvent B (10 mM NH4OH in acetonitrile) and solvent 
A (10 mM NH4OH in water) were used at 1 mL/min flow rate. 
Method C: Positive linear gradients of solvent B (0.1% formic acid and 5% THF in methanol) 
and solvent A (0.1% formic acid in water) were used at 1 mL/min flow rate. 
Method D: Negative linear gradients of solvent B (10 mM NH4OH and 5% THF in methanol) 
and solvent A (10 mM NH4OH in water) were used at 1 mL/min flow rate. 
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Analytical reversed-phase high performance liquid chromatography (HPLC) for small 
molecules: 
Analyses were performed on a Varian prostar system using CC 125/4 Nucleodur C4 Gravity 
columns (Macherey-Nagel), autosampler prostar 410 and UV/Vis detector with Varian prostar 
335. Linear gradients were used at 1 mL/min flow rate (A: water, B: acetonitrile, C: 2% TFA 
in water). 
Method: 
95% A            95% A              15% A          10% A          10% A          95% A           95% A              
Preparative reverse-phase high performance liquid chromatography (prep HPLC): 
Purification of compounds was performed on an Varian Prostar system using VP 250/21 
Nucleodur C4 Gravity 5 mm column (Macherey-Nagel), fraction collector prostar 701 and 
detection at 220 ~ 240 nm with UV/Vis prostar 340. Linear gradients of solvent A (water) and 
solvent B (acetonitrile) were used at 6 mL/min flow rate. 
Method: 
90% A            90% A              20% A          10% A          10% A          95% A           95% A              
Thin layer chromatography (TLC): 
TLC was carried out on Merck precoated silica gel plates (60F-254) using ultraviolet light 
irradiation at 254 nm and 360 nm or the following solutions as developing agents:  
Staining  solution A: molybdatophosphoric acid (25 g) and cerium (IV) sulfate (10 g) in 
concentrated sulfuric acid (60 mL) and water (to 1 L); 
Staining solution B: (for detection of free amino groups): ninhydrin (300 mg) in ethanol (100 
mL) and acetic acid (3 mL). 
Staining solution C: KMnO4 (1 g), K2CO3 (6.6 g), 5% NaOH solution (1.7 mL) in H2O (to 
100 mL). 
MALDI-TOF-mass spectrometry: 
MALDI spectra were recorded on a Voyager-DE Pro Biospectrometry workstation from 
Applied Biosystems (Weiterstadt, Germany). Protein samples were desalted using small GF 
spin columns (Quiagen, Hilden, Germany) and mixed with an equal volume of sample matrix 
(10 mg/mL sinapinic acid or 2,5-dihydroxybenzoic acid in water/acetonitril (1:1) containing 
0.1 % (v/v) TFA). The mixture was quickly spotted on a MALDI sample plate, air-dried and 
spectra were measured with the following device settings: acceleration voltage = 25 kV, grid 
1 min 10 min 2 min 7 min 2 min 3 min 
5 min 15 min 2 min 3 min 2 min 3 min 
voltage = 93%, extraction delay time = 750 ns and guide wire = 0.3%. The laser intensity was 
manually adjusted during the measurements in order to obtain optimal signal to noise ratios. 
Calibrations were carried out using a protein mixture of defined molecular mass (Sigma). 
Spectra recording and data evaluation was performed using the supplied Voyager software 
package. The accuracy of the method for proteins within the molecular weight range of 20-
30 kDa is ca. ± 20. 
LCMS measurements for proteins: 
LCMS analysis was performed on an Agilent 1100 series chromatography system (Hewlett 
Packard) equipped with an LCQ electrospray mass spectrometer (Finnigan, San Jose, USA) 
using Jupiter C4 columns (5 µm, 15 x 0.46 cm, 300 Å pore-size) from Phenomenex 
(Aschaffenburg, Germany). For LC-separations a gradient of buffer B (0.1 % formic acid in 
acetonitrile) in buffer A (0.1% formic acid in water) with a constant flow-rate of 1 mL/min 
was employed. Upon sample injection, a ratio of 20% buffer B was kept constant for 4 min. 
Elution was achieved using a linear gradient of 30-80% buffer B in buffer A for 5-15 min 
followed by a steep gradient (70-90% buffer B) for 15-17 min. The column was extensively 
flushed for 17-19 min with 90-10% buffer B. Data evaluation and deconvolution was carried 
out using the Xcalibur software package. The accuracy of the method for proteins within the 
molecular weight range of 20 kDa is ca. ± 5 Da; 50 KDa is ca. ± 20 Da. 
Analytical reversed-phase (RP) and gel filtration (GF) HPLC for proteins: 
Analytical RP and GF chromatography were performed on a Waters 600 chromatography 
instrument equipped with a Waters 2475 fluorescence detector and a Waters 2487 absorbance 
detector (Waters, Milford, MA, USA). Jupiter C4 columns (5 µm, 15 x 0.46 cm, 300 Å pore-
size) from Phenomenex (Aschaffenburg, Germany) were used for RP separations, whereas 
Biosep-SEC-2000 columns (60 x 0.78 cm, separation range 1300 kDa, Phenomenex) were 
used for gel filtration. Chromatographic GF separations were normally performed using 
50 mM sodium phosphate, pH 7.2, 50 mM NaCl, 2 mM DTE, 10 µM GDP, 1 mM MgCl2 as a 
running buffer at a flow rate of 0.5 mL/min. Separation was usually complete within 60 min. 
For RP separations the following gradient of buffer B (0.1% TFA in acetonitrile) in buffer A 
(0.1% TFA in water) at a flow rate of 1 mL/min was used: The column was equilibrated with 
5% buffer B in buffer A. Upon sample injection this ratio was kept isocratic for 2 min 
followed by a linear gradient (5-30% buffer B) over another 2 min. Individual components 
eluted upon a linear gradient (30-70% buffer B) over 10 min and another isocratic phase (70% 
   
117 
 
buffer B) of 4 min. Afterwards the column was flushed for at least 10 min with 100% buffer B 
in order to elute hydrophobic compounds (e.g. geranylgeranylated peptides). Data analysis 
was carried out using the Millenium software package provided by Waters. 
Denaturing SDS-PAGE: 
Typically 15 % SDS-PAGE gels were used for the analysis of proteins (MW of ca. 20-
60 kDa). The corresponding volumes of the individual components as indicated by Table 5-1 
were mixed and the resolving gel was cast using a Biorad Multi-casting apparatus (10 gels). 
After the resolving gel was polymerized, a stacking gel mix was prepared and cast atop the 
resolving gel. Protein samples were prepared by adding an equal amount of SDS-PAGE 
sample buffer (2 x) and heated for 5 min at 95 °C. Gels were run at ca. 10 V/cm until the 
bromphenol blue front had entered the buffer solution. Fluorescently labeled proteins were 
visualized by exposing the unstained SDS-PAGE gel to UV light. The proteins were 
subsequently stained using a solution of Coomassie brilliant blue. 
Type of gel 
(%) 
Acrylamide/ 
bisacrylamid
e (29:1, 30%) 
ddH2O 
Resolving 
gel buffer 
Stacking 
gel buffer 
TEME
D 
10% 
APS 
Resolving gel, 70 mL 
10% 23.5 mL 27.6 mL 17.1 mL --- 29 µL 700 µL 
15% 34.2 mL 15.7 mL 17.1 mL --- 29 µL 700 µL 
Stacking gel, 30 mL 
5% 4.9 mL 20 mL --- 3.7 mL 300 µL 29 µL 
Table 5-1. Pipeting scheme for SDS-PAGE gels. TEMED = N,N,N´,N´-tetramethylethylendiamine; APS = 
ammoniumpersulfate.  
Ion exchange chromatography: 
Poros HQ (PerSeptive Biosystem) and HiTrap Q Sepharose (Amersham Biosciences) anion-
exchange columns were used for ion exchange chromatography. The columns were washed 
with buffer A (10 mM NaH2PO4, pH 7.5, 2 M NaCl, 1 mM MgCl2) and subsequently 
equilibrated with buffer B (10 mM NaH2PO4, pH 7.5, 10 mM NaCl, 1 mM MgCl2, 5 mM 
MESNA). The proteins were loaded onto the column and eluted with a linear gradient from 
10 mM (buffer B) to 500 mM NaCl (buffer C: 10 mM NaH2PO4, pH 7.5, 500 mM NaCl, 1 
mM MgCl2, 5 mM MESNA). 
5.2. Solvents and reagents 
Solvent and reagent purification 
The reagents were purchased from Acros Chimica, Aldrich, Fluka, Merck, Novabiochem, 
Riedel de Haen, Roth. The carboxy-PEGn-amine reagents (n = 8 and 12) were purchased from 
Thermo scientific (www.thermoscientific.com). Deionized water was obtained using a 
Millipore Q-plus System. Dichloromethane, acetonitrile, 2,6-lutidine, DIPEA and 
triethylamine were refluxed and distilled from CaH2 under argon and stored with KOH. 
Acetonitrile, xylene and DMF were stored with molecular sieves 4 Å. Absolute ethanol was 
refluxed with Mg and I2 under argon and distilled, then stored with molecular sieves 4 Å. 
Other anhydrous solvents like ethyl acetate, diethylether, DMF, MeOH, toluene and pyridine 
were directly purchased from Sigma or Fluka. Acetic anhydride was redistilled. 
Frequently used buffers and growth media 
LB medium      SDS-PAGE running buffer (10 x) 
0.5% (w/v)   yeast extract    0.25 M Tris-HCl    
1% (w/v) tryptone    2 M glycine 
1% (w/v) NaCl     1% (w/v) SDS 
 
SDS-PAGE stacking gel buffer   SDS-PAGE resolving gel buffer 
0.5 M  Tris-HCl, pH 6.8   1.5 M   Tris-HCl, pH 8.8 
0.4% (w/v) SDS      0.4% (w/v) SDS 
 
SDS-PAGE loading buffer (2 x)   Coomassie stain solution 
100 mM  Tris-HCl, pH 6.8   10% (v/v)  acetic acid 
4% (w/v) SDS     40% (v/v)  methanol 
20% (v/v) glycerol    0.1% (w/v) Coomassie Blue  
200 mM  DTT       R250 
0.05% (w/v) bromophenol blue 
 
Coomassie destain solution               TAE buffer   
10% (v/v) acetic acid    40 mM  Tris acetate   
50% (v/v) methanol    2 mM   EDTA 
PBS (10 x)      DNA loading buffer (5 x)   
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80 g  NaCl     10%   Ficoll 400 
2 g    KCl     50 mM  Na2EDTA, pH 8.0 
14.4 g   Na2HPO4 ⋅ 2H2O   0.05% (w/v)  SDS 
2.4 g  KH2PO4    0.15% (w/v) bromphenol blue  
ddH2O to 1 L      0.15% (w/v) xylene cyanol (optional) 
5.3. Preparations of chemicals 
 
Bis(oxyamine) 1 (Bauer et al., 1963): A mixture of N-hydroxyphthalimide (3.3 g, 0.02 mol) 
in dimethylformamide (DMF, 20 mL), ethylene bromide (1.9 g, 0.01 mol), triethylamine 
(Et3N, 4 g, 0.04 mol) and a catalytic amount of tetramethyl ammonium iodide was allowed to 
react at 60 °C for 3 h. The precipitate that had formed was filtered off and washed with small 
amount of DMF and water for several times. The white product was mixed with glacial acetic 
acid (10 mL) and concentrated HCl (20 mL). The resulting suspension was refluxed for 1 h. 
On cooling, the filtrate was concentrated to totally remove the solvent. The residue was 
washed with chloroform, filtered, and crystallized from methanol-chloroform to give 320 mg 
white crystals 1, yield 20% over two steps. 1H NMR (400 MHz, D2O) δ 3.31-3.29 (m, 4H). 
13C NMR (100 MHz, D2O) δ 72.42. ESI-MS for [M+H]+: 93.00 (calculated for C2H9N2O2, 
93.07).  
 
Keto-coumarin 2 (Sethna et al., 1945): A mixture of salicylaldehyde (0.13 g, 1.1 mmol), α-
angelica lactone (0.098 g, 1 mmol) and 1 mL Et3N in CH2Cl2 (30 mL) was refluxed for 1 h. 
The reaction mixture was diluted in CH2Cl2 and washed with 1 M HCl, water and brine. The 
organic layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure to 
give a crude mixture. The product was purified by flash chromatography on silica gel with 
pentane-EtOAc (2:1) as eluent to yield the desired product as a light yellow solid (155 mg; 
yield 77%). 1H NMR (400 MHz, CDCl3) δ 7.58 (s, 1H), 7.51-7.39 (m, 2H), 7.33-7.18 (m, 2H), 
3.66 (s, 2H), 2.29 (s, 3H). ESI-MS for [M+H]+: 203.27 (calculated for C12H11O3, 203.07). 
 
Keto-fluorescein 3. To a solution of fluorescein (0.26 g, 0.69 mmol) and 5-amino-2-
pentanone ethylene ketal (0.1 g, 0.68 mmol) in dry DMF was added 1-ethyl-3-(3-
dimethyllaminopropyl)carbodiimide (EDC, 0.143 g, 0.75 mmol) and Et3N 186 µL. The 
solution was stirred at room temperature overnight. Upon removal of DMF in vacuo, the 
residue was dissolved in ethyl acetate and washed with 1 M HCl, water and brine. The 
organic layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure. The 
crude product obtained was deprotected by treatment with 10 mL TFA/CH2Cl2/H2O (2:7.5:0.5) 
at room temperature for 3 h. After removal of the solvent in vacuo, the mixture was further 
purified by flash chromatography using 10% MeOH in CH2Cl2, yield 85% (0.26 g). Rf = 0.4 
in 10% MeOH in CH2Cl2. 1H-NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 8.19 (d, J = 8.04 Hz, 
1H), 7.29 (d, J = 8.04 Hz, 1H) 6.69-6.67 (m, 2H). 6.61-6.51 (m, 4H), 3.42 (t, J = 6.8 Hz, 2H), 
2.61 (t, J = 7.2 Hz, 2H), 2.16 (s, 3H), 1.90-1.86 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 
210.0, 167.2, 167.0, 152.9, 152.9, 136.7, 134.2, 129.2, 129.1, 124.5, 112.7, 112.6, 109.7, 40.2, 
39.3, 28.7, 23.3. ESI-MS for [M+H]+: 460.22 (calculated for C26H22NO7, 460.13). HRMS for 
[M+H]+: 460.1396 (calculated for C26H22NO7, 460.1383). 
 
Model molecule 4. Attachment of the building block to the solid support was carried out by 
shaking the 2-chlorotritylchloride (2-Cl-trt) resin under dry conditions with a CH2Cl2 solution 
containing 3 eq of the Fmoc-LysOAll and N,N'-diisopropylethylamine (DIPEA, 6 eq). 
Loading efficiency was determined by means of the fluorenylmethoxycarbonyl (Fmoc)-
removal method. After deprotection of allyl group, benzotriazol-1-yl-
oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP, 5 eq), 1-hydroxy-7-
azabenzotriazole (HOAt, 5 eq), DIPEA (10 eq) and 1 (5 eq) in DMF was used for coupling 
directly (4 h). The result compound was released from the resin with a solution of 2.5% 
trifluoroacetic acid and 5% triethylsilane in CH2Cl2 (twice). Combined filtrates were 
evaporated to dryness, and the final model molecule 4 was purified by Prep-HPLC. The 
typical yield is 40%. 1H NMR (400 MHz, MeOD) δ 7.80 (d, J = 7.6 Hz, 2H), 7.65 (d, J = 
7.6Hz, 2H), 7.40 (t, J = 7.6 Hz, 2H), 7.31 (t, J = 7.6 Hz, 2H), 4.46-4.36 (m, 2H), 4.22 (b, 5H), 
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4.05-4.01 (m, 1H), 2.91 (t, J = 7.2 Hz, 2H), 1.85-1.67 (m, 4H), 1.46-1.35 (m, 2H). 13C NMR 
(100 MHz, CDCl3) δ 173.2, 161.9, 158.5, 145.3, 142.7, 132.4, 129.9, 128.9, 128.2, 126.1, 
121.0, 78.3, 73.0, 67.9, 53.9, 40.5, 31.6, 28.1, 23.8. ESI-MS for [M+H]+: 443.10 (calculated 
for C23H31N4O5, 443.22). HRMS for [M+H]+: 443.22817 (calculated for C23H31N4O5, 
443.22890). 
 
Keto-dansyl 8. To a solution of dansyl chloride (0.185 g, 0.68 mmol) in CH2Cl2 was added 5-
amino-2-pentanone ethylene ketal (0.1 g, 0.68 mmol) and 2 eq Et3N. The mixture was 
allowed to stand overnight at room temperature. The reaction mixture was diluted with 
CH2Cl2 and washed with water and brine. The organic layer was dried over anhydrous 
Na2SO4 and concentrated under reduced pressure to give a crude mixture, which was further 
purified by flash chromatography using CH2Cl2 as the eluent. The product obtained was 
deprotected with 10 mL TFA/CH2Cl2/H2O (2:7.5:0.5) at room temperature for 3 h. Upon 
removal of solvent in vacuo, the mixture was further purified by flash chromatography using 
5% MeOH in CH2Cl2, yield 91% (0.207 g). Rf = 0.3 in 5% MeOH in CH2Cl2. 1H-NMR (400 
MHz, CDCl3) δ 8.80 (d, J = 8.4 Hz, 2H), 8.51 (d, J = 6.8 Hz, 2H), 8.29 (d, J = 7.2 Hz, 2H), 
7.78-7.66 (m, 3H), 5.68 (b, 1H), 2.90 (t, J = 6.4 Hz, 2H), 2.45 (t, J = 6.4 Hz, 2H ), 2.06 (s, 
3H), 1.69-1.64 (m, 2H). 13C-NMR (100 MHz, CDCl3) δ 210.2, 139.2, 136.9, 130.5, 127.6, 
127.5, 127.3, 126.2, 125.7, 118.5, 47.3, 47.1, 42.8, 40.4, 30.0, 23.4. ESI-MS for [M+H]+: 
335.47 (calculated for C17H23N2O3S, 335.14). HRMS for [M+H]+: 335.1423 (calculated for 
C17H23N2O3S, 335.1424). 
 
5-Amino-2-pentanone ethylene ketal 9. To a solution of 5-chloro-2-pentanone ethylene 
ketal (1.5 g, 9.1 mmol) in DMF (20 ml) was added potassium phthalimide (1.7 g, 9.1 mmol). 
The solution was refluxed for 14 hours. The reaction mixture was added into 1000 ml water, 
and the resulting white precipitate was filtrated. The white solid was washed with water and 
ether. Then the solid was dissolved in 95% ethanol and NH2NH2·H2O (0.4 g, 8 mmol) was 
added. After refluxing for 1 hour, the reaction mixture was treated with a 2 N KOH solution. 
Then ten-times volume ether was added. The ether layer was further washed with water and 
brine, dried over anhydrous Na2SO4 and concentrated to yield compound 1 (0.46 g, 3.2 mmol, 
yield 35%). 1H NMR (400 MHz, CDCl3) δ 3.90 (m, 4H), 2.69 (t, J = 7.0 Hz, 2H), 2.08 (bs, 
2H), 1.64 (m, 2H), 1.53 (m, 2H), 1.29 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 110.0, 64.7, 
42.2, 36.5, 27.9, 23.9. ESI-MS for [M+H]+: 146.07 (calculated for C17H23N2O3S, 146.22). 
HRMS for [M+H]+: 146.11713 (calculated for C17H23N2O3S, 146.11756).  
 
Coumarin-thioester 10: To a solution of coumarin (0.261 g, 1 mmol) in dry THF HATU 
(0.314 g, 0.83 mmol) and Et3N (0.22 mL) was added. The mixture was stirred for 10 minutes 
on ice, followed by addition of amino thioacetic acid S-benzyl ester (0.15 g, 0.83 mmol) 
dissolved in a minimal amount of DMF. The resulting solution was stirred overnight at room 
temperature. After removal of the solvent in vacuo, the resulting mixture was taken up in 
ethyl acetate and washed with 1 N HCl, water and brine. The organic layer was dried over 
anhydrous Na2SO4 and concentrated in vacuo to afford a yellow solid, which was further 
purified by flash chromatography (silica gel, n-pentane/EtOAc = 1:2) to afford coumarin-
thioester 10 (300 mg, 84%). Rf = 0.7 in 8% MeOH in CH2Cl2. 1H NMR (400 MHz, CDCl3) δ 
9.26 (t, J = 5.7 Hz, 1H), 8.62 (s, 1H), 7.34 (d, J = 9.0 Hz, 1H), 7.26-6.93 (m, 5H), 6.57 (dd, J 
= 9.0, 2.4 Hz, 1H), 6.41 (d, J = 1.8 Hz, 1H), 4.31 (d, J = 6.1 Hz, 2H), 4.07 (s, 2H), 3.38 (q, J = 
7.1 Hz, 4H), 1.16 (t, J = 7.1 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 197.0, 163.9, 162.7, 
157.9, 152.9, 148.7, 137.1, 131.4, 129.0, 128.7, 127.4, 110.2, 109.4, 108.4, 96.7, 49.3, 45.2, 
33.1, 12.5. ESI-MS [M+H]+: found  m/z 425.13. HRMS [M+H]+: calculated for C23H24N2O4S 
425.15295; found 425.15256. 
 
Keto-rhodamine 12. To a solution of sulforhodamine B sulfonyl chloride (0.294 g, 0.51 
mmol) in DMF, 9 (0.075 g, 0.51 mmol) and 1 eq triethylamine was added. The mixture was 
allowed to stand overnight at room temperature. The solvent was evaporated to give a crude 
product, which was further purified by flash chromatography by using 5% MeOH in CH2Cl2 
as the eluent. The obtained product was treated with 10 mL TFA/CH2Cl2/H2O (2:7.5:0.5) at 
room temperature for 3 h. After removal of the solvent in vacuo, the keto-rhodamine 12 was 
obtained without further purify, yield 91%. Rf = 0.4 in 8% MeOH in CH2Cl2. 1H NMR (400 
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MHz, d6DMSO) δ 8.42 (s, 1H), 7.92 (d, J = 6.1 Hz, 2H), 7.46 (d, J = 6.1 Hz, 2H), 7.02-6.91 
(m, 6H), 5.98 (bs, 1H), 3.62 (q, J = 7.2 Hz, 8H), 2.84 (t, J = 6.4 Hz, 2H), 2.48 (t, J = 6.4 Hz, 
2H), 2.05 (s, 3H), 1.58 (m, 2H), 1.19 (t, J = 7.2 Hz, 12H). 13C NMR (100 MHz, d6DMSO) δ 
208.5, 156.2, 157.8, 155.8, 148.7, 142.3, 133.7, 133.4, 132.3, 131.3, 127.2, 126.4, 114.9, 
114.2, 96.4, 96.1, 46.0, 30.5, 23.9, 13.1. ESI-MS [M+H]+; found m/z 642.67. HRMS [M+H]+ 
calculated for C32H39N3O7S2 642.23022; found 642.22966. 
 
Synthesis of CysN3 14. 15 was prepared according to literature report methods (Abedin et al., 
2009). 1H-NMR (400 MHz, CDCl3) δ 4.81 (br s, 1H), 3.36-3.32 (m, 2H), 3.28 (t, J = 6.0 Hz, 
2H), 1.39 (s, 9H); ESI-MS: m/z [M+H]+ = 187.1. 15 (1 g) was treated by 10 mL TFA/DCM 
(1:1) at room temperature for 2 h to give 16 (95% yield). 1H-NMR (400 MHz, CDCl3) δ 3.67 
(t, J = 5.6 Hz, 2H), 3.08 (t, J = 5.6 Hz, 2H). Synthesis of 17: The coupling reaction of 16 with 
1.1 equivalent of Fmoc-Cys(StBu)-OH in the presence of 1.1 equivalent HATU, 1.1 
equivalent HOBT and 2.2 equivalent DIPEA in 25 mL CH2Cl2 was stirred at room 
temperature for 24 h. Then the solution was washed with 10% NaHCO3 and brine, dried over 
Na2SO4, and concentrated in vacuo. The residue was purified by chromatography (silica gel, 
2% methanol in CH2Cl2) to yield 2.5 g (5 mmol, 87%) light yellow solid 17, Rf = 0.3 (1% 
MeOH in CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 7.5 Hz, 2H), 7.59 (d, J = 7.4 
Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.31 (td, J = 7.5, 1.1 Hz, 2H), 6.66 (s, 1H), 5.72 (d, J = 6.9 
Hz, 1H), 4.45 (dd, J = 10.3, 7.2 Hz, 3H), 4.22 (t, J = 6.9 Hz, 1H), 3.43 (s, 4H), 3.20-2.91 (m, 
2H), 1.35 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 170.5, 156.3, 143.8, 141.5, 128.0, 127.3, 
125.3, 120.2, 67.6, 54.9, 50.8, 48.7, 47.3, 42.2, 39.3, 30.1. ESI: m/z found, 499.95; calcd for 
[M+H]+, 500.18. Synthesis of 14: compound 17 (0.5 g, 1 mmol) in 1:4 piperidine-CH2Cl2 was 
stirred at room temperature for 24 h. After removing the solvent, the product was isolated 
from the remaining residues by flash chromatography (silica gel, 5% methanol in CH2Cl2) to 
yield CysN3 as colorless oil in 89% yield (0.247 g). Rf = 0.4 (5% MeOH in CH2Cl2). 1H NMR 
(400 MHz, CDCl3) δ 7.75 (s, 1H), 7.19 (d, J = 0.4 Hz, 2H), 4.29 (s, 1H), 3.50-3.24 (m, 4H), 
3.09 (qd, J = 14.4, 6.7 Hz, 2H), 1.27 (s, 8H); 13C NMR (100 MHz, CDCl3) δ 168.1, 53.4, 50.4, 
49.2, 40.9, 39.4, 29.8; ESI-MS: m/z found, 277.89; calculated for [M+H]+, 278.11; HRMS 
(ESI): found, 278.11043; calculated for C9H20N5OS2, 278.11038.  
 
FmocCys(GerGer)OH 18 (Brown et al., 1991): N-chlorosuccinamide (690 mg, 5.1 mmol) in 
10 mL dry CH2Cl2 was cooled to -40 ºC by using dry-ice-acetone; and then 380 μL (CH3)2S 
was added dropwise. The mixture was stirred at -40 ºC for 5 min, 0 ºC for 5 min, and again 
kept at -40 ºC. In this stage, GerGerOH (1.0 g, 85%, 2.93 mmol) in 7 mL CH2Cl2 was added 
slowly. The resulting mixture was stirred at -40 ºC for 30 min, 0 ºC for 30 min, and room 
temperature for 2 h. The reaction solution was poured into ice-cold brine, and extraction with 
CH2Cl2. The CH2Cl2 solution was dried by MgSO4, concentrated to obtain 1.04 g 
geranylgeranyl chloride (GerGerCl), which is directly used in the next-step reaction. L-
cysteine (569 mg) was dissolved in 26 mL 4 M solution of ammonia in methanol on ice bath, 
and the obtained GerGerCl was added into the solution slowly. The reaction solution was 
allowed to react at 0 ºC for 3 h and room temperature for 1 h. After removing the solvent, 40 
mL CH2Cl2 containing 0.2 mL MeOH was added at 0 ºC, followed by the supplementation of 
1.2 g FmocOSu in 10 mL CH2Cl2, and 492 μl triethylamine. The reaction was stirred 
overnight, and the solvent was removed at reduced pressure. The residue was dissolved in 
CH2Cl2 and washed with water and brine. The organic layer was dried by MgSO4 and 
concentrated. The product was purified by flash chromatography (silica gel, 2% methanol in 
CH2Cl2) to give light-yellow oil in 83% yield (1.5 g). 1H NMR (400 MHz, CDCl3) δ 10.36 (s, 
1H), 7.67 (d, J = 7.5 Hz, 2H), 7.52 (d, J = 5.3 Hz, 2H), 7.31 (t, J = 7.4 Hz, 2H), 7.22 (t, J = 
7.4 Hz, 2H), 5.58 (d, J = 7.8 Hz, 1H), 5.14 (t, J = 7.3 Hz, 1H), 5.07-4.92 (m, 3H), 4.53 (d, J = 
6.8 Hz, 1H), 4.32 (d, J = 5.3 Hz, 2H), 4.15 (t, J = 7.0 Hz, 1H), 3.12 (p, J = 12.9 Hz, 2H), 2.96-
2.82 (m, 2H), 2.06-1.75 (m, 12H), 1.59 (s, 3H), 1.57 (s, 3H), 1.51 (s, 9H). 13C NMR (100 
MHz, CDCl3) δ 174.1, 155.1, 142.9, 142.8, 140.4, 139.3, 134.5, 134.0, 130.3, 126.8, 126.2, 
124.2, 123.5, 123.3, 122.8, 119.1, 118.6, 66.5, 52.7, 46.2, 38.8, 38.8, 38.7, 32.4, 29.2, 25.9, 
25.7, 25.6, 24.79, 15.2, 15.1, 15.1. ESI-MS, found, 615.80; calculated for [M+H]+: 616.34.  
Synthesis of alkyne-functionalized lipidated peptides 19-21. Attachment of the building 
block to the solid support was carried out by shaking the 2-Cl-trt resin under dry conditions 
with a solution containing 2 eq of the Fmoc-Cys(R)OH (R = StBu or GerGer) and 4 eq of 
DIPEA. Successful attachment was determined by means of the fluorenylmethoxycarbonyl 
(Fmoc)-removal method (Brunsveld et al., 2005). For N-terminal elongation, the Fmoc 
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protecting group was removed with 20% piperidine in dimethylformamide (DMF) (twice, 10 
min each). Fmoc-protected amino acids (4 eq) were preactivated by the treatment with O-(6-
chlorobenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HCTU) (4 eq) 
and DIPEA (8 eq) for 5 min in DMF to yield a 0.1 M solution, which was used for coupling 
directly (2-4 h). The N-terminal alkyne group was incorporated into peptides by the reaction 
of the activated CH2Cl2 solution of 3 eq propiolic acid and 3 eq N,N'-diisopropylcarbodiimide 
(DIC) with the resin at 0 °C. After completion of the synthesis, the peptides were released 
from the resin with a solution of 1% trifluoroacetic acid and 3% triethylsilane in CH2Cl2 twice. 
The released solution was evaporated to dryness, and the prenylated peptides were purified by 
flash chromatography (5% chloroform/methanol as eluent).  
Yields for 19, 53%, 55 mg. Rf = 0.1 (10% MeOH in CH2Cl2). ESI-MS ([M+H]+) for 19: 
1085.67 (calculated for C54H81O9N6S4, 1085.48); MALDI-TOF MS ([M+Na]+): 1107.83; 
HRMS ([M+H]+): 1085.49376 (calculated for C54H81O9N6S4, 1085.49424). 
Yields for 20, 50%, 48 mg. Rf = 0.2 (10% MeOH in CH2Cl2). ESI-MS ([M+H]+) for 20: 
998.73 (calculated for C51H75O7N5S4, 998.45); MALDI-TOF MS ([M+Na]+): 1020.65; HRMS 
([M+H]+): 998.46270 (calculated for C51H75O7N5S4, 998.4622). 
Yields for 21, 70%, 70 mg. Rf = 0.3 (4% MeOH in CH2Cl2). ESI-MS ([M+H]+) for 21: 998.73 
(calculated for C51H75O7N5S4, 998.45); MALDI-TOF MS ([M+Na]+): 1020.77; HRMS 
([M+H]+): 998.46232 (calculated for C51H75O7N5S4,  998.4622). 
 
 
Synthesis of 23. A solution of propiolic acid (280 mg, 4 mmol) in CH2Cl2 was cooled to -20 
°C. Dicyclohexylcarbodiimide (DCC, 910 mg, 9.1 mmol) and 1-hexadecylamine (536 mg, 
2.22 mmol) were added and the reaction was allowed to warm up to room temperature. After 
overnight, the solution was filtered. After removing the solution, the resulting oil was purified 
by flash chromatography (2% MeOH in CH2Cl2) to give white power 23, yield, 81% (0.52 g). 
1H NMR (400 MHz, CDCl3) δ 6.15 (s, 1H), 3.27 (t, J = 7.1 Hz, 2H), 2.75 (s, 1H), 1.51 (m, 
2H), 1.29-1.14 (m, 26H), 0.86 (t, J = 6.9 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 152.3, 77.6, 
72.9, 40.0, 32.0, 29.7, 29.7, 29.7, 29.6, 29.6, 29.4, 29.3, 29.3, 26.9, 22.7, 14.2. ESI-MS for 
[M+H]+: 294.18 (calculated for C19H36ON, 294.27). HRMS for [M+H]+: 294.27896 
(calculated for C19H36ON, 294.27914).  
 
PEG-1 24. Attachment of the building block to the solid support was carried out by shaking 
the tritylchloride resin under dry conditions with a CH2Cl2 solution containing 3 eq of the 
Fmoc-Cys(StBu)OH and 6 eq of DIEA. Loading efficiency was determined by means of the 
fluorenylmethoxycarbonyl (Fmoc)-removal method. For N-terminal elongation the Fmoc 
protecting group was removed with 20% piperidine in DMF (twice, 10 min each). Fmoc-
protected amino acids (4 eq) were preactivated by treatment with HCTU (4 eq) and DIPEA (8 
eq) or PyBOP (5 eq), 1-hydroxy-7-azabenzotriazole (HOAt, 5 eq) and DIPEA (10 eq) for 5 
min in DMF to yield a 0.1 M solution, which was used for coupling directly (4 h). After 
completion of the synthesis, the peptides were released from the resin with a solution of 5% 
trifluoroacetic acid, 5% triethylsilane and 2% H2O in CH2Cl2 (twice times). Combined 
filtrates were evaporated to dryness, and the final PEG-1 24 was purified by Prep-HPLC. The 
typical yield is around 8%. 1H NMR (400 MHz, MeOD) δ 3.65-3.62 (m, 4H), 3.59-3.57 (m, 
4H), 3.51 (t, J = 6, 4H), 3.31-3.29 (m, 10H), 3.27-3.21 (m, 6H), 3.15 (t, J = 7.2, 2H), 2.57-
2.49 (m, 4H), 2.13 (s, 3H), 1.79-1.66 (m, 6H), 1.33 (s, 18H). 13C NMR (100 MHz, MeOD) δ 
209.3, 173.8, 173.2, 171.2, 169.2, 161.1, 158.1, 76.6, 69.7, 69.2, 69.1, 68.8, 62.2, 50.1, 48.4, 
48.2, 46.1, 40.5, 39.2, 33.0, 31.4, 31.4, 31.3, 30.8, 30.5, 29.7, 28.5, 25.5, 25.2, 24.6, 22.9. 
ESI-MS ([M+H]+): 886.16 (calculated for C37H68O11N5S4, 886.39); HRMS ([M+H]+): 
886.3792 (calculated for C37H68O11N5S4, 886.3792). 
 
PEG-2 25. A mixture of dithiodiglycolic acid (0.5 mmol), N-hydroxysuccinimide (NHS, 1.05 
mmol) and DCC (1.05 mmol) in 20 mL CH2Cl2 was stirred at room temperature for 1 h and 
the precipitated dicyclohexylurea (DCU) was removed by filtration. Then, PEG8 (1 mmol) 
and Et3N (1 mmol) were added into the filtrate. The reaction was stirred for another 1 h, and 
the solvent was removed at reduced pressure. The residue was dissolved in CH2Cl2 and 
washed with water and brine. The organic layer was dried over Na2SO4 and the solvent was 
evaporated under reduced pressure. The resulting intermediate was actived by DCC (1 mmol) 
and NHS (1 mmol) in 20 mL CH2Cl2. After filtration, 1,4-dioxa-8-azaspiro[4.5]decane (1 
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mmol) and Et3N (1 mol) were added into the filtrate for reaction. After finishing the reaction, 
the solution was washed with water and brine, and treated by 20% TFA in CH2Cl2 at room 
temperature overnight. After removing the solution, the resulting oil was purified by flash 
chromatography (10% MeOH in CH2Cl2) to give 25 with 31% yield (0.369 g). TLC: Rf = 0.6 
(5% MeOH in CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.49 (bs, 2H), 3.82 (t, J = 6.0, 4H), 
3.78-3.70 (m, 8H), 3.58-3.54 (m, 64H), 3.45 (s, 4H), 3.42 (t, J = 4.4, 4H), 2.67 (t, J = 6.0, 4H), 
2.47 (t, J = 6.4, 4H), 2.40 (t, J = 6.0, 4H). 13C NMR (100 MHz, CDCl3) δ 206.9, 172.0, 170.7, 
169.3, 70.2, 69.9, 69.2, 67.3, 64.2, 44.3, 42.1, 40.9, 40.7, 39.7, 33.3, 25.2. ESI-MS ([M+H]+): 
1191.67 (calculated for C52H95O22N4S2, 1191.58); HRMS ([M+H]+): 1191.58687 (calculated 
for C52H95O22N4S2, 1191.58739).   
  
Boc-Ile-Ala-Leu 26. The tripeptide was synthesized based on SPPS technique on 2-Cl-trt 
resin. Attachment of Fmoc-LeuOH to the solid support was carried out by shaking the resin 
under dry conditions with a CH2Cl2 solution containing 3 eq of the Fmoc-LeuOH and 6 eq of 
DIEA (Loading efficiency, 0.56 mmol/g). For N-terminal elongation the Fmoc protecting 
group was removed with 20% piperidine in DMF (twice, 10 min each). Fmoc-AlaOH and 
Boc-IleOH (4 eq) were preactivated by treatment with HCTU (4 eq) and DIPEA (8 eq) for 5 
min in DMF to yield a 0.1 M solution, which was used for coupling directly (4 h). After 
completion of the synthesis, the peptides were released from the resin with a solution of 1% 
trifluoroacetic acid and 3% triethylsilane in CH2Cl2 twice. No obvious deprotection of Boc 
was observed under such condition. After removing the solution, the resulting oil is pure 
enough for following synthesis. 1H NMR (400 MHz, CDCl3) δ 7.65-7.20 (m, 2H), 5.36 (bs, 
1H), 4.7-4.4 (m, 2H), 4.1-4.0 (m, 1H), 1.82-1.60 (m, 3H), 1.42 (s, 9H), 1.36 (d, J = 5.2, 3H), 
0.93-0.87 (m, 12H). ESI-MS ([M+Na]+): 438.53 (calculated for C20H38O6N3, 438.25); HRMS 
([M+Na]+): 438.2571 (calculated for C20H38O6N3, 438.2574).  
   
Boc-Ile-Ala-Leu-PEG12 27. A mixture of 26 (1.2 mmol, 0.50 g), NHS (1.22 mmol, 0.14 g) 
and DCC (1.25 mmol, 0.25 g) in 20 mL CH2Cl2 was stirred at room temperature for 1 h and 
the precipitated dicyclohexylurea (DCU) was removed by filtration. Then, PEG12 (1.2 mmol, 
741 mg) and Et3N (1.2 mmol, 167 µL) were added into the filtrate. The reaction was stirred 
for another 1 h, and the solvent was removed at reduced pressure. The residue was dissolved 
in CH2Cl2 and washed with water and brine. The organic layer was dried over Na2SO4 and the 
solvent was evaporated under reduced pressure. The resulting oil was purified by flash 
chromatography (30% MeOH in CH2Cl2) to give 27. Yield, 89% (1.1 g). TLC: Rf = 0.4 (10% 
MeOH in CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.46-7.20 (m, 3H), 5.46-5.40 (m, 1H), 
4.58-4.45 (m, 2H), 4.05-3.96 (m, 1H), 3.72 (t, J = 6.8, 2H), 3.66-3.53 (m, 46H), 3.50 (t, J = 
5.2, 2H), 2.56 (t, J = 6.4, 2H), 1.84-1.45 (m, 3H), 1.38 (s, 9H), 1.29 (d, J = 6.8, 3H), 0.89-0.81 
(m, 12H). 13C NMR (100 MHz, CDCl3) δ 173.9, 172.3, 172.1, 171.7, 155.9, 79.7, 70.4, 70.3, 
70.2, 70.0, 69.4, 66.5, 59.2, 51.6, 48.8, 41.3, 39.1, 37.3, 34.8, 28.2, 24.6, 22.7, 21.9, 18.3, 15.4, 
11.3. ESI-MS ([M+Na]+): 1037.93 (calculated for C47H90O19N4Na, 1037.61); HRMS 
([M+Na]+): 1037.60645 (calculated for C47H90O19N4Na, 1037.60915). 
 
Boc-Ile-Ala-Leu-PEG12-Cys 28. A mixture of 27 (0.3 mmol, 0.3 g), NHS (0.35 mmol, 40 mg) 
and DCC (0.35 mmol, 35 mg) in 20 mL CH2Cl2 was stirred at room temperature for 1 h and 
the precipitated dicyclohexylurea (DCU) was removed by filtration. Then, Cys(StBu)OH (0.3 
mmol, 63 mg) and Et3N (0.35 mmol, 49 µL) were added into the filtrate. The reaction was 
stirred for another 1 h, and the solvent was removed at reduced pressure. The residue was 
dissolved in CH2Cl2 and washed with water and brine. The organic layer was dried over 
Na2SO4 and the solvent was evaporated under reduced pressure. The resulting oil was purified 
by flash chromatography (30% MeOH in CH2Cl2) to give 28. Yield, 67% (242 mg). TLC: Rf 
= 0.5 (10% MeOH in CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.48-7.12 (m, 3H), 5.53-5.52 (d, 
J = 7.2, 1H), 4.57-4.41 (m, 2H), 3.97-3.94 (m, 1H), 3.75-3.70 (m, 3H), 3.66-3.56 (m, 46H), 
3.49 (t, J = 5.2, 2H), 3.45-3.16 (m, 2H), 2.49 (bs, 1H), 1.81-1.46 (m, 3H), 1.38 (s, 9H), 1.32 
(d, J = 6.8, 3H), 1.25 (s, 9H), 0.95-0.83 (m, 12H). 13C NMR (100 MHz, CDCl3) δ 172.3, 
171.9, 156.0, 79.7, 70.3, 70.2, 69.9, 69.5, 67.1, 59.6, 53.7, 51.8, 49.3, 47.6, 43.6, 43.5, 41.1, 
39.0, 37.2, 36.6, 30.8, 29.7, 28.2, 24.7, 24.6, 22.8, 21.8, 18.1, 15.5, 11.3. ESI-MS ([M+H]+): 
1206.47 (calculated for C54H104O20N5S2, 1206.67); HRMS: 1206.67269 (calculated for 
C54H104O20N5S2, 1206.67106). 
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Boc-Ile-Ala-Leu-PEG12-CysCys 29. A mixture of 27 (0.2 mmol, 0.2 g), NHS (0.21 mmol, 
24 mg) and DCC (0.21 mmol, 21 mg) in 20 mL CH2Cl2 was stirred at room temperature for 1 
h and the precipitated dicyclohexylurea (DCU) was removed by filtration. Then, 
Cys(StBu)Cys(StBu)OH (0.2 mmol, 80 mg) and Et3N (0.4 mmol, 56 µL) were added into the 
filtrate. The reaction was stirred for another 1 h, and the solvent was removed at reduced 
pressure. The residue was dissolved in CH2Cl2 and washed with water and brine. The organic 
layer was dried over Na2SO4 and the solvent was evaporated under reduced pressure. The 
resulting oil was purified by flash chromatography (30% MeOH in CH2Cl2) to give 29. Yield, 
45% (125 mg). TLC: Rf = 0.7 (10% EtOAc in MeOH). 1H NMR (400 MHz, CDCl3) δ 7.67-
7.44 (m, 2H), 7.19-6.88 (m, 2H), 5.31-5.30 (d, J = 7.2, 1H), 4.77-4.65 (m, 1H), 4.50-4.42 (m, 
2H), 4.05-3.90 (m, 1H), 3.84-3.71 (m, 3H), 3.68-3.59 (m, 46H), 3.53 (t, J = 5.2, 2H), 3.47-
3.10 (m, 4H), 2.54 (bs, 1H), 1.81-1.50 (m, 3H), 1.41 (s, 9H), 1.32-1.25 (m, 21H), 0.91-0.82 
(m, 12H). 13C NMR (100 MHz, CDCl3) δ 172.2, 172.0, 171.7, 170.0,  156.0, 80.0, 70.5, 70.1, 
69.5, 67.0, 59.4, 51.8, 49.2, 48.1, 47.9, 41.3, 39.2, 37.3, 36.7, 30.5, 29.8, 28.2, 24.7, 22.9, 21.9, 
18.3, 15.5, 11.4. ESI-MS ([M+H]+): 1397.36 (calculated for C61H117O21N6S4, 1397.71); 
HRMS ([M+2H]2+): 699.36226 (calculated for C61H118O21N6S4, 699.36110). 
 
A solution of 1,4-dioxa-8-azaspiro[4.5]decane (1 mmol), succinic anhydride (1.2 mmol) and 
Et3N (1.2 mmol) in CH2Cl2 was stirred at room temperature for 2 h. The solvent was removed 
at reduced pressure. The residue was dissolved in CH2Cl2 and washed with water and brine. 
The organic layer was dried over Na2SO4 and the solvent was evaporated under reduced 
pressure. The resulted crude product was dissolved in methanol (500 µL), and then ether (25 
mL) was added. After keeping the mixture at -20 °C overnight, colorless crystals of 32 were 
isolated with 40% yield (97 mg). 1H NMR (400 MHz, CDCl3) δ 9.35 (S, 1H), 3.94 (S, 4H), 
3.65 (t, J = 6, 2H), 3.52 (t, J = 5.6, 2H), 2.65-2.64 (m, 4H), 1.68 (t, J = 5.6, 2H), 1.64 (t, J = 
6.0, 2H). 13C NMR (100 MHz, CDCl3) δ 176.5, 169.9, 106.6, 64.2, 43.3, 40.0, 35.2, 34.5, 29.3, 
27.8. ESI-MS ([M+H]+): 244.13 (calculated for C11H18O5N, 244.11); HRMS ([M+H]+): 
244.11841 (calculated for C11H18O5N, 244.11795). 
 
Keto-PEG8 33. A mixture of 32 (0.3 mmol, 73 mg), NHS (0.33 mmol, 36 mg) and DCC 
(0.33 mmol, 68 mg) in 20 mL CH2Cl2 was stirred at room temperature for 1 h and the 
precipitated dicyclohexylurea (DCU) was removed by filtration. Then, PEG8 (0.3 mmol, 132 
mg) and Et3N (0.4 mmol, 56 µL) were added into the filtrate. The reaction was stirred for 
another 1 h, and the solvent was removed at reduced pressure. The residue was dissolved in 
CH2Cl2 and washed with water and brine. The organic layer was dried over Na2SO4 and the 
solvent was evaporated under reduced pressure. The resulting oil was purified by flash 
chromatography (30% MeOH in CH2Cl2) to give 33. Yield, 90% (180 mg). TLC: Rf = 0.5 
(10% MeOH in CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 3.85 (s, 4H), 3.61 (t, J = 6.4, 2H), 
3.54-3.40 (m, 32H), 3.27 (t, J = 4.2, 2H), 2.57-2.52 (m, 4H), 2.45 (t, J = 6.4, 2H), 2.37 (t, J = 
7.2, 2H), 1.77-1.73 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 172.5, 170.2, 157.5, 105.9, 70.1, 
69.8, 66.4, 65.4, 64.1, 64.0, 43.2, 39.7, 38.9, 35.0, 34.3, 33.4, 30.7, 28.1, 25.3, 25.1, 24.6. 
ESI-MS ([M+H]+): 667.47 (calculated for C30H55O14N2, 667.36); HRMS ([M+H]+): 
667.36599 (calculated for C30H55O14N2, 667.36478). 
 
Keto-PEG8-IAL-PEG12-Cys 36. 28 (0.08 mmol, 97 mg) was dealt with 1:1 TFA-CH2Cl2 
solution firstly and then the solvents were removed to produce 30. A mixture of 33 (0.135 
mmol, 90 mg), NHS (0.135 mmol, 16 mg) and DCC (0.28 mmol, 28 mg) in 20 mL CH2Cl2 
was stirred at room temperature for 1 h and the precipitated dicyclohexylurea (DCU) was 
removed by filtration. A mixture of Et3N (0.2 mmol, 28 µL) and 30 (0.08 mmol) in CH2Cl2 
was added into the filtrate. The reaction was stirred for another 1 h, and the solvent was 
removed at reduced pressure. The residue was dissolved in CH2Cl2 and washed with water 
and brine. The organic layer was dried over Na2SO4 and the solvent was evaporated under 
reduced pressure. The resulting oil was purified by flash chromatography (50% EtOAc in 
MeOH) to give 34. Yield, 19% (26 mg). TLC: Rf = 0.2 (10% MeOH in CH2Cl2). 1H NMR 
(400 MHz, CDCl3) δ 4.38-4.27 (m, 2H), 4.17-4.08 (m, 1H), 3.82-3.68 (m, 7H), 3.66-3.55 (m, 
80H), 3.49 (t, J = 5.2, 2H), 3.40-3.33 (m, 4H), 2.69 (t, J = 6.4, 2H), 2.54-2.44 (m, 5H), 2.39 (t, 
J = 7.2, 2H), 2.10 (s, 4H), 1.83-1.48 (m, 7H), 1.37-1.18 (m, 21H), 0.88-0.79 (m, 12H). 13C 
NMR (100 MHz, CDCl3) δ 206.8, 172.7, 172.4, 172.2, 171.8, 171.6, 171.5, 170.8, 70.4, 70.3, 
70.1, 69.7, 69.4, 67.5, 66.9, 58.9, 57.8, 53.3, 52.2, 51.9, 49.6, 48.0, 43.9, 42.3, 41.0, 40.9, 40.7, 
39.3, 39.2, 36.8, 36.6, 36.4, 31.0, 30.8, 29.7, 29.6, 28.1, 25.0, 24.8, 22.9, 18.3, 15.4, 11.2, 8.2. 
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ESI-MS ([M+H]+): 1710.73 (calculated for C77H144O30N7S2, 1710.94); HRMS ([M+2H]2+): 
855.97122 (calculated for C77H145O30N7S2, 855.97331). 
 
Keto-PEG8-IAL-PEG12-Cys-Cys 37. A mixture of 33 (0.135 mmol, 90 mg), NHS (0.135 
mmol, 16 mg) and DCC (0.28 mmol, 28 mg) in 20 mL CH2Cl2 was stirred at room 
temperature for 1 h and the precipitated dicyclohexylurea (DCU) was removed by filtration. 
Then, 31 (0.08 mmol, from deprotection Boc group of 29) and Et3N (0.2 mmol, 28 µL) were 
added into the filtrate. The reaction was stirred for another 1 h, and the solvent was removed 
at reduced pressure. The residue was dissolved in CH2Cl2 and washed with water and brine. 
The organic layer was dried over Na2SO4 and the solvent was evaporated under reduced 
pressure. The resulting oil was purified by flash chromatography (50% EtOAc in MeOH) to 
give 37. Yield, 13% (20 mg). TLC: Rf = 0.2 (10% MeOH in CH2Cl2). 1H NMR (400 MHz, 
CDCl3) δ 4.48-4.31 (m, 2H), 4.13-4.08 (m, 1H), 3.88-3.72 (m, 7H), 3.70-3.57 (m, 80H), 3.54 
(t, J = 5.2, 2H), 3.47-3.38 (m, 4H), 3.19-3.13 (m, 2H), 2.75 (t, J = 6.8, 2H), 2.60-2.43 (m, 5H), 
2.45 (t, J = 6.0, 2H), 2.15 (s, 4H), 1.86-1.54 (m, 7H), 1.41-1.22 (m, 30H), 0.91-0.86 (m, 12H). 
ESI-MS ([M+H]+): 1901.60 (calculated for C84H157N8O31S4, 1901.98); HRMS 
([M+C2H5OH+3Na]3+): 671.99519 (calculated for C86H162N8O32S4Na3, 671.99570). 
5.4. Biochemical methods 
5.4.1. Expression and purification of RabGGTase, REP-1, RabGDI-1, RhoGDI, and 
Rab7wt 
  All these proteins were kindly prepared and provided from Goody’s group. Mammalian 
RabGGTase was purified from E. coli BL21(DE3) codon plus cells expressing a 
hexahistidine-GST tagged  αsubunit and an untagged β-subunit. Briefly, following cell 
growth, induction and lysis of the cells, GGTase-II was purified from crude homogenate using 
Ni-NTA Sepharose columns (Pharmacia). The affinity tag was removed by digestion with 
TEV protease. A second Ni-NTA chromatography was performed in order to remove the 
cleaved-off hexahistidine tag, uncleaved GGTase-II and TEV protease. REP-1 was purified 
from insect cells infected with recombinant baculovirus or from recombinant yeast S. 
cerevisiae. The protein was purified by a combination of Ni-NTA affinity and gel filtration 
chromatography. RabGDI and Rab7 wild-type proteins were expressed and purified in a 
similar manner. RhoGDI was cloned in frame with Maltose Binding Protein (MBP) using the 
pOPINM vector (Berrow et al., 2007), expressed in E. coli, and purified by Ni-NTA 
chromatography. The MBP tag was removed by proteolysis with Precision protease, and the 
protein was further purified by gel filtration on a Superdex 200 26/60 column (GE Helthcare). 
5.4.2. Expression and purification of thioester proteins 
  The plasmid coding for the desired protein-Intein-CBD construct was transformed into 
E.coli BL21(DE3) cells using electroporation and transformants were selected on ampicillin 
(50 mg/L) agar plates. A single colony was inoculated into 5 mL of LB medium containing 
125 mg/L Ampicillin and the culture was grown overnight at 37 °C. This pre-culture was used 
to seed 2 L of fresh LB medium (containing 125 mg/L ampicillin) and the culture was 
incubated at 37 °C until the absorbance at 600 nm (OD600) reached 0.5-0.7. The cells were 
cooled down on ice, IPTG was added to a final concentration of 0.5 mM and overnight 
induction was performed at 20 °C. The cells were cooled down to 4 °C and all subsequent 
steps were performed at this temperature. Cells were harvested by centrifugation (5000 rpm, 
20 min, 4 °C) and washed once in PBS. Cells could be stored frozen at -80 °C at this point. 
Levels of protein expression before and after induction were determined by SDS-PAGE. The 
bacterial pellet was resuspended in lysis buffer (25 mM sodium phosphate, pH 7.5, 0.5 M 
NaCl, 1 mM PMSF, 2 mM MgCl2, 10 μM GDP) and the cells were lysed by passing them 
twice through a Microfluidizer. A fresh portion of 0.5 mM PMSF and Triton X-100 (1 % final 
concentration) were added. The lysate was cleared by ultracentrifugation (30000 rpm, 40 min, 
4 °C) and the supernatant was transferred to Falcon tubes. An appropriate amount of chitin 
beads, equilibrated with lysis buffer containing 1 % Triton X-100 was added and the mixture 
was incubated for 2 h on a rotating wheel at 4 °C (1 mL of beads can bind about 2 mg of 
fusion-protein. The total amount of expressed fusion protein can be estimated by SDS-PAGE 
and Coomassie Blue staining. The suspension was centrifuged (2500 rpm, 5 min, 4 °C) and 
the supernatant removed. To remove unspecifically bound material beads were washed 4 
times with lysis buffer containing 1 % Triton X-100 followed by 4 times washing with buffer 
without detergent. Cleavage of the fusion protein was induced by adding powdered MESNA 
to the beads suspension to a concentration of 0.5 M and overnight incubation at room 
temperature. The supernatant was collected by centrifugation and was passed over a gel 
filtration column equilibrated with ligation buffer (20 mM sodium phosphate, pH 7.5, 1 mM 
MgCl2, 10 μM GDP). The pooled fractions were concentrated to at least 10 mg/mL and shock 
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frozen using liquid nitrogen. The proteins could be stored at 80 °C for at least 2 years without 
observious change in LCMS spectra. Yields typically ranged from 5-10 mg of protein 
thioester per liter of bacterial culture.  
  For the plasmid coding for the desired protein-Intein-His construct, the protein expression is 
similar with that of protein-Intein-CBD. The details of protein purification are optimized in 
the following part 5.4.3. 
5.4.3. Universal C-terminal protein labeling with oxyamine ligation 
1. Clone target gene into modified pTWIN vector using NdeI and SapI sites. 
2. Express fusion protein (target-Intein-His) in BL21(DE3) cells. 
3. Collect cells in 25 mL ice-cold Breaking buffer freshly supplemented with 1 mM PMSF. 
CRITICAL: PMSF should be added freshly. Don’t add any reducing substances. 
4. Lyse cells using a microfluidizer or ultrasonication.  
5. Add 1% Triton X-100 into cell lysate and centrifuge at 35,000 rpm, 4 °C for 30 min. 
6. Filter supernatant through a 0.2 µm filter.  
7. Load cell lysate onto a Ni-NTA column equilibrated with buffer A (50 mM NaH2PO4, pH 
8.0, 0.3 M NaCl). 
8. Wash column with Buffer A and continue with 2% Buffer B (Buffer A + 0.5 M imidazole) 
until absorbance reaches baseline. 
9. Elute column with a gradient of 2-100% Buffer B. Collect eluted fractions. 
10. Identify and collect fractions of interest by SDS-PAGE. 
11. Add MESNA powder to protein solution to a concentration of 0.5 M and incubate 
overnight at 20 °C. 
12. Dilute solution with 5-fold volume of Buffer A 
13. Load them onto a Ni-NTA column equilibrated with Buffer A containing 10 mM 
MESNA. Collect flow-through. 
14. Wash column with 2-5% Buffer B containing 10 mM MESNA. Collect and pool flow-
through and concentrate protein. 
15. Run a gel filtration on a Superdex column using Elution Buffer (30 mM NaH2PO4, pH 
7.5, 50 mM NaCl, 10 mM MESNA). CRITICAL: Prepare fresh solution, filter buffer through 
a 0.2 µm filter and degas for 0.5 h at room temperature. 
16. Identify and collect fractions of interest by SDS-PAGE. Concentrate protein and snap-
freeze in liquid nitrogen. Store protein at -80 °C.  
17. Incubate 200 μl protein-thioester (5-25 mg/mL) with 100 μl bis(oxyamine) (1 M stock 
solution in reaction buffer, final 333 mM) in Reaction Buffer (30 mM NaH2PO4, pH 7.5, 50 
mM NaCl) on ice overnight. The reaction is monitored by ESI-MS. 
18. Dialyze protein twice against 1 L Dialysis Buffer (30 mM NaH2PO4 pH 7.5, 50 mM NaCl, 
2 mM DTE) at 4 °C. 
19. Incubate 50 μM protein-ONH2 with 0.5 mM Keto-Coumarin 2 for 20 h or 1 mM 2 
overnight on ice in the presence of 100 mM Aniline in Incubation Buffer (30 mM NaH2PO4, 
pH 7.0, 50 mM NaCl, 2 mM DTE). CRITICAL: If your protein can tolerate an acidic 
environment, the reaction can also be performed by incubating 50 μM protein-ONH2 with 1 
mM 2 for 4 h in sodium acetate buffer (50 mM, pH 5.5, 50 mM NaCl, 2 mM DTE). 
20. Remove excess dye using a desalting column preequilibrated in Dialysis Buffer. 
Note: For GTPases, 1 mM MgCl2 and 10 μM GDP were added in all buffers. 
5.4.4. Universal N-terminal protein labeling with NCL 
1. Clone target gene containing N-terminal tobacco etch virus (TEV) protease recognition site 
(ENLYFQC) into modified pET-His vector using NdeI and XhoI sites. 
2. Express protein (His-TEV-Cys-protein) in BL21(DE3) cells. 
3. Collect cells in 25 mL ice-cold Breaking Buffer freshly supplemented with 1 mM PMSF 
and 2 mM β-mercaptoethanol. CRITICAL: PMSF and β-mercaptoethanol should be added 
freshly. Don’t add any reducing substances. 
4. Lyse cells using a microfluidizer or ultrasonication. 
5. Centrifuge cell lysate at 35,000 rpm, 4 °C for 30 min. 
6. Filter supernatant through a 0.2 µm filter.  
7. Load cell lysate onto a Ni-NTA column equilibrated with Buffer A (50 mM NaH2PO4 pH 
8.0, 0.3 M NaCl, 2 mM β-mercaptoethanol). 
8. Wash column with Buffer A and continue with 2% Buffer B (Buffer A + 0.5 M imidazole) 
until absorbance reaches baseline. 
9. Elute column with a gradient of 2-100% Buffer B. Collect eluted fractions. 
10. Identify and collect fractions of interest by SDS-PAGE. 
11. Add tobacco etch virus (TEV) protease at 1:20 molar ratio to the protein in the dialysis 
membrane tubing. 
12. Dialyze sample against Dialysis Buffer (30 mM NaH2PO4 pH 7.5, 50 mM NaCl, 2 mM 
DTE) overnight. 
13. Centrifuge dialyzed solution at 8000 rpm for 10 min. Collect supernatant. 
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14. Add MgCl2 and imidazole to the supernatant to a final concentration of 5 mM and 10 mM, 
respectively. 
15. Load onto a Ni-NTA column equilibrated with Buffer A. Collect flow-through. 
16. Wash column with 2% Buffer B and collect flowthrough. 
17. Pool and concentrate protein from flow-through. 
18. Run a gel filtration on a Superdex column using Dialysis Buffer. CRITICAL: Prepare 
fresh solution, filter buffer through a 0.2 µm filter and degas on a vacuum-membrane pump 
by stirring for 0.5 h at room temperature. 
19. Identify and collect fractions of interest by SDSPAGE. Concentrate protein and snap 
freeze in liquid nitrogen. Store proteins at -80 °C. 
20. Incubate 50 μM N-Cys-protein with 500 μM coumarin-thioester 10 in the presence of 200 
mM MPAA in Reaction Buffer (30 mM NaH2PO4 pH 7.5, 50 mM NaCl) on ice overnight. 
The reaction is monitored by ESI-MS.  
21. Remove excess dye using a desalting column preequilibrated in Dialysis Buffer. 
Note: For GTPases, 1 mM MgCl2 and 10 μM GDP were added in all buffers. 
5.4.5. Universal C/N-terminal protein dual-labeling 
1. Clone target gene containing N-terminal tobacco etch virus (TEV) protease recognition site 
(ENLYFQC) into modified pTWIN vector using NdeI and SapI sites. 
2. Express fusion protein (TEV-Cys-target-Intein-His) in BL21(DE3) cells. 
3. Collect cells in 25 mL ice-cold Breaking Buffer freshly supplemented with 1 mM PMSF. 
CRITICAL: PMSF should be added freshly. Don’t add any reducing substances. 
4. Lyse cells using a microfluidizer or ultrasonication. 
5. Add 1% Triton X-100 to cell lysate and centrifuge at 35,000 rpm, 4 °C for 30 min. 
6. Filter supernatant through a 0.2 µm filter. 
7. Load cell lysate onto a Ni-NTA column equilibrated with Buffer A (50 mM NaH2PO4, pH 
8.0, 0.3 M NaCl). 
8. Wash column with Buffer A and continue with 2% Buffer B (50 mM NaH2PO4, pH 8.0, 0.3 
M NaCl, 0.5 M imidazole) until absorbance reaches baseline. 
9. Elute column with a gradient of 2-100% Buffer B. Collect eluted fractions. 
10. Identify and collect fractions of interest by SDS-PAGE. 
11. Add MESNA powder to protein solution to a concentration of 0.5 M and incubate 
overnight at 20 °C (intein cleavage). 
12. Dilute solution with 5-fold volume of Buffer A 
13. Load onto a Ni-NTA column equilibrated with Buffer A containing 10 mM MESNA. 
Collect flow-through. 
14. Wash column with 2-5% Buffer B containing 10 mM MESNA. Collect and pool flow-
through and concentrate protein. 
15. Run a gel filtration on a Superdex column using Elution Buffer (25 mM NaH2PO4, pH 
7.2, 30 mM NaCl, 10 mM MESNA). CRITICAL: Prepare fresh solution, filter buffer through 
a 0.2 µm filter and degas on a vacuum-membrane pump by stirring for 0.5 h at room 
temperature. 
16. Identify and collect fractions of interest by SDS-PAGE. Concentrate protein. 
17. Incubate 200 μl TEV-Cys-protein-thioester (5-25 mg/mL) with 100 μl bisoxyamine (1 M 
stock solution in reaction buffer, final 333 mM) in Reaction Buffer (30 mM NaH2PO4, pH 
7.5, 50 mM NaCl) on ice overnight. The reaction is monitored by ESI-MS. 
18. Dialyze protein twice against 1 L Dialysis Buffer (30 mM NaH2PO4, pH 7.5, 50 mM 
NaCl, 2 mM DTE) at 4 °C. 
19. Incubate 50 μM resulting TEV-Cys-protein-ONH2 with 5 μM TEV protease for 1 h at 
room temperature. 
20. Load solution onto a Ni-NTA column equilibrated with Buffer A containing 2 mM β-
mercaptoethanol. Collect flow-through.  
21. Wash column with 2-5% Buffer B containing 2 mM β-mercaptoethanol. Collect and pool 
flowthrough and concentrate protein. 
22. Remove peptide and exchange buffer using a desalting column pre-equilibrated with 
Elution Buffer (30 mM NaH2PO4, pH 7.0, 50 mM NaCl). 
23. Incubate 50 μM N-Cys-protein-ONH2 with 0.5 mM 10 and 0.5 mM 3 in the presence of 
200 mM MPAA and 100 mM Aniline in Reaction Buffer on ice for 24 h. The reaction is 
monitored by ESI-MS. 
24. Remove excess dyes using a desalting column preequilibrated with Dialysis Buffer. 
Note: For GTPases, 1 mM MgCl2 and 10 μM GDP were added in all buffers. 
5.4.6. Protein refolding based on the dual-labeling Rab probe 
  For unfolding: 10-20 μl dual-labeling protein probe (0.1 mg/mL) in buffer A (50 mM 
HEPES, pH 7.2, 50 mM NaCl, 2 mM MgCl2, 5 mM DTE) was added into 980 μl buffer A 
containing 0-8 M G.HCl. Then the emission spectrum (420-700 nm) with excitation at 400 
nm was recorded. For refolding: 20 µL protein (0.1 mg/mL) was added into 200 µL cold 
methanol. After centrifugation, the supernatant was removed. Then 10 µL denaturing buffer 
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(50 mM HEPES, pH 7.2, 6 M G.HCl) was added to dissolve the protein, and the solution was 
added into 990 µL buffer A containing 50 µM GDP or GppNHp. The emission spectra were 
recorded at different time points with excitation at 400 nm at 25 ºC. The solution was not 
stirred. 
5.4.7. Ligation of PEG-1 24 with Rab-ONH2 
  Proteins (about 1 mg/mL) in sodium phosphate buffer (30 mM, pH 7.0) were incubated with 
ketone molecules 24 (0.5 mM) in the presence of 100 mM aniline on ice overnight. The ESI-
MS indicated that the oxyamine-containing proteins were singly and quantitatively modified 
by ketone molecules. Unreacted small molecules were removed by passing the reaction 
mixture over a NAP-5 desalting column pre-equilibrated with 30 mM sodium phosphate (pH 
7.5, 50 mM NaCl, 1 mM MgCl2, 10 µM GDP, and 5 mM DTE). 500 mM MESNA was added 
as solid into the protein solution, which was further incubated on ice for 2 h. The ESI-MS 
indicated that both the StBu groups were totally removed. Then analysis gel filtration was 
used to purify the ligated protein in prenylation buffer (50 mM HEPES, pH 7.2, 50 mM NaCl, 
5 mM DTE, 2 mM MgCl2, 10 µM GDP). The protein fractions were collected by 
centrifugation and concentrated to about 1-5 mg/mL for further prenylation and 
microinjection studies. 
5.4.8. Preparation of GEF:GTPase complexes 
  The complex between GEE and nucleotide-free GTPase was generated by mixing 1:1 ratio 
of the proteins (GEF and its GTPase:GDP) with a 10-fold excess of EDTA (50 mM) over 
MgCl2 (5 mM) overnight on ice. The resulting complex was further purified by gel filtration 
with nucleotide-free buffer (50 mM HEPES, pH 7.2, 50 mM NaCl, 5 mM dithioerythritol, 2 
mM MgCl2). 
5.5. Lipid-Protein ligation by click reaction 
  Preparation of the 10 × catalysis for click reaction. 10 mM CuSO4 (from 100 mM stock 
solution), 10 mM ligand tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA, from 20 
mM methanol stock solution), 20 mM sodium ascorbate (from 200 mM freshly stock 
solution) were prepared, pre-mixed and incubated at room temperature for 5 minutes. For 
every reaction the catalysis was prepared freshly and used immediately. 
  Lipid-protein Ligation. Rab proteins (final concentration, 1 mg/mL) in 30 mM sodium 
phosphate buffer (pH 7.4) containing 10 mM CTAB were mixed with 1 mM (final 
concentration) alkyne-containing lipopeptide. Then the catalysis solution (final concentration 
of 1 mM) was added to start the reaction at room temperature. After 30-40 minutes, the 
reaction solution was centrifuged and 1 mM EDTA was added to quench the reaction. SDS-
PAGE indicated the band shift after the click lgation and LC-MS indicated that the click 
ligation was completed.  
  Prenylated protein purification. After the click reaction, the solution was diluted with 10 
to 15 times in ice-cold acetone or methanol. After centrifuge, the pellet was washed by 4 
times with 2 mL of methanol, 4 times with 2 mL of CH2Cl2, and 3 times with 1 mL of Milli-Q 
water. The precipitate was dissolved in denaturing buffer (100 mM Tris-HCl, pH 8.0, 8 M 
G.HCl, 500 mM MESNA, 1% CHAPS, 1 mM EDTA) to a final protein concentration of 0.5-
1.0 mg/mL and incubated overnight at 4 °C with slight agitation. Protein was refolded by 
diluting it at least 25-fold dropwise into refolding buffer (50 mM HEPES, pH 7.5, 2.5 mM 
DTE, 2 mM MgCl2, 10 μM GDP, 1% CHAPS, 400 mM arginine-HCl, 400 mM trehalose, 0.5 
mM PMSF, 1 mM EDTA) with an equimolar amount of REP-1 or GDI-1 or excess 
dilipidated BSA. The mixture was further incubated at room temperature for 30 min and on 
ice for 1 h. The mixture was dialyzed twice against 2 L dialysis buffer (25 mM HEPES, pH 
7.5, 2 mM MgCl2, 10 μM GDP, 5 mM DTE, 100 mM (NH4)2SO4, 10% glycerol, 0.5 mM 
PMSF, 1 mM EDTA). The dialyzed material was concentrated to a protein concentration of 2-
5 mg/mL using size exclusion concentrators (MWCO, 10 kDa) and loaded on a Superdex-200 
gel filtration column (Pharmacia) equilibrated with gel filtration buffer (25 mM HEPES, pH 
7.5, 2 mM MgCl2, 10 μM GDP, 5 mM DTE, 50 mM NaCl). The fractions containing Rab-
REP complex were collected. 
5.6. Protein immobilization by oxyamine ligation 
  Generation of protein expression lysates. Proteins were expressed as described above. 
After harvesting the bacteria, the cells were lysed in lysis buffer (25 mM sodium phosphate 
pH 7.5, 500 mM NaCl, 1 mM MgCl2, 10 µM GDP (for GTPases only), 1 g cells/1 mL lysis 
buffer) by passing them multiple times through a fluidizer (110 S, Microfluidics) and 
subsequently centrifuged. Then the soluble fraction was isolated and treated with a 500 mM 
MESNA solution (final concentration) at room temperature overnight and with a 300 mM 
bis(oxyamine) solution (final concentration) on ice for at least 4 h. The resulting solution was 
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dialyzed twice against 1 L of the dialysis buffer at pH 7.5, and against 1 L of dialysis buffer at 
pH 7.0 to remove the excess of bis(oxyamine). The resulting cell lysates containing 
oxyamine-modified proteins are ready for spotting. For control experiments, the cellular 
lysates were treated with 500 mM MESNA only and then dialyzed again dialysis buffers as 
described.  
  General procedure for protein spotting and immobilization. Protein spotting was carried 
out by a non-contact microarray robot to generate five identical subarrays per slide that can be 
separated by GeneFrames (ABgene, Thermoscientific) (spot volume: 250 pL; spot size: 400 
μm diameter). The spotting buffer contains 20 % glycerol to prevent the drying of protein 
spots on the slides. After incubating in a humidity chamber at room temperature for several 
hours, the slides were washed with washing buffer (25 mM HEPES pH 7.4, 50 mM NaCl, 2 
mM MgCl2, 2 mM DTE, 0.05% Tween 20) three times (3 × 5 min) to remove unreacted 
proteins. Then, the slides were blocked with blocking buffer (1% BSA in washing buffer) for 
30 min at room temperature. The resulted slides were further washed with washing buffer and 
rinsed with doubly distilled H2O and dried under an argon stream for subsequent fluorescence 
scanning or interaction with other proteins. The data were analyzed and quantified with the 
software ImageQuant TL (GE Healthcare). 
  Time-dependent immobilization of EGFP-Rab7-ONH2. A 50 µM solution of EGFP-
Rab7-ONH2 in phosphate buffer (30 mM, pH 7.0, 50 mM NaCl, 2 mM MgCl2, 2 mM DTE, 
20 µM GDP, 20% glycerol, 2% Tween 20) was spotted on a ketone-coated slide to generate 
five identical EGFP-Rab7 subarrays that were separated by applying GeneFrames and 
incubated in a humid chamber. One subarray was washed with washing buffer at each time 
point to stop the oxime ligation (2, 4, 5, 6, and 7 hours). Finally, after rinsing with water and 
drying under argon, the microarray was scanned and analyzed as described above. 
  pH-dependent immobilization of EGFP-Rab7-ONH2. Different 45 µM solutions of 
EGFP-Rab7-ONH2 in phosphate buffers with different pH values were spotted on the ketone-
coated slide to generate five subarrays per slide separated by GeneFrames, followed by 
incubation in a humid chamber for 6 hours. The microarray was washed, scanned and 
analyzed as described above. 
  Aniline-catalysis of EGFP-Rab7-ONH2. Considering the fact that aniline is insoluble in 
water, we prepared a 2 M aniline stock solution in methanol. A 50 µM solution of EGFP-
Rab7-ONH2 containing or not 100 mM of aniline was spotted on ketone-coated slides 
followed by incubation in a humidity chamber for 6 hours. The slide was washed, scanned 
and analyzed as described above. 
  Preparation of Cy3-REP-1 and Cy3-RabGDI. To a solution of REP-1 (7.0 mg/mL, 50 µL) 
in labeling buffer (50 mM HEPES, pH 7.2, 50 mM NaCl, 2 mM MgCl2, 2 mM DTE),  Cy3-
NHS-ester (GE healthcare PA23001) dissolved in 50 µL labeling buffer (0.1 mM) was added 
and then the reaction mixture was shaken at room temperature for 30 min and one hour on ice. 
After this, the labeled protein was separated using Hi-Trap desalting columns (Pharmacia 
Biotech) to obtain the desired Cy3-REP-1 with a final molar dye/protein (D/P) ratio 1.28. 
Cy3-RabGDI was prepared analogously with a final molar dye/protein (D/P) ratio 1.10. 
  Interaction analysis of EGFP-Rab7 microarrays with Cy3-REP-1 and Cy3-RabGDI. 
The EGFP-Rab7 microarrays were generated as mentioned above. Blocking was done by 
covering the slide surface with washing buffer containing 1% of BSA for 30 min. Two 
subarrays separated by GeneFrames were respectively incubated with 100 µL solution of 200 
nM Cy3-REP-1 or 1 μM Cy3-RabGDI for 30 min, followed by washing three times with 
washing buffer (3 x 5 min). After rinsing with doubly distilled H2O and drying under argon, 
the slide was scanned and quantified as described above. 
  Interaction analysis of PKA microarrays with FITC-labeled PKA antibody. The PKA-
antibody (sc-365615) was purchased from Santa Cruz Biotechnology. The FITC-labeled 
antibody was prepared using a FITC protein labeling kit (Invitrogen). Different concentrations 
of PKA-ONH2 (5-100 µM) were spotted on ketone-coated slides (pH 7.0) and incubated at 
room temperature for 6 hours. After washing and blocking, the slide was incubated with 500 
nM FITC-labeled antibody for 30 min, followed by washing, drying and fluorescence 
detection as described above. 
  Immobilization of protein expression lysates. Both cellular lysates containing expressed 
EGFP-Rab7 or PKA were prepared as described above. Cellular lysates containing EGFP-
Rab7-ONH2 (0.5 g and 1 g cell/mL lysis buffer) were mixed with glycerol (final concentration 
20%) and Tween 20 (final concentration 2%) and then spotted on a ketone-coated slide to 
generate three identical EGFP-Rab7 subarrays that were separated by applying GeneFrames 
and incubated in a humidity chamber for 6 h at room temperature. EGFP-Rab7-COSR cellular 
lysate (1 g cell/mL lysis buffer) was used as negative control. After washing with washing 
buffer and doubly distilled H2O, the slide was dried under an argon stream. The microarray 
was scanned and analyzed as described above. The PKA-ONH2 cellular lysate (1 g cell/mL 
lysis buffer) was immobilized using a similar protocol. After washing and blocking, the slide 
was incubated with 500 nM FITC-labeled PKA antibody for 30 min., followed by washing, 
drying and fluorescence detection as described above. 
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5.7. In vitro protein prenylation 
  PEGylated Rab or wild type or mutants (4 µM), REP-1 (6 µM), RabGGTase (6 µM) were 
incubated in prenylation buffer (50 mM HEPES, pH 7.2, 50 mM NaCl, 5 mM dithioerythritol, 
2 mM MgCl2, 10 µM GDP) at 25 °C, and 100 µM NBD-FPP was added to initiate the 
reaction. At defined time intervals, 10 µL samples were withdrawn and quenched by addition 
of 10 µL of 2 × SDS-PAGE sample buffer. For an end-point assay, 6 µM PEGylated Rab7 or 
wild type, 10 µM REP, and 6 µM RabGGTase were mixed with 40 µM NBD-FPP in 
prenylation buffer and incubated for 1.5 h at 37 °C, followed by quenching with 2 × 
SDSPAGE sample buffer. The samples were boiled at 95 °C for 10 min and were loaded onto 
15% SDS-PAGE. The fluorescence bands corresponding to the NBD-farnesylated protein 
were visualized in the gel using a Fluorescent Image Reader FLA-5000 (Fuji, excitation laser: 
473 nm, cut-off filter: 510 nm) followed by staining with Coomassie Blue and scanning. The 
fluorescence intensities of the bands were quantitatively analyzed using AIDA densitometry 
software. The traces were fitted to a single exponential equation using Orgin 6.0. 
  For lipidated Rabs: For prenylation reactions by fluorescent SDS-PAGE assay, typically 
RabGGTase (4.5 μM) and Rab1-G:REP-1 complex (4-4.5 μM) was premixed in 10 μL buffer 
(50 mM HEPES, pH 7.2; 50 mM NaCl, 5 mM DTE, 2 mM MgCl2, 100 μM GDP), and then 
20 μM NBD-FPP (final concentration) was added to initiate the reaction. The reaction was 
allowed to proceed for 1 h at room temperature and was quenched by addition of SDS-PAGE 
sample buffer, after which the samples were resolved on SDS-PAGE and scanned for 
fluorescence using a laser fluorescent image reader, and photographed in UV light and visible 
light after Coomassie blue staining. For real-time monitoring of prenylation reactions, 
typically 50-100 nM of dansyl-labeled semisynthetic Rab1-G:REP-1 complex was mixed with 
an equal amount of RabGGTase in a cuvette containing 1 mL buffer (50 mM HEPES, pH 7.2; 
50 mM NaCl, 5 mM DTE, 2 mM MgCl2, 10 μM GDP). Following five minutes incubation at 
25 °C, the reaction was initiated by adding GGPP to a final concentration of 30 μM. 
Excitation and emission monochromators were adjusted to 280 and 510 nm, respectively. 
Data were fitted to a double exponential equation using Orgin 7.5. 
5.8. Biophysical methods 
  Fluorescence measurements were performed either with an Aminco SLM 8100 
spectrofluorometer (Aminco, Silver Spring, MD, USA) or a Spex Fluoromax-3 
spectrofluorometer (Jobin Yvon, Edison, NJ, USA). Measurements were carried out in 1 mL 
quartz cuvettes (Hellma) with continuous stirring and thermostated at 25 °C unless otherwise 
indicated. Stopped-flow measurements were performed on an Applied Photophysics 
SX.18MV-R apparatus (Surrey, UK). All buffers used in these experiments were filtered 
through a 0.2 µm membrane filter (Whatman) and degassed on a vacuum-membrane 
(ILM/VAC GmbH) pump by stirring for 0.5 h at room temperature. To observe the FRET 
effect between coumarin and fluorescein, the excitation was at 400 nm in Fluoromax-3 
spectrometer or 406 nm in stopped-flow apparatus, and the emission was monitored at 520 nm 
in the fluorescence spectrometer or observed through a 530 nm cut-off filter. 
5.8.1. Fluorescence titrations – determination of Kd 
  Steady-state fluorescence measurements for monitoring interactions between labeled Rab7 
and REP-1 were followed in 50 mM Hepes, pH 7.2, 50 mM NaCl, 5 mM DTE, 1 mM MgCl2 
and 10 µM GDP. Typically the fluorophore-labeled Rab7 probe was placed in a cuvette in 
1 mL of buffer to give a final concentration of ca. 100-200 nM. Small aliquots of REP-1 or 
interaction protein were then added to the cuvette, until the fluorescence signal was saturated 
or showed a continuous linear increase. The change in fluorescence was plotted as a function 
of the total REP-1 concentration and corrected for unspecific fluorescence. The data was 
fitted to the following equation using GraFit 5.0 (Erithacus software): 
 
where Y is the observed fluorescence after each step of titrator addition, Ymin is the initial 
value at [L]0 = 0, Ymax is the final value at saturation, [L]0 is the total (cumulative) 
concentration of REP-1, [P]0 is the Rab7:REP-1 complex concentration, and Kd is the 
equilibrium constant, which is to be determined. 
5.8.2. Monitoring the prenylation reaction 
  The prenylation of the semisynthetic Rab7 proteins was analysed using a Spex Fluoromax-3 
spectrofluorometer (Jobin Yvon, Edison, NJ, USA) for long-term measurements, whereas a 
stopped-flow apparatus (Applied Photophysics, Surrey, UK) was used for examining the fast 
events occurring upon start of the reaction. 
Long-term measurements 
  Typically, 50-100 nM of dansyl labeled semisynthetic Rab7:REP-1 complex was mixed with 
an equal amount of GGTase-II in a cuvette, containing 1 mL of buffer (50 mM Hepes, pH 7.2, 
[ ] [ ] [ ] [ ]( ) [ ] [ ]{ } [ ]0 minmax0020000min 24 P YYLPPLKPLKYY dd −−++−+++=  
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50 mM NaCl, 5 mM DTE, 1 mM MgCl2, 10 µM GDP). Following a 5 min incubation at 
25° C permitting temperature equilibration, the reaction was started by adding 
geranylgeranyl-pyrophosphate to a final concentration of approximately 10 µM. Excitation 
and emission monochromators were adjusted to 280 nm and 510 nm, respectively. The data 
were fitted to a double exponential equation using GraFit 5.0 (Erithacus software): 
tktk eAeAYY 21 210
−− ++=  
where Y is the observed fluorescence, Y0 is the fluorescence at t = ∞, A1 and A2 are the signal 
amplitudes, t is the time, and k1 and k2 are the rate constants. 
5.8.3. Transient kinetics  
Stopped-flow measurements 
  Fluorescent reactant A in buffer (50 mM HEPES, pH 7.2, 50 mM NaCl, 5 mM DTE, 1 mM 
MgCl2) was rapidly mixed in the stopped-flow apparatus with an equal volume of reactant B 
in the same buffer. Excitation was at 406 nm for coumarin, while fluorescene was recorded 
through a 530 nm cut-off filter. Mixing and measuring chamber were thermostated at 25 °C 
using a water bath. Typically, traces of 3 independent experiments were averaged using the 
software package provided by Applied Photophysics. The data were fitted to a single- or 
double-exponential equation using GraFit 5.0 (Erithacus software) 
Determination of koff 
  For determination of koff, the coumarin-GEF:GTPase-fluorescein complex (50 nM for 
DrrA:Rab1 and 500 nM for Ran:Rcc1) was mixed with 10-20 equal amount of GEF at 25 °C 
in the stopped-flow apparatus (buffer: 50 mM Hepes, pH 7.2, 50 mM NaCl and 5 mM DTE, 1 
mM MgCl2). Excitation was at 406 nm for coumarin, while fluorescene was recorded through 
a 530 nm cut-off filter. The obtained displacement curve could be fitted to a single 
exponential equation: 
tkoffAeYY −+= 0  
where Y is the observed fluorescence, Y0 is the fluorescence at t = ∞, A is the signal amplitude, 
t is the time, and k is the rate constant, which equals koff for dissociation of GEF from the 
GEF:GTPase complex. Data analysis was carried out using GraFit 5.0 (Erithacus software). 
5.9. Molecular biology method 
5.9.1 Preparation and transformation of competent cells 
  1 L of LB medium was inoculated with 1 mL of an overnight-grown culture of the desired 
E.coli strain. Cells possessing antibiotic resistance genes (e.g. BL21(DE3) codon plus RIL) 
were grown in the presence of the corresponding antibiotic. The culture was incubated at 37 
°C on a shaker, until the OD600 reached 0.5 (ca. 4 h). The culture was cooled on ice for 20 
min, transferred to sterile centrifugation vessels and centrifuged for 10 min at 4 °C and 2000 
rpm. The supernatant was decanted. 
Variant A.: Transformation by Electroporation 
  The bacterial cell pellet was gently (!) resuspended in 5 mL of ice-cold sterile GYT (0.125% 
(w/v) yeast extract, 0.25% (w/v) tryptone, 10% (v/v) glycerol) and recentrifuged as described 
above. Cells were resuspended in a final volume of 1 mL GYT, dispensed in 50 µL aliquots, 
shock frozen in liquid nitrogen and stored at 80 °C. For transformation, approximately 1 ng of 
DNA was added to the thawed cell suspension in a chilled cuvette. Electrotransformation was 
carried out by applying a high voltage pulse using a E.coli Pulser from Biorad (conditions: 
25 µF, 200 Ω, 2.5 kV). 1 mL of LB medium was added to the cell suspension and the culture 
was grown at 37 °C for 1 h. Transformed Cells were selected on agar plates containing the 
corresponding antibiotics. 
Variant B.: Transformation using CaCl2 
  The pellet was gently resuspended in 20 mL of ice-cold sterile 100 mM CaCl2 solution and 
incubated on ice for 30 min. The cells were centrifuged at 2000 rpm for 5 min at 4 °C and 
were resuspended in 1-5 mL of TFBII buffer (10 mM MOPS, pH 7.0, 75 mM CaCl2, 10 mM 
NaCl, 15 % glycerol). Aliquots of 50-100 µL were shock frozen in liquid nitrogen and stored 
frozen at 80 °C. For transformation, cells were thawed rapidly and approximately 1 ng of the 
desired plasmid DNA was added. The mixture was incubated on ice for 30 min without 
shaking. Cells were heat-shocked at 42 °C for 60 s and immediately cooled on ice for 2 min. 1 
mL of LB medium was added to the tube and the culture was incubated at 37 °C for 1 h, 
before recombinants were selected on agar plates supplemented with the corresponding 
antibiotics. 
5.9.2. Purification of DNA 
DNA fragments 
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  DNA fragments produced by PCR amplification or restriction enzyme digestion were 
purified by preparative agarose gel electrophoresis. The band of interest was excised and 
extracted from the gel using a gel extraction kit from Quiagen or PQLab according to the 
instructions of the manufacturer.  
Agarose gel electrophoresis 
  Depending on the size of the DNA fragment, the agarose concentration was between 0.8 and 
1.2% (w/v). The required amount of agarose was solubilized by heating in TAE buffer. 
Ethidium bromide was added to a final concentration of 0.01% (w/v), the gel was poured into 
the gel casting equipment and allowed to polymerize. Samples were prepared in DNA loading 
buffer and the gels were run horizontally at 10 V/cm immersed in TAE-buffer until fragment 
separation was complete. A 1 kb DNA ladder (GibcoBRL) was used as a molecular weight 
standard. 
Preparation of Plasmid DNA 
  Plasmid DNA was prepared using the plasmid mini-prep kit (Quiagen or PQLab) as follows: 
A single bacterial colony was used to seed 2 mL of LB medium containing the appropriate 
antibiotic(s). The culture was grown overnight (10-12 h) at 37 °C. Cells were harvested by 
centrifugation (2000 rpm, 5 min) and lysed by alkaline/SDS treatment. The precipitate 
(chromosomal DNA, lipids, proteins) was removed by centrifugation and the supernatant was 
loaded on a silica spin column. Following washing, the plasmid DNA was eluted using sterile 
TAE buffer or deionized water. 
 Ethanol precipitation 
  The salt concentration of the DNA sample was adjusted to 250-300 mM sodium acetate, pH 
5.5 and DNA was precipitated by adding ethanol (96%) to a final concentration of ca. 70% 
followed by a 30 min incubation at room temperature. After centrifugation (13000 rpm, 
10 min, RT) and removal of the supernatant, the precipitate was washed once with 70 % 
ethanol and dried under vacuum. 
5.9.3. PCR 
Preparative PCR 
  Typically, a 50 µL reaction mixture comprised 1-5 ng of template (plasmid) DNA, 0.5-
1.0 µM of upstream and downstream primers, 200 µM of each dNTP, 2-3 units of Expand 
High Fidelity Polymerase mix (Roche Diagnostics, Mannheim, Germany) and the 
corresponding reaction buffer and salts. A Biorad PE 9700 thermocycler from Applied 
Biosystems (Weiterstadt, Germany) was used for temperature control and cycling. 
Denaturation was for 1 min at 96 °C, annealing for 1 min at 50-62 °C depending on primer 
length and GC content, and extension was for 2-4 min (depending on the length of the 
amplicon). In general, 20-25 cycles were sufficient for efficient amplification.   
Colony PCR screen 
  Colonies were picked and resuspended in 20 µL of sterile ddH2O in a PCR test tube using 
sterile eppendorf tips. 6 µL of this suspension were mixed with 6 µL of PCR mix (containing 
400 µM of each dNTP, 5 pmol of each primer, 1 unit of Taq polymerase (Sigma, Taufkirchen, 
Germany) in Taq buffer (2 x)). The PCR reactions were carried out under the following 
conditions: Cells were disrupted by heating the PCR tubes for 3 min at 96 °C followed by 25 
cycles of denaturation for 30 s at 96 °C, annealing for 30 s at 50-62 °C, and primer extension 
for 40 sec at 72 °C. The PCR products were analyzed by agarose gel electrophoresis. An 
aliquot (1 µL) of the initially obtained cell suspension was plated on agar plates containing 
the corresponding antibiotics. 
DNA Sequencing  
  For DNA sequencing of the cloned fragments the BigDyeDesoxy terminator cycle 
sequencing kit and a ABI Prism 373XL machine (Applied Biosystems, Weiterstadt, Germany) 
was used. The sequencing reactions contained 0.5-1 µg plasmid DNA, 3 pmol of the 
corresponding primers, and 8 µL BigDye termination mix in a final volume of 20 µL. 
25 cycles were performed with the following parameters: denaturation for 30 s at 96 °C (for 
the first cycle 1 min), annealing for 1 min at 50 °C, and primer extension for 4 min at 60 °C. 
The DNA was ethanol precipitated (see above), washed twice with 70% ethanol, dried, and 
analyzed by the in house sequencing facility.  
5.9.4. Restriction enzyme digestion 
  Restriction enzyme digests of DNA fragments were performed as recommended by the 
manufacturer. The reaction was stopped by addition of DNA loading buffer. Fragments 
produced by restriction enzyme digestion were separated using agarose gel electrophoresis. 
5.9.5. Ligation 
  For ligation 1-10 ƒmol plasmid DNA was mixed with a 10 fold molar excess of fragment 
DNA. Ligation was performed in T4 DNA ligase buffer in a volume of 12.5 µL, using 0.2 
units of T4 DNA ligase (Roche Diagnostics, Mannheim, Germany) for 16 h at 16 °C.  
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7. Appendices 
7.1. Selected LCMS spectra of proteins 
ESI-MS spectra of proteins in the project for FRET-based GEF 
sensors 
 
 ESI-MS spectra of proteins in the project for dual-labeling Rab7 
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ESI-MS spectra of proteins in the project of PEGylated Rab probe 
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 7.2. Selected NMR spectra 
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